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Abstract 
The potential of using nanosecond pulsed atmospheric pressure plasma in contact with liquid 
has been investigated 1) to fabricate an improved hybrid nanostructures, and 2) to 
decontaminate milk with extended shelf life whilst maintaining nutrition. The electrical 
discharges in contact with liquid provide a combination of unique physical and chemical 
environment, enabling to achieve these complex processes in a simple and efficient way. 
Two experimental set ups were used to generate plasma, (1) plasma above the de-ionized water 
surface (set up I) and (2) plasma in gas bubbles immersed in milk (set up II). 
In the fabrication of hybrid nanostructures, using set up I, argon plasma treatment shortened 
the length and functionalized boron nitride nanotubes (BNNTs) in one step. Gold nanoparticles 
(GNPs) were successively assembled onto the functionalized short nanotubes. The reactive 
species from the plasma along with the nanosecond pulsed electric field seem to play a role in 
the fabrication of BNNT-GNP hybrids. The potential for targeted drug delivery was tested 
using doxorubicin-loaded plasma treated nanotubes which were effective at killing ~99% of 
prostate cancer cells. 
In the treatment of raw milk, using set up II, argon plasma treatment at 90 and 120 seconds 
effectively reduced the bacterial load and significantly increased the shelf life to at least six 
weeks compared to pasteurization, which showed reduced bacterial load but started to 
deteriorate after two weeks. β-lactoglobulin (β-LG) was significantly reduced in 90 s plasma 
treated milk compared to raw and pasteurized milk. β-LG, α-lactalbumin and immunoglobulins 
were significantly reduced in 120 seconds plasma treated milk compared to raw and pasteurized 
milk. Lactoferrin was significantly reduced in pasteurized milk compared to 90 and 120s 
plasma treated milk and raw milk. Casein proteins were significantly increased in 90 and 120 
s plasma treated milk whereas it was significantly reduced in pasteurized milk compared to raw 
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milk. The total lipids, saturated fatty acids and carbohydrates were significantly reduced in 
pasteurized milk compared to raw and plasma treated milk (both 90 and 120 s). Plasma treated 
milk had significantly increased miRNA concentration compared to pasteurized milk. Raw 
milk and 90 s plasma treated milk did not effect the viability of human fetal intestinal cells 
whereas pasteurized and 120 s plasma treated milk significantly reduced viability compared to 
untreated cells. Annexin V staining showed this loss of viability was due to apoptosis.  
These results demonstrated that plasma treatment as a superior method to decontaminate and 
increase shelf life of milk compared to pasteurization. This plasma approach could be 
potentially extended to treat human breast milk and used in other dairy applications for 
manufacturing of cheese, butter and yoghurt to retain nutrition. 
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Outline of Thesis 
In this PhD thesis, the potential of nanosecond pulsed atmospheric pressure plasma in contact 
with liquid has been investigated to fabricate hybrid nanostructure without the use of toxic 
chemicals and to decontaminate bovine milk, prolong shelf life without damaging the nutrition.  
In Chapter 1, a comprehensive literature review is presented and focused on plasma in contact 
with liquids 1) to fabricate hybrid nanostructure for biological applications and 2) to 
decontaminate and extend shelf life of bovine milk whilst maintaining nutrition. The research 
challenges are identified, summarized and a strategy to address the research challenges have 
been discussed. 
The chapter 2 presents the investigation of argon plasma to shorten and functionalize BNNTs 
and assemble GNPs onto them using set up I, i.e. plasma in gas phase above the liquid surface. 
The pH, conductivity and reactive species in plasma treated water were measured to understand 
the plasma mediated fabrication of hybrid nanostructure. The drug loading, delivery and anti-
cancer potential of plasma treated BNNTs were studied in prostate cancer cells. 
In Chapter 3, a prelude has been given to summarize the key challenges faced during the 
generation of plasma in gas phase above the liquid surface and the development of gas bubble-
in-liquid method (set up II), and the research motivation behind in investigating the potential 
of set up II to decontaminate milk. The plasma was generated in bubbles immersed in water 
using set up II to optimize the plasma conditions before experimenting with milk. The plasma 
frequency and treatment time in water was varied to study the changes in pH, temperature and 
hydrogen peroxide. After optimization, plasma was generated in milk using set up II to 
investigate its ability to kill bacteria and increase shelf life. The results of plasma treated milk 
have been compared with commercially pasteurized milk and raw milk. DNA sequencing was 
performed to analyze the bacteria survived after plasma treatment. 
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In Chapter 4, the effects of argon plasma treatment on proteins, lipids, carbohydrates and 
miRNA present in bovine milk compared to commercially pasteurized milk and raw milk is 
presented. The total protein, lipid and carbohydrate measurements in milk have been presented. 
The changes in casein and whey proteins were studied using methods that include high 
performance liquid chromatography (HPLC), Western Blot and sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE). The changes in fatty acids, total and micro 
RNA were studied using gas chromatography (GC), NanoDrop spectrophotometer and 
Bioanalyzer. The cytotoxic and apoptotic potential of plasma and pasteurized milk have been 
studied in human intestinal cells. The main contents of this chapter are abstract, introduction, 
detailed experimental section, results and discussion and conclusion. 
The chapter 5 presents the general discussions of this study and potential future works. 
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Chapter 1 Background 
1.1 Plasma Introduction 
Although the history of plasma dating back to eighteenth century, Sir William Crookes (1832-
1919) was the one who correctly identified “radiating matter” as “the fourth state of matter” in 
discharge tubes.1 Later Irving Langmuir, observed oscillations in an ionized gas through the 
measurements of its electron density and mass and then termed it as ‘plasma oscillations’.2 The 
supply of sufficient energy to gas, breaks the bond between the atoms and ionizes the atoms to 
create ions and electrons. The interactions between these electrically charged particles and the 
neutral gas, ionizes the significant number of atoms present in the gas. This results in the 
electrically neutral medium composed of equal positive and negative charged particles, free 
radicals, ions and reactive species, which constitutes plasma.3 
Generally, plasmas are distinguished as equilibrium and non-equilibrium plasmas. In 
equilibrium plasma, the temperature of the electron (Te) and ion (Ti) are equivalent to the 
temperature of gas (Tg). The collision process is generally high in equilibrium plasma, which 
govern the transitions and chemical reactions between the species. The electrons in the plasma, 
loses energy favourably toward ions to let other particles reach thermal equilibrium. These type 
of plasmas have higher ionization percentages (~100%) and average temperatures ranges 
between 103 and 104 K (called thermal plasmas). In contrast to equilibrium plasma, the electron 
temperature is greater than the gas temperature (Te>>Tg, Ti) in non-equilibrium plasma. In this 
case, the electrons possess high temperature that ranges from 104 and 105 K, whereas the ions 
and gas temperature are at ambient temperature. These are called as non-thermal plasmas and 
have very low percentages of ionization.  
The application of energy in the form of heat, electrical or electromagnetic radiation to a gas 
that is filled in between two electrodes generates plasma. The properties of plasma changes 
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with respect to its electron density and temperature. Plasmas can also be classified according 
to the type of input energy and the transfer of energy to the plasma (Figure 1.1).4 
 
Figure 1.1. Classification of plasmas using electron density and temperature.4, 5 
The plasmas can be generated at low or atmospheric pressure. Atmospheric pressure plasmas 
are extensively studied in both gas and liquid phases for various applications.5 This thesis 
mainly focuses on plasma in and in contact with liquids. Depending upon the mode of plasma 
generation, electrode configurations and power sources, the electrical discharges can be 
categorized as follows: 
1) Discharges directly in liquids (in which both the electrodes are immersed) 
2) Discharges in gas phase when two or one electrode above the liquid surface 
3) Discharges in bubbles that are externally introduced into liquids 
1.2 Discharges directly in liquids 
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The plasmas that can be directly generated in liquids are highly dynamic and transient. Earlier, 
the electrical breakdown in liquid was considered based on either electron multiplication theory 
or bubble mechanism theory.6 Later, few researchers explained that the application of high 
voltage in liquid leads to the formation of discharge through the pre-existing bubbles or formed 
bubbles in liquid, low density regions and joule heating.7, 8 However, till date, there is no single 
theory that completely addresses all the aspects of electrical breakdown in liquid.9 Liquids are 
denser and have a short mean free path of electrons which demands higher electric strength in 
the order of MV/cm to breakdown, compared to gases (kV/cm).10, 11 Moreover, the presence of 
impurities could also play a significant role in the breakdown process. These factors make it 
challenging to understand the plasma induced chemistry in liquids. Pulsed corona and arc or 
spark discharges in liquids were commonly reported discharge patterns.12, 13 The power sources 
applied to generate direct discharge in liquid can be direct current (DC), alternating current 
(AC), high frequency (HF) or microwave (MW). Tendero et al. have documented the 
advantages and disadvantages of these power resources in generating plasmas.5 The electrode 
configurations used for these types of discharges are pin-plate electrode, pin-pin and diaphragm 
or capillary discharge.14-16 An example of direct discharge in liquid using pin-plate electrode 
configuration is shown in Figure 1.2. Based on the type of discharges, the intense physical 
processes such as UV, shock waves, cavitation and active chemical species like hydroxyl 
radicals (OH-), oxygen (O2), ozone (O3), hydrogen (H2) and hydrogen peroxide (H2O2) are 
produced.17 The electrical discharges directly in liquids have been employed in applications 
like removal of organic compounds, micro-organisms in water and breaking kidney stones.17, 
18 The higher electric field requirements and the erosion of electrodes during operation are the 
main bottlenecks of direct discharge in liquids.19, 20 
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Figure 1.2. Schematic of direct discharge in liquid using pin-plate electrode configuration.11 
1.3 Discharges in gas phase above the liquid surface 
Unlike the direct discharge in liquids, the discharges can be generated in the gas phase while 
keeping one or two electrode above the liquid surface. The discharges in gas phase have been 
studied extensively by researchers.21, 22 Plasma jets, corona and dielectric barrier discharges are 
the common types of plasma that have been studied so far.23-25 An example of discharge in gas 
phase above the liquid surface using pin-plate electrode configuration is shown in Figure 1.3. 
The gas mixture, electrode material, field polarity and the properties of liquids such as pH, 
conductivity and temperature could play an important role in determining the composition or 
properties of plasma.11, 17, 26 Depending upon the feed gas, input power and type of plasma, the 
reactive species like OH, O3, H2O2, nitrite (NO2), peroxynitrite (ONOO-) and nitrate (NO3) can 
be formed.27-29 The gas phase discharges have been widely used for applications such as 
removal of organic compounds, micro-organisms in liquid and solid surface and bio-
medicine.30-33 Although the gas phase discharges were quite easy to operate and less complex 
in understanding the interaction between the reactive species, the difficulty in the selectivity of 
gas phase species, interference from atmospheric air and formation of unwanted by-products 
hindering further developments of this appraoch.34, 35 
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Figure 1.3. Schematic of discharge in gas phase above the liquid surface using pin-plate 
electrode configuration.11 
1.4 Discharges in bubbles that are externally introduced into liquids 
As mentioned earlier that the direct discharge in liquid requires higher electric field, results in 
faster electrode erosion and thereby reduces the life time of electrodes, whereas the discharge 
in gas phase facing issues of less selectivity in reactive species, interference from atmospheric 
air and formation of unwanted by-products.19, 20, 34, 35 To overcome the afore-mentioned 
challenges, several researchers developed the concept of introducing gas into liquids to produce 
plasma in bubbles.36, 37 The discharge in bubbles that are externally introduced into liquids can 
be two types 1) using capillary tube and 2) using hollow needle (in which needle acts as one 
electrode).11, 34 An example of the above two types are shown in Figure 1.4. This approach 
needs lesser electrical strength to generate discharge in bubbles that are externally injected into 
liquids compared to the electrical strength requirement for liquids.34, 38 The other advantages 
in this method includes high surface to volume ratio and clearly defined bubble boundaries i.e, 
plasma-liquid interface which all provides the opportunity to manoeuvre the chemical reactions 
between species and liquid with chosen feed gas.38 It was reported that the discharge pattern 
inside the bubble could be glow to spark or streamer to spark or develop in the form of 
streamers according to the power sources.39-41 In this case, the gas temperatures, electron 
densities and physical processes mainly depend on the composition of gas in the bubble (and 
its size), conductivity of the liquid and input power.11 These factors affect the local chemistry 
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through decomposition and charged species acceleration induced by electric field.42 It was 
found that the formation of discharge and reactive species mainly occur at the bubble (gas) and 
gas-liquid interface.43 Plasma generation in bubbles, immersed in liquids have been applied to 
synthesize nanomaterials, produce synthetic fuel, and improve plants growth.34, 44, 45 
 
Figure 1.4. Schematic of discharge in bubbles that are externally a) introduced into liquids 
using capillary tubes and b) introduced into liquids using a hollow needle, which acts as one 
electrode while plate acts as another electrode.11, 34 
1.5 Advantages of plasma technology compared to conventional methods 
The chemical methods such as chlorination, ozonation and hydrogen peroxide and physical 
methods such as UV radiation, and ultrasound have been studied as separate or in combination 
and reported elsewhere for water treatment applications.46-52 Yang et al. have discussed the 
advantages of plasma in and in contact with liquids compared to conventional technologies like 
chlorination, use of in-line filters, pulsed electric field, UV radiation and ozonation in water 
treatment and applications.53  
Plasma in and in contact with liquids is an exciting new approach to initiate both chemical and 
physical effects in liquid and has limitless potential to act in applications such as fabrication of 
nanomaterials, decontamination, plasma medicine and agriculture.17, 54-58 It has been reported 
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that the formation of chemical species during plasma treatment mainly depends upon the type 
of gas used. The chemical reactive species such as OH-, H2O2, H2, O2, O3, atomic oxygen (O.) 
and superoxide anion (O2-) were produced while using argon and oxygen gases whereas the 
use of air produced reactive species like NO2, ONOO- and NO3.17, 27-29, 34 Plasma treatment 
includes the physical processes such as electric field, ultraviolet (UV) radiation, shock waves 
and cavitation which are based on the intensity of the input power and the conductivity of 
liquid.17 Compared to conventional methods, plasma requires lower energies to deliver the 
afore-mentioned physical and chemical process in a single step to effectively remove the 
organic pollutants and micro-organisms in liquids.32, 53, 59-62 This could make plasma 
technology as a potential and viable alternative in achieving the applications with higher 
efficiency compared to the individual physical and chemical counterparts.  
In this thesis, the plasma was produced in contact with the liquid using two set ups 1) in gas 
phase above the liquid surface (set up I, Figure 1.7) to fabricate hybrid nanostructure and 2) in 
bubbles that are externally introduced in milk (set up II, Figure 1.8) to decontaminate and 
extend shelf life while maintaining nutrition. A comprehensive literature review for the 
applications 1) and 2) have been discussed in the following context. 
1.6 Fabrication of boron nitride nanotube-gold nanoparticle hybrids 
The use of toxic chemicals, longer preparation time and damage to structure of materials has 
constantly demanded alternative methods to synthesize nanomaterials. In case of hybrid 
nanomaterials fabrication, the above challenges could be even worse. Here, plasma was 
produced in gas phase above the liquid surface to fabricate BNNT-GNP hybrid nanostructure. 
The choice of material (nanotubes and nanoparticles), their properties, synthesis and 
functionalization methods, applications, the research challenges and our approach to addresses 
the research challenges have been discussed in detail in the following sections. 
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1.6.1 Hybrid nanostructure 
Hybrid nanostructures possess the advantage of delivering multifunctional properties when two 
different classes of nanomaterials are incorporated. The fabrication of hybrid nanostructures 
helps to integrate the useful properties of two different materials to overcome each of their 
drawbacks and also to benefit from the synergies of their physical and chemical properties. In 
this work, nanotubes and nanoparticles were used to fabricate hybrid materials using plasma in 
contact with liquid approach.  
1.6.2 Choice of material 
Inorganic nanomaterials such as nanocrystals, nanotubes and nanowires have advantageous 
physical,  chemical and biological properties for biological applications.63, 64 In particular, 
nanotubes have a number of advantages because they possess 1) a larger inner volume 
which enables them to encapsulate more drug molecules, 2) their volume is readily accessible, 
3) the end caps could be removed easily to deliver drugs and 4) their inner and outer surfaces 
could be functionalized for targeted delivery.  
Nanotubes have a hexagonal network of atoms connected together in a rolled fashion. Since 
their discovery, carbon nanotubes (CNTs) have been studied in detail.65-67 Recently, their 
potential of CNTs in biological application has become uncertain due to cyto-compatibility 
issues.68 Boron nitride nanotubes (BNNTs) are a structural analogue of carbon nanotubes with 
promising properties compared to CNTs.69-72 A brief comparison of the properties of CNTs 
and BNNTs is given in Table 1.1. 
Table 1.1. Comparison of BNNT and CNT properties 
Properties BNNTs CNTs 
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Mechanical(Young’s 
Modulus) 
~1.18 TPa ~1.25 TPa 
Thermal 
conductivity 
~350 W/mK ~300 W/mK and >3000 W/mK (varies 
based on the diameter of tube) 
Chemical stability stable up to 1100 °C in air stable up to ~500 °C in air 
Electrical properties constant wide band gap 
(~5.5 eV) 
based on the  diameter, chirality and the 
number of walls, it could be semi-
metallic or semiconducting 
Optical properties applicable in the deep-
UV regime 
applicable in the near-IR regime 
1.6.3 Structure of BNNTs 
Boron nitride (BN) is isoelectronic and is similar to carbon in terms of structure and properties 
(Figure 1.5), and also to other compounds such as gallium nitride. Based on its preparation, 
BN crystallizes into a tetra-hedrally linked structure, like graphite and diamond. The 
similarities between BN and carbon could be understood from their isoelectronic structure.73 
BN exists in four different polymorphic forms with different properties, namely hexagonal BN 
(h-BN), rhombohedral BN (r-BN), cubic BN (c-BN) and wurtzite BN (w-BN). 
It was first synthesized from a reaction between molten boric oxide and potassium cyanide.74 
The first product obtained was amorphous BN powder, which was converted into crystalline 
h-BN by annealing in nitrogen flow at > 1500 °C. Later, several methods were reported for 
producing other polymorphic forms of BN.73 Nanotubes of BN are quite similar to CNTs in 
which alternating B and N atoms replace C atoms.65 BNNTs could be either multi-walled or 
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single-walled. The latter are difficult to produce, because single-layer BN does not appear to 
be as stable as multi-layers. The ionic character of BN may stabilize multi-walled BNNTs 
because of strong “lip-lip” interactions between the adjacent layers.75 
 
 
 
 
Figure 1.5. Schematic of boron nitride nanotube (left) and carbon nanotube (right) 
1.6.4 Properties of BNNTs 
1.6.4.1 Mechanical properties 
Min Feng Yu et al. studied the elastic modulus and the resonance behaviour of BNNTs under 
the electric field induced resonance inside a transmission electron microscope (TEM) and 
showed that the elastic modulus of BNNTs was 722 GPa comparable to the theoretical estimate 
of ~850 GPa.76 The Young’s moduli of both the CNTs (1.25 TPa) and BNNTs (1.18 TPa) are 
similar which could be the reason both BNNTs and CNTs are used for various mechanical 
applications.77, 78 
1.6.4.2 Thermal and Chemical properties 
There is a big demand for nanomaterials with high thermal conductivity to handle high 
radiation generating electronic devices. The thermal performance of BNNTs has been studied 
using theoretical methods like tight binding, density functional theory and the valence shell 
model.79-81 The experimental studies showed that BNNTs possess a higher low-temperature 
thermal conductivity compared to CNTs.82 Another important thermal property of BNNTs is 
their pronounced resistance to oxidation. Han et al. obtained BCN nanotubes from BN 
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nanotubes under oxidation and claimed that they were more stable than CNTs.8 3   
1.6.4.3 Electronic properties 
Theoretical calculations showed that BNNTs are expected to have a uniform electronic band 
gap (~5.5 eV), independent of the diameter and chirality of the nanotube.69, 84 This exhibited 
the uniform electrical behavior of BNNTs, unlike CNTs which are either metallic or 
semiconducting.  However, zigzag BNNTs (n, 0) possess a direct band gap whereas armchair 
BNNTs (n, n) have an indirect  band gap.84 The band gap of BNNTs could be tuned by several 
factors including doping with carbon, applying a transverse electric field and radial 
deformation.85-88 
1.6.4.4 Piezoelectric properties 
Mele et al. studied the piezoelectric properties of BNNTs using a model electronic 
Hamiltonian and suggested that BNNTs are piezoelectric and pyroelectric depending upon 
the direction of the spontaneous electric field that changes with the index of the tubes.89 
Golberg et al. found that elastic deformation of BNNTs occurred only when extending the 
bending angles beyond 30-40°, which was continued until the generation of consecutive 
momentary kinks.90 This suggested that BNNTs are promising piezoelectric systems whose 
mechanical and electrical properties could be tuned under defined conditions to achieve greater 
efficiency in nanoscale sensors, actuators and advanced nanoelectromechanical systems. 
1.6.4.5 Optical properties 
Cathode luminescence of multi-walled BNNTs showed a strong and weak absorption band at 
~3.9 eV and ~5.3 eV.91 Chen et al. found the band gap of multi-walled BNNTs as 5.75 eV 
using photoluminescence and optical absorption measurements.92 These studies suggests that 
BNNTs emit light in the deep ultraviolet region (around 200 nm) and might be useful in 
applications like information storage technology, medicine and environmental protection.93 
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1.6.5 Synthesis of BNNTs 
BNNTs could be synthesized by a range of methods including arc discharge, laser ablation, 
substitution reactions from CNTs, chemical vapour deposition (CVD) and ball milling and 
have been discussed in the following sections. 
1.6.5.1 Arc discharge 
The arc discharge method was the first successful method to synthesize BNNTs and was 
apparently similar to the method for growing CNTs.94 In this method, a rod of hexagonal BN 
was inserted into a tungsten electrode which acts as an anode with a rapidly cooled pure 
copper electrode as cathode. A constant potential drop and environmental helium gas were 
maintained at optimum conditions during the arc discharge. This led to the deposition of 
dark grey soot on the copper cathode which contained some spattered BNNTs at the end.  
1.6.5.2 Laser ablation 
Yu et al. have demonstrated that BNNTs could be fabricated by means of excimer laser 
ablation at high temperature.95 The factors such as wavelength, energy density of the laser 
beam, pressure, flow rate, temperature and the nature of target materials could be used to 
control growth, thereby a superior quality crystalline structure of one to several atomic layers 
and high yield could be obtained using laser ablation. In another report, Lee et al. have 
elaborated the bulk synthesis of BNNTs without the application of catalyst particles using 
continuous CO2 laser ablation.96 
1.6.5.3 Substitution reactions from CNTs 
Due to the structural similarity of CNTs and BNNTs, the synthesis methods of CNTs were 
used as a guide for producing BNNTs. This helped to extend the synthesis routes of BNNTs. 
According to the reaction mentioned below, Han et al. introduced a template substitution 
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method to incorporate boron and nitrogen atoms instead of carbon atoms in CNTs leading 
to the formation of BNNTs.97, 98 In this method, boron oxide powder was heated with carbon 
nanotubes in the presence of nitrogen at 1500 °C for 30 minutes. The analysis indicated the 
traces of carbon in BNNTs which could be purified by means of oxidation at 550 °C. 
B2O3 + 3C(CNTs) + N2                      2BN (BNNTs) + 3CO  (1) 
1.6.5.4 Chemical vapour deposition  
Chemical vapour deposition (CVD) is one of the successful methods for growing CNTs.99 
Most of the adopted CVD methods produced poor crystalline structures and structures with 
traces of carbon in BNNTs.100, 101 
1.6.5.5 Ball milling method 
Unlike the previous methods explained above, where BNNTs are formed either by physical 
deposition or chemical reactions from a boron vapour phase, Chen et al. reported that BNNTs 
could be prepared by reactive ball milling at room temperature.102, 103 Ball milling is quite 
different from the other methods and the key feature is the grinding of BN into nanomaterial, 
from which the ultimate BNNTs are formed.  
In this process, elemental boron powder was used instead of BN and was ball milled in the 
presence of ammonia gas and then later annealed in nitrogen up to 1400 °C. The resultant 
BNNTs were predominantly bamboo-like structures rather than cylindrical tubes, capped by 
particles of Fe which acted as a catalyst for the growth of nanotubes. 
1.6.6 Applications of BNNTs 
1.6.6.1 Biomedical applications 
The use of BNNTs in biomedicine gained popularity when it was reported that BNNTs has no 
or less toxicity in cells.104 Ciofani et al. was the first to propose BNNTs as a potential drug 
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delivery system because of its much improved chemical stability, dispersibility and 
biocompatibility.105 In addition, filling BNNTs with magnetic nanoparticles has produced 
magnetic hybrid systems which could be used as contrasting agents for magnetic resonance 
imaging.106 The surface functionalization of BNNTs with biomolecules such as proteins, DNA 
and RNA could be used for bio-sensing and bio-imaging applications.107 
1.6.6.2 BNNT composites 
Due to their high strength and other useful properties, BNNTs could reinforce novel composite 
materials. The addition of 4 wt.% of BNNTs in barium calcium alumosilicate glass has 
increased the fracture strength by 90% and fracture toughness by 35%.108 Lahiri et al. proposed 
BNNT reinforced hydroxyapatite (HA) as a novel composite material for orthopaedic implants. 
109 This composite offered a 120% increase in elastic modulus, 129% higher hardness, 86% 
increase in fracture toughness and 75% improvement in wear resistance.  
1.6.6.3 Electronics 
BNNTs could be used to electrically insulate nanocables with embedded metallic or 
semiconducting nanowires. This kind of cable could be employed in very small electrical 
devices and complex multi-cable circuits.110 Kenji et al. claimed that they produced pure h-BN 
crystals under high pressure and temperature, which showed a dominant luminescence peak 
and a series of s-like exciton absorption bands around 215 nm, showing it to be a direct bandgap 
material.111 The latter property made BNNT as a promising material for ultraviolet lasers and 
light emitting diodes. 
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1.6.7 Shortening of BNNTs 
It has been reported that the long CNTs length makes it difficult to tailor them for applications 
in molecular electronic devices, solar cells.112, 113 In composites, avoiding agglomeration is 
important to reduce stress concentration and obtain maximum mechanical performance.114 In 
biological applications, length causes poor solubility, difficulty in cell uptake and unwanted 
toxic issues in the cells.115-117 
These suggested that next to synthesis of BNNTs, reducing the length is essential in improving 
the process-ability of BNNTs to extend its use in bio and other applications. Zhi et al. first 
reported the shortening of BNNTs using oxidation and sonication to improve its process-
ability.118 Later, Chee et al. demonstrated cutting of functionalized BNNTs in water using 
sonication.119 
The physical approaches such as ultra-sonication, ball milling and cryogenic crushing used for 
shortening of CNTs could cause damage to the nanotube structure while shortening the length 
and are time consuming methods.120-122 The chemical methods that utilized oxidizing solutions 
in shortening the CNTs are toxic and violent, hence it is hard to control the oxidation process 
in order to obtain the desired structure.123-126 Zhi et al. used very high temperature to oxidize 
the BNNTs and then sonicated them in alcohol for 5 hours to shorten BNNTs whereas Chee et 
al. functionalized the BNNTs using PEGylated phospholipids and sonicated the suspension for 
30 hours to obtain short BNNTs.118, 119 
1.6.8 Functionalization of BNNTs 
Surface modification is another approach to increase the solubility, target a specific site and to 
attach nanoparticles.127-131 Covalent bonding and weak interactions have been reported as 
effective approaches to modifying the surface of BNNTs. 
1.6.8.1 Covalent bonding 
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Covalent modification of BNNTs has been developed to improve its solubility. The bonding 
could be done either at B or N sites. The convenient methods for B site modification are 
generally lacking. Zhi et al. shown that B sites could be activated by oxidation of BNNTs using 
H2O2 under high pressure and temperature.132 The N site modification has been solely focused 
based on amino group chemistry.133 The growth of BNNTs mostly used NH3 as a reactant and 
this left occasional N-H bonds on its surface. The chemical reaction between the COCl group 
of stearoyl chloride and N-H bonds of BNNTs resulted the increase in solubility when N, N-
dimethylacetamide (DMF) was used as an organic solvent.134 
1.6.8.2 Weak interactions 
The weak interactions are more appropriate than covalent bonding to conserve nanotube 
properties. Although BNNTs are insulators because of the π electronic structure, this property 
might be used to attach molecules through π stacking interactions.135, 136 The first such 
interactions were observed when a conjugated polymer poly [m-phenylenevinylene-co-(2,5-
dioctoxy-p-phenylenevinylene)] (PmPV) was attached to BNNTs, which then showed better 
solubility in solvents such as DMF and chloroform but not in water and ethanol.136 Cation- π 
interactions and some non-specific interactions have also been used to modify BNNTs.133, 137  
From the above reports which have focused on the functionalization of BNNTs, it is 
evident that a simple and effective method of functionalization is still required to 
overcome the problems in treatment instabilities, formation of functional groups in low 
density, damage to the tube structure, poor dispersion and solubility. Physical adsorption 
methods (hydrophobic or van der Waals interactions) of BNNT modification has resulted in 
reversible and unstable functionalization.136, 138 Chemical functionalization of BNNTs has 
given higher stability and reactivity which opened up the door for many applications.133, 134, 139 
However, the convenient methods for B site modification are generally lacking. Zhi et al. 
shown that B sites could be activated by oxidation of BNNTs using H2O2 under high pressure 
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and temperature.132 Ciofani et al. demonstrated that oxidation of BNNTs using concentrated 
nitric acid solution (65% w/w) and sonication for 6 hours, introduced -OH functional groups 
at B site.140 These two B site modification methods utilized high temperature, pressure, 
concentrated chemicals, and longer treatment times to achieve the modification of BNNTs at 
B site. The N site modification has been solely focused based on amino group chemistry.133 
Again, a low density of functional groups and damage to the tube structure are reported as 
major problems while modifying N site of BNNTs.139 Moreover, the low chemical reactivity 
and poor wetting properties of untreated BNNTs does not allow them to easily solubilize in 
many organic solvents which could hamper their application prospects in biomedicine, energy 
storage and electronics.141, 142  
1.6.9 Attachment of nanoparticles onto BNNTs 
There have been a few attempts to modify BNNTs with nanoparticles such as SnO2, Au and Fe 
with the help of non-specific interactions.127, 128, 143 SnO2 nanoparticles are strongly attracted 
to BNNTs due to the change in lattice distances of both BNNTs and SnO2 through Sn-N bond 
formation or electrostatic interactions.144 The other nanoparticles Au and Fe, did not entirely 
cover BNNTs. However, Sainsbury et al. showed that Au nanoparticles could fully cover 
BNNTs using S-Au chemistry.128 In their work, the BNNTs were functionalized with a thiol 
group containing compound called 3-mercaptopropionic acid (MPA) before attachment of 
GNPs. Huang et al. synthesized Fe decorated BNNTs using an ethanol thermal process and 
they studied the magnetic properties of prepared nanocomposites.143 Yu et al. developed a 
strategy to decorate BNNTs with Pd nanoparticles using sodium dodecyl sulphate.145 Recently, 
Volkmann et al. demonstrated the direct attachment of colloidal semiconducting nanoparticles 
such as PbSe, CdSe and ZnO onto BNNTs and studied its fluorescence properties.146  
The difficulties in positioning the nanoparticles at a particular location, controlling the 
structure, morphology and damage to the nanotube structure are still remaining as major 
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challenges.127, 128, 143 
1.6.10 Research challenges, objectives and our approach 
The major challenges that handicap BNNTs for further application are 1) length and 
surface modification of nanotubes and 2) assembly of nanoparticles onto modified 
nanotubes. The highlights of the challenges associated in this research are listed in Figure 
1.6. 
 
Figure 1.6. Schematic of major challenges in synthesis, functionalization of BNNTS and 
assembling of nanoparticles onto them 
Shortening and functionalization of BNNTs 
As mentioned earlier, the previous methods used to shorten BNNTs are hazardous, not easy to 
control, time consuming and could cause damage to the tube structure. The use of short 
nanotubes and their advantages such as improved dispersibility, process-ability, 
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biocompatibility and easy cellular uptake for bio applications has been discussed earlier. Zhi 
et al. observed two main advantages of shortened BNNTs that possess 1) a hole-rich structure 
and more ends which increased the possibilities for molecules or cargoes to enter into the tubes 
instead of solely locating on the surface and 2) better dispersibility which enhanced the chances 
of BNNT-molecule interactions. These advantages suggest that shortened BNNTs might be 
useful for efficient delivery systems.118 In addition to shortening BNNTs, producing boron 
nitride nanocups (BNNCs) might be also a useful approach to achieve high dispersibility. 
BNNCs, a kind of hollow BN nanomaterials, possess cup like structures which was produced 
by the combined treatment of ball milling and followed by ultra-sonication in BNNTs.147 It 
maintains the intrinsic properties of BNNTs and also possesses other advantages such as high 
surface area and low effective densities.  
Vandsburger et al. have claimed that oxidation induced by gaseous oxygen plasma discharge 
could play a key role in reducing the length of CNTs.148 Zhi et al. have shown that oxidization 
of BNNTs at high temperature leads to shortening of the nanotubes.118 The above reports have 
shown that oxidation plays a key role in reducing the length of BNNTs. However, there are no 
reports on the use of atmospheric pressure plasma in contact with liquids to shorten nanotubes 
from bamboo like BNNTs. 
Next to shortening, the key challenges in modifying the surface of BNNTs are instability, low 
density of functional groups, maintaining the tube structure, poor dispersion and solubility. Zhi 
et al. have demonstrated the use of H2O2 under high pressure and temperature to oxidize and 
modify the BNNTs at B site.132 In another method, Ciofani et al. have used concentrated nitric 
acid solution and sonication to oxidize BNNTs and then introduce -OH functional groups at B 
site.140 Gas plasmas possess several advantages for BNNT surface modification. Point defects 
were created in BNNTs which provided nitrogen vacancies for oxygen substitution, as a result, 
a high density of functional groups was achieved in a well-controlled manner.149-151 Dai et al. 
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have successfully achieved the controlled functionalization of BNNTs by gentle plasma 
treatment while maintaining the intrinsic tube structure.152 The previous studies by others have 
shown that use of high temperature and pressure, hydrogen peroxide and nitric acid oxidizes 
the BNNTs which facilitate the shortening and functionalizing the nanotubes.118, 132, 140, 148 
However, there are no reports on the functionalization of BNNTs using atmospheric pressure 
plasma in contact with liquids. 
Assembly of GNPs onto the functionalized short BNNTs to fabricate hybrid nanostructures 
The attachment of nanoparticles with BNNTs could broaden the range of nanotube properties 
and uses, while the BNNTs could act as a support for the nanoparticles. Several reports have 
demonstrated that nanoparticles attached nanotubes could be used for applications in single 
electron transistors, plasmon waveguides and also for creating novel nanostructures.153-155 
However, as mentioned earlier, most of the approaches reported for fabrication of hybrid 
nanostructures have faced issues such as use of toxic chemicals, longer treatment times, 
positioning the nanoparticles at a particular location, controlling the structure, morphology and 
damage to the nanotubes. So far there are no studies related to the attachment of nanoparticles 
onto BNNTs using atmospheric pressure plasma in contact with liquids. 
Atmospheric pressure plasma-aided nanofabrication is one of the alternative approaches to 
produce nanostructures and uniformly tailor the surface of nanomaterials in a well-controlled 
manner.156-159 It was demonstrated that gas-liquid interfacial discharge plasma could be used 
to attach nanoparticles onto CNTs using ionic liquids.160-162 As mentioned earlier, there are no 
reports which have investigated the use of atmospheric pressure plasma in contact with liquids 
to shorten, functionalize BNNTs and attach nanoparticles onto them. This is the first study 
which aimed to fabricate functionalized short BNNTs-GNPs hybrid nanostructures using 
nanosecond pulsed atmospheric pressure plasma in gas phase above the liquid surface (set up 
I is shown in Figure 1.7), to address the afore-mentioned challenges. Gold nanoparticles 
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(GNPs) have been widely used and accepted due to their well-established unique physical, 
chemical and biological properties.163, 164 Hence GNPs were chosen for this study. This 
approach includes the following steps. 
 Shortening and functionalization of BNNTs 
 Assembly of GNPs onto the functionalized short BNNTs to fabricate hybrid 
nanostructures 
The development of this kind of hybrid nanostructures has potential for applications in drug 
delivery, bio-imaging and biosensors. 
 
Figure 1.7. Schematic view of nanosecond pulse atmospheric pressure plasma system, using 
argon gas. The top electrode was above the liquid and bottom electrode was immersed in 
liquid. 
1.7 Decontamination of milk to extend shelf life while maintaining nutrition 
Milk is a liquid food, that is enriched with nutrients and growth factors, that provide many 
health benefits to humans.165 The nutrients in milk also serves as an ideal substrate for the 
growth of micro-organisms.166 The consumption of raw or ineffectively processed milk causes 
milk-borne diseases in humans.167-170 Thermal pasteurization is the widely accepted technique 
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to remove bacteria in milk but this damages the nutrients in milk by several modifications.171, 
172 An alternative to pasteurization is the potential to use plasma produced in bubbles that could 
be externally introduced into milk to potentially decontaminate and extend the shelf life of 
milk. This technique may be gentler on milk constituents and therefore may maintain milk 
nutrition compared to pasteurization. 
The composition of milk that include proteins, lipids, carbohydrates, miRNA and other trace 
elements, micro-organisms, milk-borne diseases, thermal and non-thermal methods to process 
milk, research challenges and our strategy to address the challenges have been discussed in 
detail here. 
1.7.1 Composition of milk 
Milk is a nutritious liquid food secreted from the udder of mammalian species like bovine, 
goat, sheep and buffalos for the growth and development of its offspring. Milk and milk 
products have been consumed by human since early times and contributes to a significant 
health benefit in humans.173 The average composition of bovine milk constitutes 87 % water, 
3.4 % protein, 3.6 % fat, 4.9 % lactose, 0.7 % minerals and other trace elements. In cows the 
composition of milk can considerably vary depending upon the breed, genetic variation, feed, 
season, lactation stage and udder health.174, 175 Milk is a complex liquid, in which fat is present 
in the form of globules surrounded by a membrane, whereas proteins, carbohydrates and other 
substances are dispersed and solubilized in skim milk (without fat).174 The nutritional 
compounds present in milk have been discussed in the following sections. 
1.7.2 Proteins 
Proteins in milk are broadly divided into two types, namely casein and whey proteins. These 
two proteins chemically and physically differ from each other and they exist in different milk 
phases. Casein proteins are present in casein micelles which are dispersed in the skim phase of 
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milk (i.e. milk minus fat) while whey proteins are solubilized in the skim phase of milk. 
Dalgleish et al. found that casein proteins tend to precipitate at pH 4.6 at 20 °C, while whey 
proteins stay in solution under the same conditions.176 This showed that both proteins 
characteristically differ in terms of stability. Milk is composed of 80% casein and 20% whey 
proteins. The casein (CN) proteins are majorly classified into alpha (αs1-CN, αs2-CN), beta (β-
CN) and kappa casein (κ-CN) according to the homology of their primary strcurure.177 In 
bovine milk the whey proteins mainly consist of β-lactoglobulin (β-LG) and α-lactalbumin (α-
LA), bovine serum albumin (BSA), and immunoglobulins (Ig)178, while human milk is devoid 
of β-LG. 
1.7.2.1 Casein proteins and micelles 
Caseins are the major proteins in milk and they are distinguished as αs1-CN, αs2-CN, β-CN and 
κ-CN, approximately present in the ratio about 11:3:10:4. Each of them has its unique amino 
acid composition, genetic variations, and functional properties.179 Each components of casein 
contain high amounts of ester bound phosphate, proline residues with no or less disulphide 
bonds. Due to this, CN proteins have low levels of secondary structure and they lack tertiary 
structure.180 This keeps the caseins in an open structure and expose its hydrophobic residues 
which provides stability against denaturation by heat because there is very less structure to 
unfold.181 This open structure also makes caseins susceptible to gastrointestinal proteolytic 
digestion which results in the release of bioactive peptides that might contribute to a lower risk 
against type-1 diabetes, cardiovascular disease, schizophrenia, dental caries and autism.182-184 
The hydrophobic nature of CN proteins allow them to react or associate with each other to  
make them soluble in water.177 These self-associated CN proteins together with calcium 
phosphate (CCP) constitutes the casein micelles.175 The casein micelle is made up of 94% 
casein protein and 6% CCP.185 The CCP plays a key role in the formation and stability of the 
CN micelles. The surface of the CN micelle is mainly composed of κ-CN, which behaves as 
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an emulsifier by keeping the hydrophilic C-terminal region in the soluble phase and the 
hydrophobic region inside the micelle. The size of the CN micelles varies from <50 nm to >500 
nm based on the content and genotype of κ-CN.175, 186 These micelles play a key role in 
providing fluidity to casein molecules and solubilize phosphate and calcium. Moreover, it has 
been suggested that the casein‐micelle complex with calcium phosphate helps in preventing 
the calcification of the mammary glands.187, 188  
1.7.2.1.1 Alpha casein 
The common alpha caseins identified so far are αs1 and αs2-CN. αs1-CN has a high net negative 
charge and a high phosphate content (i.e. 7-9 per molecule).175, 189, 190 Hydrophobic interactions 
are also involved in the association of this protein. It has five to nine variants and are reported 
as αs1-CN A, B, C, D, E, F, G, H and I. αs1-CN B is the common variant and accounts for about 
34% in milk. This protein contains 199 amino acid residues and has a molecular weight of 
23.614 kDa.191 αs1-CN is sensitive to calcium and it can be precipitated by calcium at very low 
levels 175, 177, 189 
The αs2-CN have four variants such as αs2-CN A, B, C and D and they vary based on the number 
of ester phosphate groups (i.e. 10-14 per molecule).175 This protein consists of 207 residues 
and the molecular weight was calculated as 24.350 kDa. It contains two cysteines, resulting in 
intermolecular disulphide (–S–S–) bridges (no carbohydrate groups) and exists as either a 
monomer or dimer. αs2-CN is the most hydrophilic CN and contributes to about 8% of the 
proteins in milk. 174, 179, 191 This protein can also be precipitated at very low levels of calcium. 
175, 177, 189 
1.7.2.1.2 Beta casein 
β-Casein (β-CN) is the most hydrophobic casein (5 phosphate groups) and constitutes 25% of 
the proteins in milk.174 13 genetic variants of β-CN are identified so far and listed as β-CN A1, 
A2, A3, B, B2, C, D, E, F, G, H1, H2 and I. The most common variant is A2 with 209 amino 
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acid residues and it has a molecular weight of 23.983 kDa.191 The charge is unevenly distributed 
in β-CN and so it is referred as amphiphilic protein.175, 189 Unlike alpha CN, β-CN is less 
sensitive to calcium precipitation. 175, 177, 189 
1.7.2.1.3 Kappa casein 
Kappa casein (κ-CN) is considerably different from αs1-CN and β-CN. Like αs2-CN, κ-CN 
contain two cysteine residues (forming an –S–S– bridge) but it also possess a carbohydrate 
group.175  To date, 12 different κ-CN protein variants (A, B, C, D, E, F1, F2, G1, G2, H, I, and 
J) and one synonymous variant (AI) have been identified. The common variant B contains 169 
amino acid residues and has a molecular weight of 19.023 kDa.191 κ-CN is positioned on the 
outside of the casein micelle and it about 9% of the proteins in milk.174, 189 κ-CN is very resistant 
to calcium precipitation which helps to provide stability to other types of caseins. The cleavage 
of κ-CN using rennet enzyme makes it to lose the stabilizing ability which results in the 
coagulation of milk through aggregation of CN micelles.175, 177, 189 
1.7.2.2 Whey proteins 
Unlike the limited number of CN proteins, the whey fraction contains a significant number of 
proteins. The whey proteins are compact, globular proteins that have a high level of secondary, 
tertiary and quaternary structure and contain intermolecular disulphide bonds that stabilize their 
structure.192 The key whey proteins in milk are α-LA, β-LG, BSA, Ig and Lf.193 They account 
for about 20% of the total protein content in milk. 
1.7.2.2.1 Beta lactoglobulin 
Beta-lactoglobulin (β-LG) is the major protein in bovine whey and constitutes about 50% of 
the whey fraction in milk. There are 11 known genetic variants of β-LG identified in bovine 
milk.191, 194 β-LG is a globular protein and naturally exists as a dimer in raw milk, each subunit 
has a molecular weight of 18.3 kDa with 162 amino acids, two disulphide bridges and a free 
thiol group. In β-LG, each β sheet has one hydrophobic side and a hydrophilic side. The 
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hydrophobic sides of β-LG subunits are tightly bound to each other through hydrophobic 
interactions.175, 195 The function of β-LG is not completely identified, however studies showed 
that the three dimensional structure of β-LG has homology to the lipocalin family, and is 
considered to bind and transfer fatty acids and Vitamin A. The members of this family generally 
have high allergenic potential and present well-conserved sequence homologies in their N-
terminus moiety where tryptophan at position 19 is always present.196-198  
1.7.2.2.2 Alpha lactalbumin 
Alpha lactalbumin (α-LA) constitutes about 2% of the whey fraction of milk.193 α-LA known 
to have three different variants is reported as α-LA A, B and C. α-LA has a molecular weight 
of 14.186 kDa with 123 amino acids and eight cysteine residues.174, 191 Native α-LA contains 
two domains, a large α-helical and small β-sheet domain, which are held together by cysteine 
residues, forming calcium binding loop.199 α-LA has a characteristic property of hydrophilic 
and hydrophobic based on the presence and absence of calcium ions.200 The biological function 
of α-LA is that it plays an important role in the formation of lactose from glucose and 
galactose.201 Dimeric α-LA has been implicated in initiation of apoptosis, and it is thought that 
this dimer is formed at weaning and initiates involution via apoptosis of mammary epithelial 
cells (sharp et al, 2016). This results in restructuring of the mammary gland back to a virgin-
like state. 
1.7.2.2.3 Bovine serum albumin 
Bovine serum albumin (BSA) is a minor whey protein which contains 582 amino acids, 17 
disulphide bridges and one thiol-group, with a molecular weight of 66.267 kDa.202, 203 BSA  
has the biological function of binding and delivering free fatty acids, other lipids as well as 
flavour compounds.201, 204 
1.7.2.2.4 Immunoglobulins 
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Immunoglobulins (Igs) are majorly classified into IgG, IgM and IgA in bovine milk and they 
are made up of 90% of protein and 10% of carbohydrate. IgG is the common type, consists of 
four polypeptide chains; two identical light chains (κ and λ, 23 kDa) and two identical heavy 
chains (53 kDa). The complete Ig or antibody molecule possesses stereo-chemically a Y-
shaped structure and has a molecular weight of about 150-160 kDa.175, 205 The light chains have 
211 to 217 amino acids in length and differ in their chain structure. Whereas the heavy chains 
possess five types γ, δ, α, μ and ε. The α and γ heavy chains contain about 450 amino acids, 
while μ and ε have approximately 550 amino acids. The light chains are joined to the heavy 
chains by disulphide bonds and the two heavy chains are held together by disulphide bonds 
near a hinge region, which it gives the molecule the flexibility needed in antibody-antigen 
interactions. The stem of the Y shaped, called Fc fragment, which consists of two heavy chains 
depending on the class of the antibody. Igs are an important component of immunological 
activity in milk and are delivered to the young to protect them from infection at a stage when 
they might be immunologically naive. Igs have multiple biological functions such as activation 
of complement proteins, bacterial opsonization, cell lysis and agglutination.205, 206 
1.7.2.2.5 Lactoferrin 
Lactoferrin (Lf) is a monomeric globular, iron binding glycoprotein composed of 
approximately 680 amino acids with a molecular weight of ~80 kDa. Lf belongs to the 
transferrin family, which contain two main domains. Each main domain consists of two α-
helical/β-sheet domains separated by a cleft that includes an iron binding site.207 Lf has multiple 
biological functions like antimicrobial, anti-viral and anti-parasitic activites.208 
1.7.3 Lipids 
Milk fat is an important source of energy, fat soluble nutrients and bio-active lipids. Milk fat 
is mainly composed of triacylglycerols (98%), di and monoacylglycerols (2%), cholesterol 
(>0.5%), phospholipids (~1%) and free fatty acids (FFA) (~0.1), averagely.209 The other trace 
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elements include ether lipids, hydrocarbons, fat-soluble vitamins and flavour compounds 
which is available based on the diet of the cow.210 The chemical composition of lipids in milk 
is also influenced by breed, lactation stage and cycle and season.211, 212 It has been reported that 
lipids in milk possess biological functions such as anticancer, anti- inflammatory, antimicrobial 
and immunosuppression properties.213  
1.7.3.1 Milk fat globule membrane 
Lipids in bovine milk are in the form of globules, as an oil-in-water emulsion.214, 215 The 
diameter of fat globules is 0.1–10 μm, but averages in the range of 1–5 μm.174 The membrane 
surrounding the lipid globules in milk is called the milk-fat-globule membrane (MFGM), which 
is assembled and secreted by the epithelial cells of the mammary gland. The MFGM enables 
the fat to remain dispersed throughout the aqueous phase of milk. The composition of MFGM 
commonly consists of a mixture of proteins, glycoproteins, enzymes, neutral lipids and 
phospholipids.216 In MFGM, proteins and enzymes are the major constituents (70%) and the 
remaining fraction compose lipids such as phospholipids (25%), cerebrosides (3%) and 
cholesterol (2%).217  
The common proteins identified in MFGM are xanthine oxidoreductase, butyrophilin, PAS 6 
and PAS 7.214 The other enzymes in MFGM are namely acetylcholine esterase, alkaline and 
acidic phosphatase.174 It is generally accepted that the role of MFGM is generally to prevent 
lipolysis in milk. Hence, if the milking and storage methods are properly done, then raw milk 
can be kept for several days without the development of a rancid off-flavor. However, during 
homogenization milk is forced through small passages under pressure which reduces the 
diameter of the globules according to the pressure applied. This causes the casein proteins to 
come in contact with the milk lipids. A very active lipoprotein lipase present in the casein 
micelles, bind to the fat globules and hydrolyzes the triacylglycerols within a few minutes. This 
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demands the pasteurization technique to inactivate lipoprotein lipase before homogenizing the 
milk.174  
1.7.3.1.1 Triacylglycerols 
Triacylglycerols are synthesised in the mammary gland through enzymatic reactions, which 
exert some selectivity over the esterification of different fatty acids at each position of the sn-
glycerol moiety.218 Triacylglycerols, composed of three fatty acids covalently bound to a 
glycerol molecule by ester bonds, form the major composition of milk lipids (~98%) which 
largely decides the properties of milk fat.214, 219 The main properties for example are, 
hydrophobicity, density and melting characteristics. Triacylglycerols are very non-polar and 
not surface active. In the liquid state, they could be used as a solvent for other non-polar 
substances such as sterols, carotenoids, and tocopherol. These properties vary with the fatty 
acid composition. These triacylglycerols are a complex mixture, and vary considerably in 
molecular weight and degree of unsaturation. This complexity could be due to the presence of 
a wide variety and large number of fatty acids, which constitute the composition of 
triacylglycerols.179 
The fatty acids in milk lipids consists of a straight chain of a number of carbon atoms, 
surrounded with hydrogen atoms and a carboxyl group at one end. In the carbon‐to‐carbon 
bond chain, if all the bonds are single, they are referred to as saturated fatty acid; the 
unsaturated fatty acid contains double bonds at any position in the length of the chain. The fatty 
acids differ by carbon length, level (example mono) and position (example cis9) of 
unsaturation, and branching. The differences in the above characteristics and the composition 
of fatty acids in milk lipids determines the flavour and texture (for example, spread-ability of 
butter).214 The fatty acids in milk lipids could be beneficial for human health while certain 
others are considered to have negative effects on human health.213 
1.7.3.1.2 Di and monoacylglycerols 
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Lok reported that fresh milk contains only less percentage of diacylglycerols, 
monoacylglycerols and free fatty acids.220 Lok identified that diacylglycerols composed mainly 
of sn-1,2 diacylglycerols and hence they may be the intermediates in the biosynthesis of 
triacylglycerols instead of a by-product from lipolysis.220 Later reports claimed that di and 
monoacylglycerols have been found in higher quantities after lipolysis. Diacylglycerols are 
largely non-polar and similar to triacylglycerols in properties. Monoacylglycerols are 
somewhat polar, surface active and accumulate mainly at an oil-water interface.179  
Some of the free fatty acids are present in fresh milk and lipolysis could increase their 
quantities. Free fatty acids consist of both longer and shorter length fatty acids. The longer ones 
are surface active and like to accumulate at an oil-water interface. The shorter fatty acids could 
be responsible for the development of rancid flavour after lipolysis.179   
1.7.3.1.3 Phospholipids 
Phospholipids are polar, amphiphilic and account for only 0.8% of milk lipids. Most of them 
are found in MFGM (65%), and remaining in the aqueous phase. Phosphatidyl choline, 
phosphatidyl ethanolamine and sphingomyelin are the major phospholipids in milk. Sterols are 
present in lower quantities (0.3% of the fat). In sterols, cholesterol is the major component.214 
The fatty acid pattern of phospholipids varies considerably in chain length and number of 
double bonds compared to triacylglycerols. For example, sphingolipids average chain length is 
longer, and phosphatidyl ethanolamine has a high proportion of polyunsaturates (double 
bonds). Due to this, the phospholipids are highly susceptible to oxidation.179   
1.7.4 Carbohydrates 
The major component of carbohydrate in milk is reducing disaccharide lactose. Lactose is 
composed of glucose and galactose linked by β 1-4 glycosidic bond.206 Both glucose and 
galactose are largely available in mammalian metabolism, lactose is synthesized only in the 
Golgi vesicles of the lactating cells, which is dependent on the presence of α-LA protein. α-LA 
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alters the action of the enzyme galactosyl-transferase to catalyze the formation of lactose from 
uridine-diphosphate-galactose and glucose.179 It is the major osmolar factor in milk and its 
synthesis is responsible for drawing water into the milk as it is being formed in the mammary 
gland.212 Lactose is also responsible for the increased absorption of calcium.221 In addition, 
glucidic compounds such as hexosamines and N-acetyl neuraminic acid are present in milk, 
however many of them are covalently bonded to membrane proteins, or in cerebrosides.179 
1.7.5 RNA and micro RNA 
Micro RNAs (miRNAs) are a new class of non-coding RNAs ranging from of 18 to 26 
nucleotides in length which play an important role in gene regulation by controlling translation 
and stability of mRNAs.222 Recent research has revealed that miRNAs are involved in an 
important biological functions such as in gene regulation, signal transduction, cellular 
communication, and human health.223-226 Micro RNAs (miRNAs) have been identified in 
bovine, human, rat and other species milk and serve as an effective biomarker for milk quality 
and udder function.227-229 Izumi et al. reported the presence of miRNAs and mRNA in bovine 
milk exosomes, which were absorbed by human macrophages, this suggest that bovine milk 
exosomes might have biological effects in humans.229 These milk miRNAs are encapsulated in 
exosomes which gives them stability and the ability to withstand harsh conditions such as the 
acid environment of the stomach.228-230 Baier et al. demonstrated that humans absorb 
biologically meaningful amounts of miRNAs from cow milk, this intake could affect human 
gene expression in vivo and in cell cultures, and the endogenous synthesis of miRNAs might 
not be sufficient for dietary miRNA deficiency in mice.231 Chen et al. identified seven miRNAs 
(miR-26a, miR-26b, miR-200c, miR-21, miR-30d, miR-99a, and miR-148a) which were 
consistently found in both colostrum and raw cow milk. They proposed that these milk specific 
miRNAs, could be potential biomarkers for the quality control of raw milk and other milk-
related products.228 
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1.7.5 Bioactive peptides/Enzymes/Vitamins/Minerals 
Milk contains bioactive peptides, enzymes, vitamins and minerals in very small quantities 
which may be beneficial to human health. Milk proteins form the major source of biologically 
active peptides.232 The proteolytic digestion of these proteins in the gastrointestinal tract or 
processing releases the bioactive peptides.233 Milk contains the naturally available bioactive 
substances such as oligosaccharides, growth factors, hormones, gangliosides, mucin and 
endogenous peptides.234 Several studies have shown that milk peptides have antihypertensive 
effects, both by inhibiting angiotensin-converting enzyme, having opoid-like activities, 
antithrombotic properties and by binding minerals.235, 236 
Milk contains a great number of enzymes which are not only useful to evaluate the quality of 
processed or heat-treated milk but could also have functional values.174 Xanthine oxidase, 
plasmin and lactoperoxidase are the common enzymes. The other enzymes include amylases, 
lipases, esterases, proteinases and phosphatases. The applications of these milk enzymes have 
been documented elsewhere.  
Milk contains many minerals, vitamins and antioxidants. Vitamin A, Vitamin E, Vitamin B12 
and folate are the common vitamins available in milk. Calcium, selenium, magnesium, iodine 
and zinc are the commonly available minerals in milk.173, 237-240 Several studies have 
documented the presence and uses of various minerals, vitamins and antioxidants present in 
milk.173, 237-240 
1.7.6 Microorganisms in milk and milk borne diseases 
The presence of large amount of nutrients with high water content and neutral pH (6.4–6.8) 
makes milk an ideal medium for the growth of many organisms.241, 242 Microorganisms in milk 
can be divided into three main groups, probiotics, spoilage and pathogenic. Probiotic 
microorganisms are those which provide beneficial effects for the host or humans by providing 
microbial balance in the gut.243 The common probiotics identified in milk are Lactobacillus, 
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Bifidobacterium and Enterococcus species.244 These probiotics can also be classified into the 
spoilage micro-organisms category because of their ability to produce lactic acid which can 
sour milk.245  
Spoilage organisms have the potential (using enzymes such as protease, peptidase, lipase, 
esterase, oxidase, polymerase, β-galactosidase) to hydrolyze protein, fat and lactose present in 
milk to produce substances which are appropriate for their growth. This kind of hydrolysis lead 
to spoilage, off-flavours and odours, modification of appearance and texture in milk. They can 
be classified in to two types, gram positive and negative bacteria. The gram negative bacteria 
are the psychrotrophs such as Pseudomonas spp, Enterobacteriaceae, Flavobacterium, 
Aeromonas and the gram positive bacteria are spore-forming bacteria which include 
Geobacillus stearothermophilus, B. licheniformis, B. cereus, B. subtilis and Clostridium 
spp.241, 246, 247 
Several pathogenic organisms have been identified in raw milk which varies according to the 
geographical area, season, farm size, hygiene and management practices. They are namely 
toxin-producing Escherichia coli, Staphylococcus aureus, Listeria monocytogenes, 
Campylobacter jejuni, Salmonella spp. and Yersinia enterocoliticase which cause outbreaks of 
illness in humans through milk-borne diseases.248, 249 The outbreaks related to milk-borne 
diseases are always a serious concern in Australia and at the global level.250-252 The list of 
pathogenic micro-organisms and its associated milk-borne diseases are provided in below table 
1.2. 
Table 1.2 List of pathogenic micro-organisms and its associated milk-borne diseases  
Micro-organisms Diseases 
Campylobacter jejuni Campylobacteriosis253 
Brucella spp Brucellosis254 
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Streptococcus uberis Mastitis255 
Staphylococcal enterotoxins Food poisoning256  
Salmonella species Salmonellosis257 
Mycobacterium tuberculosis 
and Mycobacterium bovis 
Tuberculosis258 
Escherichia coli 0157:H7 Haemorrhagic colitis and 
haemolytic uraemic syndrome259 
Listeria monocytogenes Listeriosis260 
 
1.7.7 Processing technologies in milk 
Thermal methods (pasteurization), are in practice, to decontaminate and sterilize milk to reduce 
the risk associated with the afore-mentioned harmful micro-organisms. In addition to thermal 
methods, non-thermal methods are also emerging in recent years to improve microbial safety 
and quality of milk. A detailed review, advantages and disadvantages of these milk processing 
technologies have been discussed here. 
1.7.7.1 Pasteurization 
Pasteurization is the process of applying heat to milk to destroy microorganisms and make it 
safe for human consumption. The history of pasteurization starts with William Dewes (40 years 
before Pasteur’s experiment) who suggested heating milk, before feeding to infants after 
observing that heat treatment reduces milk spoilage.261 Later Pastuer, discovered that heating 
liquids at ~60 °C improved the shelf life of wines. Germany was the first country to make a 
pasteurizer commercially in the year 1882. Denmark and Sweden adopted pasteurisation as a 
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common practice in mid-1880s. The first commercial milk pasteuriser was installed in 
Bloonwille, New York in the year 1883.262  
To date, pasteurization is the only accepted technique available for processing milk. The 
common pasteurization types are, low temperature long time (LTLT), high temperature short 
time (HTST) and ultra-high temperature (UHT).263 LTLT is generally regarded as a batch or 
holder pasteurization. In LTLT, the milk is heated at 63 °C for 30 min to decontaminate milk. 
HTST is a continuous process method in which milk gets heated at 72-75 °C for 15-30 seconds. 
HTST is the commonly followed method which has advantages such as shorter treatment time 
and less changes in milk quality compared to other methods.263 UHT is the process of sterilizing 
the milk at 135-140 °C for few seconds to increase the shelf life for several months. In all 
pasteurization methods, cooling of milk immediately followed by heating is an important step 
to prevent heat induced changes in milk. 
Milk is mainly pasteurized to destroy the pathogenic and vegetative microorganisms present in 
the milk.264, 265 This helps not only to increase and keep the quality of milk but also allows the 
milk to be used for manufacturing in other milk-related products such as cheese, butter, cream, 
yoghurt and milk powder.266 Despite these advantages, pasteurization affects the organoleptic 
and nutritional properties of milk through several modifications.171, 172, 267-269  
The components in milk start to change at 60 °C and the extent of damage gets intensified with 
the increase in temperature. Proteins such as Lf, Igs, BSA, β-LG, α-LA and caseins are 
modified in the 65-80 °C temperature range with the given treatment time.270 LTLT also results 
in damage of vitamin C, folacin, and B6.268 On the other hand, it has been reported that HTST 
causes less chemical changes when compared to LTLT.263 Siciliano et al. observed that heating 
milk at high temperatures (70-120 °C) damages and structurally modifies the proteins, thereby 
it showed noticeable changes in sensory qualities.269 Heating milk >70 °C denatures proteins 
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and damages the phospholipids in MFGM. The denaturation of proteins causes the release of 
H2S and results in the development of off-flavours. Furthermore, heat induces the association 
of whey proteins with MFGM through disulphide exchange reactions.271  
Martinez et al. reported that heating the milk above 100 °C results in lactose degradation and 
calcium phosphate precipitation that causes the formation of organic acids which finally results 
in drop of pH value.272 During UHT pasteurization, the milk components (lactose and lysine) 
react with each other through non-enzymatic browning reactions called Maillard reactions. 
This result in off-flavours, change in colour, and loss of amino acid lysine which has high 
nutritional benefits.273  
Although, pasteurization eliminates the vegetative and pathogenic bacteria in milk, heat has 
limited effect in spore-forming bacteria (example, B. Cereus spores). These bacterial spores 
can survive pasteurization processes and might contaminate milk again, thus limiting the shelf 
stability of the product.274 
Nada et al. have extensively studied and reported that the manufacturing and distribution 
dynamics in the milk industry are constantly affected while improving the shelf-life and 
safety.275 Moreover, the shelf-life of unopened, pasteurized milk is 8-14 days based on the 
intensity of the treatment. This utilizes a significant amount of energy to produce a short 
shelved product and hence the pasteurization process are neither effectively robust nor cost 
effective.268, 276 
1.7.7.2 High hydrostatic pressure 
High hydrostatic pressure (HHP) is extensively studied and considered as one of the emerging 
non-thermal methods in processing milk and to produce modified functional foods. It is the 
process of applying high pressure in the range 50-1000 MPa according to the type of food and 
the micro-organisms present. In 1899, Hite studied the effect of HHP on microbial inactivation 
in milk and found that HHP treatment at 680 MPa for 10 min delayed the spoilage of milk.277 
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The commercially available HHP treated products include juices, yoghurts, jellies etc.278-280 
Rastogi et al. found that HHP can be successfully applied to inactivate enzymes with minimal 
effects on nutritional and sensory components compared to heat treatment 281 
Several authors have reported that the vegetative bacteria in foods can be destroyed using HHP. 
The common proposed mechanism of inactivation is that HHP permeabilize the membrane to 
cause leakage of the contents of bacterial cells and also alters the proteins, enzymes and nucleic 
acids in them.282-284 The effect of HHP on microbial inactivation is dependent on the type and 
state of growth, the pressure and time of application, and the physico-chemical characteristics 
of food. HHP produces a restricted effect on bacterial spores compared to vegetative cells. Due 
to this, several authors used the combined treatment of HHP with heat and/or additives (for 
example, sorbic and benzoic acid, lysozyme, chitosan) to effectively inactivate microorganisms 
in foods.285, 286 The use of temperature in combination with HHP complements each other in 
inactivating spores and it is suggested that the increase in temperature affects the cells and its 
germination properties.287, 288 The effects of HHP on enzymes such as alkaline phosphatase, 
lactoperoxidase, γ-glutamyltransferase and phosphohexoseisomerase which are naturally 
present in milk, have been studied and commonly found that this technology can only partially 
inactivate or denature the enzymes.289, 290  
The effect of HHP on milk and milk products has been studied by several authors and studies 
suggest that this technology inactivates infectious food-borne pathogenic microorganisms, 
modifies functional properties and could be applied to the manufacture cheese, yoghurt and 
other dairy related products.291-297 
Several reports suggested that HHP alone has fewer effect on enzymes compared to thermal 
methods.289, 290, 298, 299 The effect of HHP on milk components mainly depends upon pH, 
treatment temperature and time. HHP treatment induces changes in milk appearance and casein 
particle size, denaturation of whey proteins such as β-LG, α-LA and Lf and induces the 
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interaction of whey proteins with casein micelles and MFGM through sulfhydryl-disulphide 
exchange with the thiol group from β-LG or from MFGM proteins.292-295  
Despite HHP treatment of milk being studied extensively, the commercialization of this 
technique is far behind due to the extent of changes that it induces to milk components, less 
effect on enzymes and the requirement of heat to accomplish the complete microbial 
inactivation. Moreover, HHP treatment of milk requires high capital cost and energy which 
therefore could increase the cost of processing and affect the affordability to consumers.300 
1.7.7.3 Pulsed electric field 
Pulsed electric fields (PEF) is emerging as one of the interesting alternatives to conventional 
thermal processing methods in liquid foods. In the early 1960s, PEF was introduced to 
inactivate microbes in foods.263 PEF is the process of applying electric field (approximately 
20-80 kV/cm) in foods to inactive microorganisms, enzymes, and/or modifying the product. 
The application of PEF causes temporal destabilization and perforation of the lipid bilayer and 
proteins of bacteria, and they re-seal once the electric field is stopped or removed. Whereas 
high intensity electric fields cause irreversible damage to microorganism through leakage of 
cellular contents or lysis of the cell wall preventing repair.301 The key factors that determine 
the efficiency of PEF in microbial inactivation are electric field strength, pulse length, pulse 
shape, number of pulses and initial temperature.302, 303 
PEF has been used in processing of liquid foods such as juices, milk, yoghurt, soups and liquid 
eggs. PEF was shown to inactivate various spoilage and pathogenic microorganisms with a 
marginal increase in temperature. Moreover, PEF has the advantage of causing lower fouling 
compared to thermal methods.304 Sampedro et al. did not observe a significant influence of 
PEF on the physical, chemical or sensorial properties of milk and taste was similar compared 
to pasteurised milk.305 Bendicho et al. observed a small reduction in the vitamin content of 
milk after intense PEF treatment with a large number of pulses.302 
62 
 
Shamsi et al. studied PEF treatments (25-37 kV cm-1 and up to 50 kV cm-1) plus temperature 
ranges of 30 °C to 75 °C in skim milk. They found that combining PEF treatment with heat 
increased the inactivation level of all enzymes and showed an increasing trend with the 
increasing field intensity and temperature. The size of casein micelles and fat globules was not 
affected by PEF treatment while severe heating of milk at 97 °C for 10 min decreased both 
micelle and fat globule sizes marginally.306 
Fernandez-Molina et al. found that PEF treatment is more effective in combination with high 
temperature. The high temperature and PEF enhanced the microbial inactivation, especially the 
temperature effects are dominated on the cell membrane properties, and reduced the thickness 
of the lipid bilayer to cause cell damage. They have shown that treated milk using this method 
has potential storage for up to 30 days.307 
Several authors found that PEF has limited effect on bacterial spore and enzyme inactivation. 
The recent investigations have focused on the use of combining PEF and heat to increase the 
inactivation efficiency in milk.305, 308 Wouters et al. reported that both microbial and enzyme 
inactivation by PEF are largely dependent on liquid composition, conductivity, ionic strength 
and pH.309 The presence of high fat and/or protein content seem to have a protective effect for 
bacteria during PEF treatment in milk, whereas PEF is more effective in liquid foods with low 
conductivity, i.e. low salt or ionic strength, however, other studies did not notice any influence 
of the above-mentioned parameters.302  
Bendicho et al. investigated the inactivation kinetics of enzymes such as alkaline phosphatase, 
plasmin, lipase and peroxidase present in milk using PEF. 302 The authors found varying effects 
on enzyme activity during PEF treatment. In their other work on enzymes of bacterial origin, 
they found only 13% inactivation of lipase from P. fluorescens.310 In contrast, it was found that 
PEF has effectively inactivated protease enzyme from Bacillus.303 Floury et al. found that PEF 
also affected proteins, especially casein micelles, decrease in viscosity and enhanced 
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coagulation properties of PEF-treated milk.311Xiang et al. observed an increase in the effective 
volume of the fat globule due to interaction with denatured skim milk serum proteins.312 The 
electric field intensity, number of pulses, and concentration of proteins in their study 
contributed to the alteration of whey proteins.312 Belloso found that the whey protein denatured 
in the order of α-LA > BSA > β-LG after PEF treatment.313 
1.7.7.4 Ultraviolet light 
Ultraviolet (UV) irradiation or light is also considered as one of the potential non-thermal 
methods. UV light is the process of applying light energy to foods to decontaminate and extend 
the product shelf life.  The common three types of UV light are, UV-A (315-400nm), UV-B 
(280-315nm) and UV-C (200-280nm).314, 315 The UV-C (200-280nm) possess antimicrobial 
activity and is effective to kill pathogens in this wavelength range, however beyond 300 nm 
this potential is limited. It was shown that this wavelength is efficient to kill micro-organisms 
such as bacteria, algae, yeasts, moulds, protozoa and viruses.316-318 The exposure of micro-
organism to UV-C light results in damage of DNA molecule due to thymine dimer formation 
which prevents the genetic processes such as transcription and replication that eventually leads 
to cell death.316-318 The key factors such as resistance of micro-organisms based on their type 
to UV light, and absorption properties of medium in which micro-organisms are suspended, 
and the UV dose applied to the medium determines the efficacy of UV light treatment.319, 320 
UV treatment have certain advantages such as low installation, production and maintenance 
costs, emits less carbon when compared to traditional decontamination methods.321, 322 UV light 
is generally regarded as suitable to reduce the microbial load in pumpable fruit and vegetable 
products. Moreover, since 2000, United States Food and Drug Administration (USFDA) has 
approved the use of UV radiation to treat fruit juices.323 
UV treatment received considerable interest as an alternative non-thermal method to treat 
milk.324 Several authors have reported the use of UV-C to decontaminate raw cow and goat 
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milk with different fat amounts and at different temperatures.325-327 Choudhary et al. used two 
coiled tube reactors and investigated the use of UV-C to inactivate Escherichia coli W1485 
and Bacillus cereus endospores in non-skimmed and skimmed raw cow milk at room 
temperature. They found that the microbial inactivation was higher in skimmed compared to 
non-skimmed cow milk.328 Krishnamurthy et al. has reported that pulsed UV has a higher 
penetration depth than continuous mode and has effectively reduced bacteria in milk.329 The 
key elements such as UV wavelength, intensity, thickness of the radiation path and flow 
turbulence determines the UV effects in milk. Werrrs et al. showed that the combination of 
H2O2 and UV radiation with or without heat produces a greater lethal effect on bacterial spores 
suspended in phosphate buffer solution compared to their individual counterpart effects.330 
They explained that the UV irradiation breaks down the H2O2 into OH radicals which then enter 
into the bacterial spore to achieve the bactericidal effect and the presence of heat enhanced this 
effect.  
Matak et al. reported on sensory properties of goat’s milk treated with UV technology. The 
extent of lipid oxidation and hydrolytic rancidity was measured by TBARS and acid degree 
values. However, sensory studies indicated that the increase in free fatty acids was not enough 
to cause detectable off-odors in the milk. The formation of pentanal, hexanal, and heptanal was 
identified and they were increasing significantly with the increase in UV dose. The chemical 
analyses supported the findings from the olfactory studies showed that UV irradiation at the 
wavelength 254 nm was detrimental to certain chemical properties of fluid milk.331 
Although UV treatment possess certain advantages in terms of capital and operating costs, it 
suffers in maintaining the sensory and nutritional quality of milk. The limitations in 
inactivating the microbes, loss of nutrients, lipid oxidation and formation of off-flavors in milk 
after UV treatment still remain as major challenges.324, 327, 331, 332  
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1.7.7.5 Ultrasound technology 
Ultrasound or ultrasonication is the process of generating waves with a frequency higher than 
20 kHz, to travel through gas, liquid and solid materials.333 Although, it was reported in the 
late 1920’s that ultrasound can be used to destroy microorganisms, it was not considered as a 
sterilization method until further improvement in the ultrasound technology had been made.334 
When ultrasound waves transmit into liquid medium, alternating compressions and expansion 
cycles are produced. Ultrasound waves create small bubbles which grow in the liquid medium 
during the expansion cycle, these small bubbles implode violently once they reach a stage when 
they can no longer absorb more energy. During this implosion, very high temperatures 
(~5500°C) and pressures (~50 MPa) are exerted inside these bubbles.335, 336 This violent 
collapse breaks the cell walls of micro-organisms which eventually leads to cell death.337 The 
effects of cavitation on micro-organisms are diffusion of microbial clumps, puncturing of cell 
wall, alternation in cellular activity, and increased heat sensitivity.338 Reports claimed that these 
could be the reasons for ultrasound mediated bacterial inactivation.339 However, the efficiency 
of ultrasonication depends on what type of micro-organism are tested, the suspending medium, 
cell size, and electrical power unit.337  
Ultrasound can be classified into two types based on the operating frequencies and power 
input.340 Low intensity ultrasound is operated in the regime of high frequencies (0.1–20 MHz) 
and low power levels (≤1Wcm-2). This method generally leaves the system unaltered and could 
be used as a tool to measuring food properties. High intensity ultrasound is often operated in 
the low frequency (≤0.1 MHz) range and high power (10-1000 W cm-2) which could alter 
physico-chemical properties of products.340 
Ultrasonication in milk depends on factors such as frequency, power, and stimulation time.341 
Ultrasonication is mainly used for the reduction of fat globules present in milk which efficiently 
homogenizes the milk. This technique reduces the particle size of MFGM and uniformly 
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distributes the smaller milk fat globules.342, 343  Also, this causes changes in the composition 
and structure of the  fat globule membrane that improves the homogenization in casein gel 
when compared to other methods.344 Ultrasonication treatment causes changes in milk protein 
secondary structure, protein particle aggregation, and denaturation which could help in the 
processing of several dairy foods.345 Many researches have demonstrated that the high power 
ultrasound technique improves the cheese or yogurt making process, by destroying bacteria 
and inactivating enzymes.346, 347  
The use of ultrasound in milk and milk products is generally to inactivate bacteria and enzymes, 
homogenize the fat globules, extract enzymes and hydrolyze lactose.348 Zenker et al. reported 
that ultrasound aided thermal treatments required lower processing temperatures to 
decontaminate milk compared to conventional thermal methods.349 Mano-thermo-sonication 
(MTS) is the method of combining ultrasound, heat and pressure to process liquid foods. Vercet 
et al. found that the use of MTS did not significantly affect the nutrient content of milk, whereas 
higher non-enzymatic browning was observed under MTS than under heat treatment.350 The 
same author, in other work, assessed the effect of MTS in milk for the production of yoghurt 
and found that MTS yoghurts had stronger structures which could be due to the increased 
viscosity and whey protein denaturation.351  
Annandarajah studied the feasibility of integrating ultrasound at short durations (≤ 60 s) to 
inactivate plasmin enzyme in milk as an adjunct to pasteurization, thereby extend shelf life. 
The author did not find any significant difference in reducing plasmin activity between control 
pasteurized and psychrosonicated samples followed by pasteurization, thus confirming that the 
major reduction of plasmin activity is a result of pasteurization.352  
Several authors studied the effect of high intensity ultrasound and heat treatment on fat, 
proteins and native enzymes in milk. They commonly found little effect on enzymes when 
ultrasound alone was used. On the other hand, the size of the fat globule was significantly 
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reduced and distributed evenly, whey proteins such as α-LA and β-LG and native enzymes 
such as alkaline phosphatase, lactoperoxidase and γ-glutamyltranspeptidase were highly 
denatured when ultrasound and heat was used combinedly.343, 353 It was reported that the 
ultrasonication hydrolyzed lactose into glucose and galactose by releasing the enzyme β-
galactosidase.354  
Ultrasound related studies in milk showed that this technique could produce only a slight effect 
on microbes and enzymes and could work better only in combination with heat and/or pressure 
treatments.349, 351 This requires higher energy consumption and increases the cost of processing. 
Although it has not been well studied,  ultrasonication treatment might induce changes in some 
physiochemical properties, off-flavours of food products, degradation of some components and 
changes in physical properties.355 Moreover, this might be difficult to scale up and bring the 
technology to commercial application.  
1.7.8 Research challenges, objectives and our approach 
As discussed current pasteurization techniques are known to induce changes in the physico-
chemical characteristics of milk and milk products. These changes are protein denaturation, fat 
agglomeration, loss of vitamins, lactose degradation, browning reactions, and flavor.263, 268-271, 
273   
Non-thermal technologies such as high hydrostatic pressure, ultrasound, pulsed electric field 
and UV radiation suffer from lower efficiencies, extensive treatment times, specialized 
equipment requirements and the requirement of additional heat to achieve effective 
inactivation, energy consumption, capital and processing costs. These significant challenges 
make the emerging non-thermal technologies difficult to scale up to an industrial level.  
Atmospheric pressure plasma is one of the emerging potential non-thermal technique which 
has been demonstrated to kill bacteria either in solid or liquid food matrices without a 
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significant increase in temperature during food processing.356, 357 Plasma, in and in contact with 
liquid, produces both chemical (short lived species mainly O, OH radicals and long lived 
species mainly H2O2, NO3) and physical effects (PEF and UV radiation).17, 358 These effects 
were reported to involve etching of the cell surface or membrane, leakage of contents, DNA 
damage and volatilization of compounds.61, 359  
However, there are very few studies examining plasma treatment on microbial quantity, shelf 
life and physicochemical characteristics in milk.360, 361 Gurol et.al demonstrated that corona 
discharge can significantly reduce E. coli colony forming units without having any negative 
effects on pH and color measurements in milk.360 Kim et.al achieved aerobic bacterial 
reduction using dielectric barrier discharge and noticed non-significant changes in the fatty 
acid composition of milk.361 Rahman et.al investigated pulsed high voltage discharges and 
proposed shock waves might play a critical role to kill bacteria in milk.362 The previous plasma 
related milk studies have produced plasma (such as corona and dielectric barrier discharge) 
above the liquid (milk) surface where it might be difficult to achieve high production of 
controlled and selective reactive species. This could be due to the interference from the 
atmospheric air and recombination of reactive species in the air before diffusing into milk. 
Therefore, a technology which improves the microbial safety and extend shelf life while 
maintaining nutritional qualities of milk is still lacking.  
As mentioned earlier, the direct discharge in liquid requires higher electric field, resulting in 
faster electrode erosion and thereby reducing the life time of electrodes, whereas the discharge 
in gas phase faces issues of less selectivity in reactive species, interference from atmospheric 
air and formation of unwanted by-products.19, 20, 34, 35 Several researchers have developed a 
method of generating plasma in bubbles that are externally injected into liquids to reduce the 
energy consumption, electrode erosion, control and increase the gas-liquid interface reactions, 
thereby improving the productivity of physical and chemical processes in liquid.19, 20, 34-38 
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These advantages can help extend the application of plasma technology to treating thermally 
sensitive materials, especially liquid foods. 
Several authors reported that the discharge in bubbles that are externally injected into liquids 
(water) produce chemical and physical effects based on the composition of gas in the bubble 
(and its size), conductivity of the liquid and input power.11 In other work, we have shown that 
the discharge at higher frequency created more fragmentation in gas bubbles which decreased 
the size and increased the number of bubbles in DI water.34 This increased the interface 
reactions between the gas-plasma and liquid. The increase in the interface reactions, along with 
the movement of bubbles, enabled higher production of selective reactive species based on the 
chosen gas.34  
The major requirements of the dairy industry are the use of low temperature and fewer 
chemicals to reduce the bacterial load, increase shelf life with minimal or no changes in the 
nutritional quality of milk. To address these challenges associated with thermal and non-
thermal decontamination technologies, our approach aimed to develop a technique using 
nanosecond pulsed atmospheric pressure plasma in bubbles that are externally introduced in 
milk (set up II is shown in Figure 1.8) to decontaminate, extend shelf life whilst protecting 
nutrition. This approach includes the following steps. 
 Decontamination of milk to extend shelf life  
 Assessing the effect of plasma on proteins, lipids, carbohydrates and micro RNA 
present in milk  
The development of this kind of technology has potential applications in the dairy industry, 
including in cheese making, butter, cream and yoghurt production. This technology may also 
be used to treat human breast milk and other types of milk (for example buffalo, goat and sheep 
etc.). 
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Figure 1.8. Schematic view of plasma in bubbles that are externally introduced using a hollow 
needle electrode (top) and mesh electrode (bottom) immersed in liquid (milk or water) 
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Chapter 2 Fabrication of Boron Nitride Nanotube-Gold Nanoparticle Hybrids using 
Pulsed Plasma in Liquid 
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Abstract  
Plasma, generated in liquid at atmospheric pressure by a nanosecond pulsed voltage, was used 
to fabricate hybrid structures from boron nitride nanotubes and gold nanoparticles in de-ionized 
water. The pH was greatly reduced, conductivity was significantly increased and concentration 
of reactive oxygen and nitrogen species in the water were increased by the plasma treatment. 
The treatment reduced the length of the nanotubes, giving more individual cup-like structures, 
and introduced functional groups onto the surface. Gold nanoparticles were successively 
assembled onto the functionalized surfaces. The reactive species from the liquid plasma along 
with the nanosecond pulsed electric field seem to play a role in the shortening and 
functionalization of the nanotubes and the assembly of gold nanoparticles. The potential for 
targeted drug delivery was tested in a preliminary investigation using doxorubicin-loaded 
plasma-treated nanotubes which were effective at killing ~99% of prostate cancer cells. 
Graphical Abstract 
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Plasma in liquid was used to shorten and functionalize boron nitride nanotubes yielding short 
tubes and nanocups with attached gold nanoparticles 
Note: In this chapter, the term ‘liquid plasma’ refers to the plasma in gas phase generated above 
the liquid surface. 
2.1 Introduction 
Hybrid nanostructures using assemblies of nanotubes and nanoparticles have been investigated 
for hetero-junctions, hydrogen storage and gas sensors.129, 364, 365 The hybrid structure can help 
to integrate the useful properties of the nanotubes and nanoparticles and also benefit from 
synergies of their physical and chemical properties. These hybrid nanostructures have been 
used in biosensors but also have other bio-applications such as drug delivery and anti-cancer 
treatment.366, 367 The aim here was to fabricate a hybrid structure of boron nitride nanotubes 
(BNNTs) with gold nanoparticle using the new technique of generating plasma in liquids and 
evaluation of their potential for drug delivery. The fabrication necessitated shortening and 
functionalization of the BNNTs and assembly of gold nanoparticles onto the functionalized 
surface.  
Carbon nanotubes (CNTs) have been predominantly been used in hybrids, so far, but possible  
CNT cytotoxicity remains an issue.368, 369 Boron nitride nanotubes are structural analogues of 
CNTs with promising mechanical, thermal and chemical properties compared to CNTs, which 
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makes them suitable for potential bio-applications.70, 71, 78, 370-372 However, improving the 
process-ability, i.e. shortening, functionalization and attachment of nanoparticles onto BNNTs, 
is the main challenge. Especially in biological applications, the long nanotubes may behave 
like an asbestos fibre with difficulty in cell uptake and cell toxicity.116, 373, 374 Recently, the use 
of short nanotubes and their advantages of improved biocompatibility and easy cellular uptake 
for bio-applications have been discussed.375 Vandsburger et al. have claimed that oxidation 
induced by gaseous oxygen plasma discharge can play a key role in reducing the length of 
CNTs.148 The production of boron nitride nanocups (BNNCs), a kind of hollow BN 
nanomaterial, might also be an additional advantage.376  
Shortening can improve the performance of BNNTs to a certain level, however 
functionalization of BNNTs is essential for specific interactions (for example in targeted drug 
delivery) and also for the attachment of nanoparticles. A simple and effective method of 
functionalization is still required to overcome the problems of instability of the treatment, 
low density of functional groups and damage to the nanotube structure.136, 138, 139 It has been 
reported that the controlled surface functionalization of BNNTs can be achieved by gentle 
low pressure gas plasma treatment while maintaining the intrinsic nanotube structure.152, 
377 
There have been a few attempts to modify BNNTs with nanoparticles such as tin dioxide 
(SnO2), gold (Au) and iron (Fe) with the help of non-specific interactions.127, 129, 143 Except for 
the SnO2 nanoparticles, either Au or Fe nanoparticles did not entirely cover the BNNTs. 
However, Sainsbury et al. showed that Au nanoparticles can fully cover BNNTs using S-Au 
chemistry.128 
Plasma-aided nanofabrication is an alternative approach that can be applied both to produce 
nanostructures and uniformly tailor the surface of nanomaterials in a well-controlled manner. 
It has been claimed that oxidation induced by a low pressure gaseous oxygen plasma discharge 
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can be used to shorten nanotubes.148 It has also been shown that low pressure gas plasma can 
be used to functionalize nanotubes.152, 377 The use of atmospheric pressure plasma in liquids is 
a new approach which has been investigated for the surface modification of different 
nanomaterials and substrates.158, 159  
In this work, a new “liquid plasma” method was developed to fabricate boron nitride nanotube-
gold nanoparticle hybrid nanostructures using a nanosecond pulse atmospheric pressure plasma 
system (NPAPP) in a two-step process. The first step was to shorten and functionalize the 
BNNTs and the second step was to assemble the gold nanoparticles onto the functionalized 
short BNNTs, both using liquid plasma. In order to understand the chemistry, the changes in 
pH, conductivity and the concentration of reactive oxygen and nitrogen species were recorded 
after the plasma treatment in water. The plasma treated materials were characterized by 
transmission electron microscopy and X-ray photo electron spectroscopy. The potential of the 
plasma treated nanotubes to deliver drugs was tested in a preliminary investigation in which 
prostate cancer cells were exposed to the untreated and plasma-treated BNNTs at different 
volumes, with and without the model drug doxorubicin. 
2.2 Experimental Section 
2.2.1 Plasma system description 
Liquid plasma is a system that consists of a nanosecond pulse generator, two output channel 
electrodes and the reaction chamber with 10 mL of DI water. The two electrodes, with one 
electrode inside the liquid (bottom) and the other electrode 3 mm above the liquid (top) are 
shown in scheme 2.1. The plasma is generated between the top electrode and the bottom 
electrode using argon gas with a flow rate of 0.083 L/min. The pulse parameters were 10 
nanosecond pulse width, 10 kHz frequency and ±15 kV voltage. 
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Scheme 2.1. Schematic view of nanosecond pulse atmospheric pressure plasma system, using 
argon gas 
2.2.2 Synthesis of BNNTs 
Ball milling was used to produce the BNNTs. Initially, a few grams of B powder and 10 wt% 
Fe (NO3)3.9H2O were sealed in a rotating steel-milling jar with four hardened steel balls where 
the ball to powder ratio was 132:1. Prior to the milling treatment, anhydrous ammonia (NH3) 
as the reaction gas was aerated into the jar with a static pressure of 300 kPa. The milling process 
lasted for 150 hours to produce nanosized B particles with metastable structures. Finally, the 
milled sample was placed in a crucible which was positioned in the middle of a horizontal tube 
furnace and heated to 1100 °C in N2 + 15% H2 atmosphere to produce BNNTs.378 The BNNTs 
had a length of 12-15 µm. 
2.2.3 Synthesis of GNPs 
An equal volume of aqueous hydrogen tetrachloroaurate (III) solution (HAuCl4.3H2O) (5 ml, 
10 mM, 37 °C) was mixed with bovine serum albumin (BSA, Bovogen Biologicals) solution 
(5 ml, 50 mg/ml, 37 °C), under vigorous stirring. After two minutes, sodium hydroxide (NaOH) 
solution (0.5 ml, 1 M) was added to the mixture which was incubated at 37 °C for a maximum 
of 12 hr. After this addition, the colour of the solution changed from light yellow to light brown 
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and then to dark brown.379 The final product was purified by centrifugation at 7000 rpm for 15 
minutes and then filtered with a 0.22 µm syringe filter. Prior to use, all glassware was washed 
with Aqua Regia (hydrogen chloride (HCl): nitric acid (HNO3), volume ratio – 3:1) and rinsed 
with ethanol and Millipore water. 
2.2.4 Hybrid nanostructure 
Liquid plasma was used to 1) produce short BNNTs and BNNCs from long bamboo-like 
BNNTs and to functionalize the surface of short BNNTs and BNNCs and then 2) to assemble 
GNPs onto the functionalized short BNNTs and BNNCs, as shown in scheme 2.2.  
The as-synthesized BNNTs were added to 10 ml of de-ionized water and magnetically stirred 
at a constant 1000 rpm for 5 minutes to make a uniform suspension. These uniformly suspended 
BNNTs were then treated by the liquid plasma for 15 minutes with an argon gas flow rate of 
0.083 L/min.  
For comparison, pure GNPs were allowed to assemble onto the liquid plasma treated BNNTs 
separately under two conditions i) in liquid plasma for 15 minutes and ii) undisturbed for 12 
hours at room temperature. 1.4 mL of purified gold nanoparticles (1:10 dilution) were added 
to the plasma treated BNNTs, and magnetically stirred at a constant 1000 rpm for 5 minutes to 
make a uniform suspension. This solution was equally divided into two parts. 
1) One part of this solution was then treated by the liquid plasma for 15 minutes with an 
argon gas flow rate of 0.083 L/min.  
2) The other part of the solution was left undisturbed for 12 hours. 
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Scheme 2.2. Schematic view of shortening, surface functionalization of short BNNTs and 
BNNCs and attachment of GNPs 
2.2.5 pH and Conductivity 
pH (TPS, Australia) and Conductivity (TPS, Australia) probes were used to measure the pH 
and conductivity of the plasma treated de-ionized water.  
2.2.6 Reactive oxygen and nitrogen species measurement 
2.2.6.1 Hydrogen peroxide 
Hydrogen peroxide (H2O2) concentration was measured using the potassium permanganate 
method.380 In a titration, plasma treated water which contains H2O2, reduces the potassium 
permanganate to a colourless product.  
2.2.6.2 Nitrite and Nitrate 
Nitrite and Nitrate concentration was measured using a flow injection analysis method (at 
Eurofins laboratory, Melbourne) 
2.2.7 Drug loading 
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Doxorubicin (Sigma Aldrich) model drug (0.6 mg/mL) was mixed with untreated and plasma 
treated BNNTs. The absorbance values were measured at 490 nm, immediately and after 16 
hours to estimate the amount of drug loaded onto the untreated and plasma treated BNNTs. 
The reduction in the absorbance values of doxorubicin at 490 nm indicated the adsorption and 
loading of the drug on to the BNNTs. Loading capacity of the BNNTs were calculated as 
follows 
%	Drug	loading	capacity ൌ ሾ ୅ୠୱ୭୰ୠୟ୬ୡୣ	୭୤	୪୭ୟୢୣୢ	ୱୟ୫୮୪ୣୱ ୅ୠୱ୭୰ୠୟ୬ୡୣ	୭୤	୆୒୒୘ୱ⁄୅ୠୱ୭୰ୠୟ୬ୡୣ	୭୤	୮୳୰ୣ	ୢ୭୶୭୰୳ୠ୧ୡ୧୬ ୅ୠୱ୭୰ୠୟ୬ୡୣ	୭୤	୆୒୒୘ୱ⁄ ሿ ൈ 100 
2.2.8 Cell Lines and cell culture conditions 
Human prostate adenocarcinoma cells (DU145) were obtained from American type culture 
collection (ATCC), Manassas, VA, USA. Minimum Essential Media with Earle’s salts 
(EMEM) was purchased from Gibco, Australia. The growth factor, fetal bovine serum (FBS) 
was purchased from Bovogen, Australia. The antimycotic-antibiotic and 
penicillin/streptomycin were purchased from Gibco, Australia. The 0.25% Trypsin/EDTA was 
purchased from Gibco, Australia. Cells were cultured at 37 °C in EMEM containing 10% FBS 
in an incubator with 5% CO₂. Media was changed every 3 days and once the cells reached a 
confluency level of 80-90% in the culture flasks, they were trypsinized.   
2.2.9 Analysis of cell proliferation by CyQuant assay  
In order to observe the effect of untreated and plasma treated BNNTs on the proliferation of 
prostate cancer cells (DU145),  a CyQuant assay was performed which has been accepted as 
an optimum quantitative measure of cell proliferation.381 2 x103 cells were seeded in 96 well 
plates and once confluent they were exposed for 24 hours to the untreated and plasma treated 
BNNTs at different volumes (30, 60 and 90 µL) with and without doxorubicin drug (0.6 
mg/mL). Untreated cells cultured in complete growth media were used as the positive control 
and the cells treated with 1% Triton-X-100 were used as the negative control. After media 
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removal, the plates were wrapped in foil and stored at -80 °C for a little over 24 hours. The 
CyQuant reagents were added to cells according to manufacturer’s instructions (Invitrogen, 
Australia). In short, 20 μL of CyQuant GR dye was diluted 400 fold in 1X lysis buffer which 
was prepared by diluting 400 μL of component B into 7.6 mL sterile water and 200 μL of this 
solution was added per well in the dark. Fluorescence readings were taken at 480/520 
(absorbance/emission) and percentage cell proliferation was calculated relative to the controls. 
Also, the changes in the cell morphology caused by the cytotoxicity of these BNNTs were 
observed using an inverted light microscope. 
2.3 Results and Discussion  
2.3.1 Shortening of BNNTS 
Long, bamboo-like BNNTs were produced by a ball milling and annealing method.378 The 
diameter of the long, bamboo-like BNNTs was in the range ~40-60 nm with lengths up to ~12-
15 µm (Figure 2.1a). The as-synthesized long BNNTs were treated by the liquid plasma for 15 
minutes which resulted not only in shortening of the BNNTs and separation into BNNCs 
(Figure 2.1) but also functionalized the short BNNTs and BNNCs in a single step (Figure 2.2).  
After liquid plasma treatment for 15 minutes, the length of the BNNTs was reduced from ~12-
15 µm to ~1-2 µm (see Fig. 2.1a and 2.1b-d) and the observed BNNCs were ~100-200 nm 
(Figure 2.1e inset). The comparison of peak length distribution of untreated (~12-15 µm) and 
plasma treated BNNTs (~1-2 µm) is shown in Figure S2.1 of the supporting information. It has 
been reported that the exposure of atmospheric pressure plasma to a liquid creates an acidic 
environment that consists of reactive oxygen (hydroxyl radicals, ozone, hydrogen peroxide, 
superoxide anions, singlet oxygen) and nitrogen species (nitric oxide, nitrite, peroxynitrite and 
nitrate).382-385  
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Figure 2.1. TEM images of a) untreated and b) to d) liquid plasma treated BNNTs on a carbon 
coated grid. e) Inset showed the magnified image of individual BNNCs 
In order to understand the chemistry of the plasma treated aqueous solution, de-ionized water 
was separately treated by liquid plasma at 5, 10 and 15 minutes. The changes in pH, 
conductivity and the concentration of reactive oxygen and nitrogen species were recorded after 
plasma treatment in water. It was found that the pH values were drastically reduced and the 
conductivity values were increased with respect to increase in plasma treatment time (Table 
S2.1, supporting information). This suggests the generation of reactive oxygen and nitrogen 
species from the plasma which has also been observed by others.385, 386 The importance was 
particularly paid to measure the increase in the concentration of long lived species like 
hydrogen peroxide (Table S2.1, supporting information) and nitrate (25 and 49 mg/L at 5 and 
10 minutes respectively) which may play a significant role in the shortening of BNNTs.  
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In X-ray photoelectron spectroscopy (XPS), it was also observed that the atomic percentage of 
oxygen on the BNNT surface was increased from 8 to 27.4% (Figure S2.2, supporting 
information) after plasma treatment, which suggests that the produced reactive oxygen species 
like hydrogen peroxide contributed for the increase in the percentage of atomic oxygen. The 
shortening of BNNTs might be attributed to the reactive oxygen species like hydrogen peroxide 
from the plasma which oxidize the nanotube ends and cup junctions, thus promoting the 
shortening of nanotubes and/or separation of the cups (Figure 2.1). This hypothesis appears 
also to be supported by reports which utilized chemical methods (using hydrogen peroxide) to 
shorten BNNTs by oxidation.387 The shortening may depend upon the level of reactive oxygen 
species formed in liquid or the plasma treatment time. It may also be due to physical processes 
such as the strong nanosecond pulsed electric field from the plasma,17 which may attack 
defective sites of nanotubes. As a result of shortening, an increase in the dispersibility of the 
BNNTs (clear suspension) was observed. Golberg et al. have also observed that the shortening 
of BNNTs increases their dispersibility and drug loading potential.375  
4.3.2 Functionalization of shortened BNNTS and BNNCS 
The X-ray Photoelectron Spectroscopy (XPS), N1s peak for the liquid plasma treated BNNTs 
is shown in Fig. 4.2a and the peak for the untreated sample is shown in the inset. The treated 
sample showed an additional peak at 406.8 eV (N-O) for the N1s peak (Figure 2.2a), which 
was only observed after liquid plasma treatment and was not observed in the gas plasma 
treatment.152 One possible mechanism is that the reactive oxygen species including hydrogen 
peroxide (H2O2) from the liquid plasma may oxidize the nitrogen sites of BNNTs. Studies of 
the oxidation of BNNTs by other methods have reported that the oxidation affects only the ‘B’ 
site.132, 388 In this work, no change in the B1s, XPS spectrum was observed after plasma 
treatment (Figure S2.3, supporting information). Another mechanism is that some NOx groups 
(nitrate-NO3- or nitrite-NO2-) formed at the gas-liquid interface, diffuse into the liquid and then 
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attach to the surface of the BNNTs and BNNCs. However, in this work, argon was used as the 
working gas (free of air) and so the amount of reactive nitrogen species formed should be less 
than that from plasma generated using air.389 This suggests that the possibility of reactive 
nitrogen species playing a role is very limited.  
It was found that the N-O component, as a fraction of the total N1s peak area, was increased 
by prolonged plasma treatment time (Figure S2.4, supporting information for more details). 
The other peaks at 397.9 eV and 399.8 eV in Fig 2.2a, correspond to N-B and N-H 
functionalities. The C1s peak for the liquid plasma treated BNNTs is shown in Figure 2.2b and 
the peak for the untreated sample is shown in the inset. The treated sample showed two 
additional peaks at 286.4 eV and 288.3 eV, indicating that OH and OOH functional groups390 
were successfully introduced onto the surface of shortened BNNTs/BNNCs. This 
functionalization facilitated the easy attachment of gold nanoparticles onto the surface of 
BNNTs and BNNCs. 
 
Figure 2.2. XPS spectra of liquid plasma treated BNNTs a) N1s and b) C1s. Inset shows the 
N1s and C1s spectra of untreated BNNTs 
4.3.3 Assembly of GNPs onto functionalized short BNNTS and BNNCS 
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Gold nanoparticles were produced using the bovine serum albumin (BSA) method (see 
experimental section).379 GNPs were chosen particularly because of their well-established 
unique physical, chemical and biological properties for applications in bio-imaging and 
biosensors. The synthesized GNPs were characterized by transmission electron spectroscopy 
(TEM) and XPS. TEM images (Figure S2.5, supporting information) showed that the average 
diameter of GNPs was ~5±2 nm. XPS showed a single doublet with a principal peak at 83.5 
eV which corresponds to (metallic) Au4f7/2 (Figure S2.6, supporting information). 
For comparison, pure GNPs were allowed to assemble onto the functionalized short BNNTs 
separately under two different conditions: in liquid plasma for 15 minutes and undisturbed for 
12 hours at room temperature. 
A comparison of Figures 2.3a and 2.3b indicates that the GNPs were more effectively 
assembled onto the BNNTs in the liquid plasma than when left undisturbed for 12 hours. 
Notably, the GNPs were partially aligned and assembled especially at the centre and cup 
joints/necks of BNNTs (see Figure S2.7, supporting information). This can be possibly 
explained by the influence of reactive oxygen species which leads to localized oxidation at the 
center and cup joints of BNNTs, and as a result of functionalization (OH and OOH groups) the 
GNPs were assembled there.  It may also be due to the increased conductivity of the liquid by 
adding GNPs, together with the defective sites of BNNTs/BNNCs, result in a redistribution of 
the electric field.  This redistributed electric field might contribute the assembly of the GNPs 
only at the center and cup joints of BNNTs. Interestingly, in some instances, the GNPs 
assembled around the tip of a short BNNT (inset Figure 2.3c) which further suggests that liquid 
plasma effect is stronger at the defective regions. 
It should be noted that the efficiency of hybrid nanostructure fabrication may depend upon the 
level of reactive species in water. The reactive species like ozone in the liquid may disappear 
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quickly due to their short lifetimes at atmospheric conditions and the long lived species like 
hydrogen peroxide may play a key role in the effective fabrication of hybrid nanostructures.  
Figure 2.3. TEM images of the functionalized BNNTs with GNPs under a) undisturbed for 12 
hours and b) liquid plasma for 15 minutes. Inset c) shows the assembly of GNPs around the tip 
of a short BNNT. Black arrows indicates the GNPs attached to BNNTs 
2.3.4 Chemistry involved in the assembly 
A proposed mechanism is that the OH and OOH functional groups at the surface of liquid 
plasma treated BNNTs and BNNCs have a strong affinity to the sulphur group from the 35 
cysteine residues of BSA covered GNPs as shown in scheme 2.3. The Sulphur (S2p) XPS 
spectra of (a) synthesized GNPs, (b) functionalized BNNTs with GNPs left undisturbed for 12 
hours and (c) functionalized BNNTs with GNPs in liquid plasma for 15 minutes (c) are shown 
in Figure 2.4. This comparison (Figure 2.4) can be used to explain the changes in chemistry 
involved in the attachment of GNPs to the surface of BNNTs/BNNCs. The XPS scans of 
sulphur showed two peaks i) sulphur (right) and ii) oxidized sulphur (left). After the liquid 
plasma treatment, the intensity of the sulphur peaks was greatly reduced and the intensity of 
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the oxidized sulphur peaks was significantly increased in (b) and (c). In addition, the position 
of the sulphur peaks was unchanged but the oxidized sulphur peaks were slightly shifted in (b) 
and (c) after the plasma treatment (brown dotted lines). This peak shift resulted from the 
conversion of the sulphur (S) to sulphones (-S(=O)2-) when attaching to OH or OOH functional 
groups on the BNNTs (as described in Scheme 2.3). These changes suggest that the BSA 
(which contains sulphur residues) covered GNPs were more oxidized in (b) and (c) compared 
to (a) due to the presence of reactive oxygen species from the plasma. It was observed that the 
intensity of the oxidized sulphur peak in (b) was also equivalent to (c). This could be due to 
the prolonged incubation (12 hours) of GNPs in the plasma treated BNNTs, but the equivalent 
intensity of oxidized sulphur peak was achieved in (c) when liquid plasma was used it for 15 
minutes. This effective assembly of GNPs to BNNTs shows that pulsed liquid plasma has the 
capability to produce hybrid nanostructures in a short time. 
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Figure 2.4. XPS, Sulphur (S2p) spectrum of synthesized GNPs (a), functionalized BNNTs with 
GNPs left undisturbed for 12 hours (b) and functionalized BNNTs with GNPs in liquid plasma 
for 15 minutes (c) 
Scheme 2.3. Schematic of chemistry involved in the attachment of GNPs to the BNNTs by the 
liquid plasma treatment 
2.3.5 Potential of plasma-treated BNNTS as an anti-cancer agent  
In a preliminary trial to understand the biological interaction of BNNTs, the ability to hold 
more drug molecules (loading capacity) and cytotoxicity of untreated and plasma treated 
BNNTs were assessed. The decrease in the doxorubicin absorbance indicated that the drug 
loading on to the BNNTs was efficient. It was observed that the plasma treated BNNTs can 
hold more drug molecules (~36%) than the untreated BNNTs (Figure 2.5). Golberg et al. also 
observed that the BNNTs shortened by chemical methods can hold more drug molecules.375 
They demonstrated that shortened BNNTs possess a hole-rich (i.e. porous) structure and more 
ends which might provide i) increased possibilities for molecules to enter the tubes instead of 
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solely locating on the surface and ii) better dispersibility which enhances the chance of BNNT-
molecule interaction. These advantages suggest that shortened BNNTs might be useful for 
efficient drug delivery systems. 
 
Figure 2.5. Doxorubicin model drug (0.6 mg/mL) was mixed with untreated and plasma treated 
BNNTs. The absorbance values were measured at 490 nm, immediately and after 16 hours. 
Results are expressed as mean ± standard deviation of triplicate determinations. 
The cytotoxicity of untreated and plasma treated BNNTs in these cells (DU145) was quantified 
by their ability to inhibit cell proliferation by CyQuant assay which measures the cellular DNA 
content to quantify the amount of cell proliferation. The results indicate that plasma treated 
BNNTs were more efficient in arresting cell proliferation when compared to the untreated 
BNNTs. An average of 36% and 80% of prostate cancer cells exposed to untreated BNNTs 
without and with doxorubicin at different concentrations were killed (Figure 2.6) respectively. 
Whereas, an average of 78% and 97% of prostate cancer cells exposed to plasma treated 
BNNTs without and with doxorubicin at different concentrations were killed (Figure 2.6). This 
result also suggests that the plasma treated BNNTs have a greater ability to deliver the cytotoxic 
drug to the cells in comparison to the untreated BNNTs. The morphology of the cells was also 
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altered upon treatment (Figure 2.7(ii)) and the integrity of cellular adherent monolayer was 
compromised resulting in the increasing number of floating cells (Figure 2.7(iv)). It was 
observed that the cells were unhealthy with the presence of several membrane blebs and 
apoptotic bodies indicating the process of apoptosis leading to cell death (Figure 2.7(iii)) and 
at a higher concentration almost all the cells were detached and were floating on the top surface 
which confirmed the cell death (Figure 2.7(v)). The increased number of dead cells in plasma 
treated BNNTs is presumably because they were shorter, easier for the cells to uptake, held 
more drug and had higher specificity because of the presence of functional groups. The 
increased cytotoxicity confirms that pulsed liquid plasma has the potential to produce hybrid 
nanostructures with significant advantages.  
Figure 2.6. Cell viability assay of DU145 Prostate cancer cells, treated with different volumes 
(30 µL and 90 µL) of i) control, ii) untreated BNNTs, iii) plasma treated BNNTs with iv) and 
without v) doxorubicin drug (0.6mg/mL). 1% Triton X was used as a negative control. Cell 
viability results are expressed as mean ± standard deviation of triplicate determinations 
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Figure 2.7. Cell culture images of DU145 Prostate cancer cells, exposed with different volumes 
(30 µL (top) and 90 µL (bottom)) of i) control, ii) untreated BNNTs, iii) plasma treated BNNTs 
without doxorubicin drug, iv) untreated BNNTs and v) plasma treated BNNTs with doxorubicin 
(0.6mg/mL). Cells were analyzed at different spots and then all images were taken at 10X 
magnification. 
2.4 Conclusion 
Liquid plasma, produced by nanosecond pulses, provided an efficient and simple way to 
shorten and functionalize BNNTs and also to fabricate a hybrid nanostructure. The chemical 
reactive oxygen and nitrogen species in synergy with physical processes such as nanosecond 
pulsed electric field from plasma, may have significantly contributed to the reduced length of 
the BNNTs, and formation of nanocups, to the surface functionalization and to the more 
efficient fabrication of hybrid nanostructures. The shortening enhanced the dispersibility and 
drug loading potential of the BNNTs and the functionalization facilitated the effective 
assembly of gold nanoparticles onto the BNNTs. The plasma treated BNNTs possess the ability 
to carry more drug molecules and contain desired functional groups on their surface for easier 
uptake by cells. These factors played a significant role in increasing cytotoxicity in prostate 
cancer cells. Deeper studies on the role of reactive species and plasma parameters in the 
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shortening and functionalization of nanotubes and assembly of gold nanoparticles are 
underway. The efficacy of an optimized nanotubes and hybrid structures for targeted drug 
delivery could then be assessed. 
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Supporting Information 
Characterization 
The physical structure of the surface of BNNTs and GNPs was analyzed by a JEOL 2010 
TEM with EDX and Gatan image filter at an acceleration voltage of 200 kV. The chemical 
structure of the surface of BNNTs and GNPs was characterized by X-ray photoelectron 
spectroscopy (XPS). The fabricated hybrid nanostructures were studied by TEM and XPS. 
XPS results 
The XPS spectra (Figure S2.2) show an increase in the atomic percentage of oxygen (O 1s 
peak area) in plasma treated BNNTs compared to untreated BNNTs. There was no change in 
the boron (B 1s) spectrum of both untreated and liquid plasma treated BNNTs (Figure S2.3). 
There is an increase in the percentage of N−O with increased liquid plasma treatment time. 
93 
 
Figure S2.1. Length distribution of plasma treated (left) and untreated BNNTs (right).  Total 
number of nanotubes, plasma treated =180, untreated = 189 
Table S2.1. pH, conductivity and hydrogen peroxide concentration measurements in deionized 
water at different plasma treatment times 
Parameters/plasma 
treatment time 
5 min 10 min 15 min 
pH 3.8 2.9 2.7 
Conductivity 
(µS/cm) 
420.3 605.0 818.0 
Hydrogen peroxide 
(mg/L) 
28.9 51.0 81.6 
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Figure S2.2. XPS, Oxygen (O 1s) spectrum showed an increase in O 1s peak area for untreated 
(8%) and plasma treated BNNTs (27.4%) 
 
Figure S2.3. XPS, Boron (B 1s) spectrum showing no significant shift (dotted lines) between 
(a) untreated and (b) liquid plasma treated BNNTs 
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Figure S2.4. XPS, Nitrogen (N 1s) spectrum showing an increase in oxidation of nitrogen 
(N−O peak area−black arrows) with increased plasma treatment time. Liquid plasma 
functionalized BNNTs with GNPs a) undisturbed for 12 h (includes functionalization of BNNTs 
(15 min)) and b) liquid plasma for 15 min (includes functionalization of BNNTs (15 min) + 
assembly of GNPs (15 min)) 
 
Figure S2.5. TEM image of synthesized GNPs. Inset shows a magnified image of the GNPs 
(scale bar 20 nm) 
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Figure S2.6. XPS spectrum of synthesized GNPs showing a single doublet with principal peak 
at 83.5 eV corresponding to Au4f7/2 (metallic) 
 
Figure S2.7. TEM images of the functionalized short boron nitride nanotubes with 
randomly assembled GNPs using liquid plasma for 15 minutes 
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Chapter 3 Argon Gas Plasma to Decontaminate and extend Shelf Life of Milk 
3.1 Prelude 
The previous chapter (2) focused on the generation of a plasma discharge in gas phase above 
the liquid surface (set up I). The key challenges faced during the generation of plasma above 
the liquid surface were the difficulty in selecting the desired reactive species and achieving 
high production of the same. The selectivity of required reactive species was hindered mainly 
due to the presence of atmospheric air present in between the top and bottom electrode (liquid) 
which interfered during the recombination of gas phase reactive species before diffusing into 
the liquid, thus limiting the productivity of required reactive species.  
To address the above challenges, Dai et al. had developed a plasma gas bubble-in-liquid 
method, in which the chosen gas was introduced into the liquid through a hollow needle to 
produce bubbles. The plasma was generated in bubbles present in between the hollow needle 
and mesh electrode (see below scheme).34 This work was published in Plasma Processes and 
Polymers Journal and I contributed 10% of this work. 
Citation: 
X. J. Dai, C. S. Corr, S. B. Ponraj, M. Maniruzzaman, A. T. Ambujakshan, Z. Chen, L. Kviz, 
R. Lovett, G. D. Rajmohan, D. R. de Celis, M. L Wright, P. R. Lamb, Y. E. Krasik, D. B. 
Graves, W. G. Graham, R. d. Agostino and X. Wang, Plasma Processes and Polymers, 2015, 
13, 306-310. 
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Schematic of plasma generation in bubbles immersed in liquid. The positive (stainless steel 
mesh) and negative electrodes (hollow needle) were immersed in liquid. Argon plasma 
produced a high density of hydrogen peroxide and air plasma produced a high density of 
nitrate and nitrite. 
It was reported that the generation of plasma directly in liquid requires an electric field of >105 
V/cm.10, 11  Moreover, this high electrical energy created strong shock waves and intense UV 
radiation in liquid which resulted in the faster erosion of electrodes and leads to contamination 
and hence makes it less feasible for treating sensitive materials.19, 20 The generation of a 
discharge in bubbles that are externally introduced into liquids requires much less power 
compared to direct plasma generation in liquid due to the large difference in dielectric constants 
of liquid and gas and this method also helps to avoid or minimize electrode erosion.34, 38 
A point-to-plate electrode assembly was used to produce discharge in bubbles immersed in 
liquid with chosen gas (see above scheme).34  This method resulted in high production of 
approximately 100% of selected reactive species with the consumption of less energy. Using 
this set up, a high concentration of H2O2 was produced when using argon gas whereas the air 
plasma produced high concentrations of NO2 and NO3 in deionized water.34 The discharge 
decreased the size and increased the number of bubbles in the liquid. This resulted in the 
increased interface reactions between the gas-plasma and liquid. The increase in the interface 
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reactions, along with the movement of bubbles, enabled higher production of selective reactive 
species based on chosen gas.34 
The capability to control and selectively produce a high concentration of H2O2 while using 
argon gas have opened up possibilities to utilize this approach mainly but not limited to 
decontamination of foods at ambient temperature. Luck et al. had documented the use of 
hydrogen peroxide as a bactericide and preservative in milk and milk products.391 This 
motivated me to use this already developed method34 i.e. using Ar as the chosen gas with slight 
modifications (defined as set up II) to investigate its potential in decontamination of milk. 
3.2 Argon Gas Plasma to Decontaminate and extend Shelf Life of Milk 
The bubble-in-liquid method using Ar gas was applied to the treatment of milk, and this work 
was published in Plasma Processes and Polymers Journal.392 In this work, as a PhD student, I 
have contributed more than 50% and all the co-authors in this publication have agreed and 
signed the % contribution declaration form set by Deakin University Higher Degrees by 
Research for Thesis by Publication. Herewith, I have attached the same declaration form. 
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Abstract 
Treatment of milk with argon gas plasma was investigated for its ability to kill bacteria and 
increase shelf life and compared with commercially pasteurized milk. The discharge was 
generated by a nanosecond pulse generator using the needle point-to-plate electrode. The total 
bacterial count of 6.8 log CFU/mL in raw milk was reduced to 1.9 log CFU/mL after two 
minutes of plasma treatment and 2.2 log CFU/mL after thirty minutes of pasteurization. The 
plasma treated milk stored at 4 °C showed no significant changes in the bacterial count for six 
weeks while the bacterial counts in pasteurized milk were significantly increased from 2.2 to 
4.2 log CFU/mL after two weeks. These results demonstrated plasma treatment as an 
alternative way to decontaminate and increase shelf life of milk. 
Graphical Abstract 
 
Argon gas plasma to reduce the bacterial count and prolong the shelf life in bovine milk. 
102 
 
3.3 Introduction 
Bovine milk is a natural food, rich in nutrients and other bioactive substances, that provide 
many health benefits to humans.165 Milk is also an ideal medium that supplies nutrients for the 
growth of micro-organisms such as Escherichia coli, Staphylococcus aureus, Listeria 
monocytogenes and Campylobacter sp.166 The consumption of raw or ineffectively processed 
milk leads to dairy-related outbreaks such as brucellosis, listeriosis, and tuberculosis in 
humans.167-170 The removal of bacteria from milk, without altering its nutritional properties, 
has long been a challenge.393 The current pasteurization and ultra-high pasteurization technique 
is known to effectively eliminate microbial populations but it induces undesirable changes in 
the nutritional properties of milk by several modifications.171, 172 This necessitates the 
development of non-thermal technology to improve the microbial safety, increase shelf life 
while maintaining the quality of milk. Non-thermal technologies such as high hydrostatic 
pressure, pulsed electric field, ultrasonication and UV radiation has been developed to replace 
conventional thermal processing in milk.291, 394-396 However, the lower efficiencies, extensive 
treatment times, the specialized equipment requirement and processing cost present significant 
challenges to scale up non-thermal technologies to an industrial level.  
The plasma technology has been widely used and investigated in applications such as 
fabrication of nanostructures, improving the efficiency of battery and solar cells and plasma 
medicine.363, 397-399 Atmospheric pressure plasma has been demonstrated to kill bacteria either 
in solid or liquid food matrices without a significant increase in temperature and therefore 
makes it a potential non-thermal technique for food processing.356, 357 However, there are very 
few studies examining plasma treatment on microbial quantity, shelf life and physicochemical 
characteristics of milk.360, 361 Gurol et.al demonstrated that corona discharge can significantly 
reduce E. coli colony forming units without having any negative effects on pH and color 
measurements in milk.360 Kim et.al achieved aerobic bacterial reduction using dielectric barrier 
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discharge and noticed non-significant changes in the fatty acid composition of milk.361 Rahman 
et.al investigated pulsed high voltage discharges and proposed shock waves might play a 
critical role to kill bacteria in milk.362 The previous plasma related milk studies have produced 
the plasmas (such as corona and dielectric barrier discharge) above the liquid (milk) surface 
where it might be difficult to achieve high production of controlled and selective reactive 
species. This could be due to the interference from the atmospheric air and recombination of 
reactive species in the air before diffusing into the liquid (milk).  
To address these challenges we developed a method of gas bubble discharge (plasma) in liquid 
that enables efficient and selective production of the required reactive species.34 Using this 
approach, a high selective production of hydrogen peroxide (H2O2) and nitrate (NO3) were 
obtained by argon and air gas respectively. The H2O2 is well known for its bactericidal and 
preservative effects in milk.391 The United States Food Drug and Administration (USFDA) 
approved the use of H2O2 in milk for cheese making and prescribed that the H2O2 weight should 
not exceed 0.05% of the weight of milk.400 The World Food and Agriculture Organisation 
permitted the use of H2O2 (0.05 - 0.25%) in milk for processing on the basis that it should be 
converted into oxygen and water by catalase before human consumption.401  
The major requirements of the dairy industry are the use of low temperature and less chemicals 
to reduce the bacterial load, increase the shelf life with minimal or no changes in the nutritional 
quality of milk. This work aims to achieve these criteria by argon gas bubble discharge in milk 
which produce H2O2 concentration lower than 0.05% (approved level of H2O2 by FDA) at near 
ambient temperature. The total bacterial reduction in plasma treated milk was significantly 
greater than pasteurization. More excitingly, the plasma treated milk stored at 4 °C showed no 
significant changes in the bacterial count for six weeks, whereas in pasteurized milk, the 
bacterial counts were significantly increased after two weeks. 
3.4 Experimental Section 
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3.4.1 Plasma system description 
The experimental setup consisted of a needle to plate electrode configuration to generate 
plasma (Scheme 3.1). The positive and negative polarities have been used in this work to 
generate plasma. A hypodermic stainless steel needle (0.6 mm diameter and 32 mm in length) 
was used as a positive (high voltage) electrode through which argon gas (25 sccm) was fed into 
the system to produce bubbles. A flat 316 stainless steel mesh (10 mm × 20 mm) was used as 
a negative electrode (high voltage). Both electrodes were immersed in liquid (both de-ionized 
water and milk) and spaced at a distance of 1 cm.  
 
Scheme 3.1. Schematic view of bubble discharge between needle electrode (top) and mesh 
electrode (bottom) immersed in liquid (milk or water). Positive high voltage polarity from 
nanosecond pulse generator was treated as channel 1 and negative high voltage polarity was 
treated as channel 2. 
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3.4.2 Plasma treatment in de-ionized water 
De-ionized (DI) water was used as an initial model to study and optimize plasma properties 
before experimenting with milk. Plasma was generated inside the bubbles immersed in DI 
water by a nanosecond pulse generator FPM 15-10MC2 (FID GmbH, Germany). The plasma 
parameters such as applied voltage at ±9 kV, 2 ns rise time and 10 ns pulse width were always 
kept constant for all experiments. The experiments in DI water were performed at least twice 
and analyzed in duplicate. The pH, temperature and hydrogen peroxide concentration in plasma 
treated DI water were optimized by varying the plasma frequency and treatment time. The 
plasma frequency was optimized by varying the plasma frequency (2, 3 and 4 kHz) at a constant 
two minutes treatment time with and without a cooling jacket. Subsequently, the treatment time 
was varied from 30 to 120 s at a constant 4 kHz plasma frequency with the cooling jacket. 
3.4.3 Measurement of pH, temperature and hydrogen peroxide in DI water 
The concentration of hydrogen ions (pH) in a solution is very important in assessing the 
system’s decontamination capabilities.360 A pH probe (TPS, Australia) was used to measure 
the pH in DI water before and after plasma treatment. A thermometer was used to immediately 
measure the temperature in all samples. A titanium sulphate colorimetric method was used to 
measure the hydrogen peroxide concentration in plasma treated DI water.402 The concentration 
of ozone, nitrate and nitrite in DI water were also measured by commercially available 
photometric assay kits (Spectroquant NOVA 60, Merck). 
3.4.4 Plasma treatment in raw milk 
The same batch of raw and full cream pasteurized (63.3 °C for 30 minutes) bovine milk samples 
were purchased from a local farm in Geelong, Australia and were stored at 4 °C. The same 
batch raw milk was immediately aliquoted for plasma treatment. The plasma treatment time in 
milk was varied from 30 to 120 seconds by keeping the plasma frequency as constant at 4 kHz. 
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The experiments in milk were repeated at least three times (each condition) and all samples 
were analyzed in triplicate. The untreated (both milk and DI water) samples (control) were left 
in the treatment chamber for two minutes with bubbling argon.  
3.4.5 Measurement of pH and temperature in plasma treated milk 
The pH and temperature in milk samples were recorded (only after a stable reading has reached) 
before and after plasma treatment. The effect of plasma treatment and pasteurisation in milk 
was compared with the raw milk samples.  
3.4.6 Measurement of bacterial count and shelf life in plasma treated milk  
Samples (100 μL) of serially diluted untreated (control), plasma treated (30 and 60 seconds) 
milk were plated onto plate count agar (PCA) media and incubated at 37 °C for 48 hours. 
Samples (100 μL) of plasma treated (90 and 120 seconds) and pasteurized milk were plated 
onto PCA without dilution and incubated at 37 °C for 48 hours.  
Milk shelf life was assessed for up to six weeks by repeating the same procedure at 7 day 
intervals for both the plasma treated and pasteurized milk. The bacterial colonies were counted 
using standard plate count method and the results were expressed in log CFU per mL.  
3.4.7 DNA sequencing of survived bacteria after plasma treatment 
The bacteria in milk that survived after highest plasma dose (4 kHz for 120 seconds) were 
randomly chosen for bacterial identification using DNA sequence analysis. One colony from 
each plasma experiment (three colonies from three individual plasma experiments) was chosen, 
based on different morphology to isolate different bacterial strains. The chosen colonies were 
streaked onto fresh plates to obtain pure stocks. One colony from each of these purified colonies 
was chosen at random for DNA sequence analysis. The fast MicroSeq®500 16S rDNA 
bacterial sequencing method was used for the identification of bacterial species at Microgenetix 
Pty Ltd Company, Melbourne, Australia. Sequences were obtained that spanned approx. 197 - 
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495 base pairs in both the forward and reverse directions. Chromatograms were further 
analyzed using Chromas software and both strands were aligned to form a consensus sequence 
for each colony obtained. Consensus sequences were blasted against a nucleotide database 
using national center for biological information.  
3.4.8 Statistical analysis 
A student’s t-test was performed to obtain the statistical significance of differences between 
treatments of the milk samples. 
3.5 Results and Discussion 
3.5.1 pH and temperature of plasma treated DI water 
DI water was treated by argon gas bubble discharge at different frequencies (2, 3 and 4 kHz) 
for two minutes without and with a cooling jacket (Figure 3.1). By increasing the frequency, 
the pH of plasma treated DI water was decreased from 5.1 (untreated) to 3.3 and 3.5 at 4 kHz 
without and with the cooling jacket, respectively. The pH reduction was slightly more without 
a cooling jacket. This could be due to the temperature differences between the treatments. The 
temperature of plasma treated DI water was found to be increased with the increase in plasma 
dose (Figure 3.2). After the highest plasma dose (4 kHz for two minutes), a final temperature 
of 65°C and 34 °C in DI water was recorded without and with cooling jacket, respectively. The 
temperature increase in the liquid was most likely due to the joule heating that occurred during 
the plasma treatment.403  
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Figure 3.1. pH of plasma treated de-ionized water without and with cooling jacket at different 
plasma frequencies (kHz) for two minutes. The untreated DI water (control) samples were left 
in the treatment chamber for two minutes with bubbling argon. The error bars indicate the 
mean ± standard error of the mean (SEM) of duplicate measurements and the statistical 
significance (* indicate P ≤ 0.05) was calculated between each plasma frequencies without 
and with cooling jacket samples. 
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Figure 3.2. Temperature of plasma treated de-ionized water without and with cooling jacket at 
different plasma frequencies (kHz) for two minutes. The untreated DI water (control) samples 
were left in the treatment chamber for two minutes with bubbling argon. The error bars 
indicate the mean and SEM of samples and the statistical significance (* indicate P ≤ 0.05) 
was calculated between each plasma frequencies without and with cooling jacket samples. 
3.5.2 Hydrogen peroxide in plasma treated DI water 
The concentration of H2O2 in DI water was measured without and with a cooling jacket and at 
different frequencies (2, 3 and 4 kHz) for two minutes to optimize the plasma frequency and 
temperature (Figure 3.3). The H2O2 concentration was increased with the increase in plasma 
input energy and found significantly higher in treatments without cooling compared to with 
cooling jacket. The highest plasma dose (4 kHz for two minutes) produced a maximum 
concentration of 119 ppm (0.0119%) and 75 ppm (0.0075%) H2O2 at 65 and 34 °C for without 
and with a cooling jacket respectively. The higher frequency created more fragmentation in gas 
bubbles which leads to the decrease in size and increase in number of bubbles in the liquid.34 
These latter effects along with the movement of bubbles greatly increased the interface 
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reactions between the gas-plasma and water, enabling higher production of selected species 
based on chosen gas. Using argon gas, the most reactive species in the plasma (energetic 
electrons, excited Ar atoms and ions, UV radiation) directly interact with water, which results 
in decomposition of the water and generation of OH radicals. H2O2 was then formed by the 
recombination of OH radicals either in gas phase or in water. A high density of H2O2 species 
in Ar plasma treated DI water was attributed by the transfer of OH and H2O2 species from 
bubbles to bulk liquid as well as the direct recombination of OH radicals in water.  
Figure 3.3. Hydrogen peroxide concentration plasma treated de-ionized water without and 
with cooling jacket at different plasma frequencies (kHz) for two minutes. The hydrogen 
peroxide values in plasma treated DI water were calculated by subtracting the untreated 
sample (control) values with plasma treated samples. The error bars indicate the mean ± SEM 
of samples and the statistical significance (** and *** indicate P ≤ 0.01 and ≤ 0.001) was 
calculated between each plasma frequencies without and with cooling jacket samples. 
After optimizing the plasma frequency and temperature, the plasma treatment time (at 4 kHz) 
was varied from 30 to 120 s in DI water with the presence of cooling jacket (Figure 3.4). The 
111 
 
concentration of H2O2 in DI water was significantly increased to 38 (0.0038%), 62 (0.0062%) 
and 75 ppm (0.0075%) with the increase in plasma treatment time (60, 90 and 120 seconds). 
Figure 3.4. Hydrogen peroxide concentrations in plasma treated DI water at varying plasma 
treatment time (seconds) in the presence of cooling jacket. The hydrogen peroxide values in 
plasma treated DI water were calculated by subtracting the untreated (control) sample values 
with plasma treated samples. The error bars indicate the mean ± SEM of samples and the 
statistical significance (* indicate P ≤ 0.05) was calculated between each treatment time.  
The highest plasma dose condition (4 kHz for two minutes) in DI water produced a maximum 
concentration of 75 ppm (0.0075%) H2O2 at 34 °C in the presence of the cooling jacket. The 
latter plasma condition was chosen for further optimization and investigation in milk, because 
an addition of 75 ppm H2O2 in milk at 34 °C for two minutes is not sufficient to effect bacterial 
reduction. Luck et al. reported that an incubation of pure 800 ppm (0.08%) H2O2 in milk at 49-
51 °C for 30 minutes is needed for milk decontamination.391 Also, pasteurization, a current 
thermal method which requires 63.3 °C for 30 minutes to kill bacteria in milk.  
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3.5.3 pH and temperature of plasma treated milk 
Argon gas bubble discharge at 4 kHz was employed for 30, 60, 90 and 120 seconds in milk to 
investigate its potential to kill bacteria and increase shelf life. The pH was slightly reduced 
from 6.76 (untreated) to 6.67 (120 s) in milk samples (Table 3.1). On the other hand, the pH of 
plasma treated DI water reduced from 5.1 to 3.5 at 4 kHz for 120 s in presence of cooling jacket 
(Figure 3.1). These stark differences in pH changes between plasma treated milk and water 
showed that the plasma-milk interaction differs from the plasma-water interaction. The 
presence of phosphate systems and casein proteins in milk exhibits buffering capacity and helps 
to resist pH changes.404 This could be the reason for the small pH change in plasma treated 
milk compared to plasma treated DI water. Moreover, the temperature difference in all plasma 
treated milk samples could also be a factor for a slight pH change (Figure 3.5). Kim et.al also 
observed changes in pH (from 6.90 to 6.60) of milk after dielectric barrier air discharge 
treatment.361 On the contrary, Gurol et.al mentioned that no negative effects on pH (6.7 ± 0.05) 
was observed in milk after atmospheric air corona discharge.360 These differences in results 
could be due to the plasma energy input and working gas. The temperature of milk was found 
to be increased with the increase in plasma dose (Figure 3.5). The final temperature 42 ± 2 °C 
was recorded at the highest plasma treatment (4 kHz for two minutes) in milk. This temperature 
was higher than the final temperature (34 °C) of the plasma treated DI water. 
Table 3.1. Shows the pH measurement of all milk (control, plasma treated and pasteurized) 
samples. The plasma treatment was performed at 4 kHz with different treatment times from 30 
to 120 seconds in the presence of cooling jacket. 
Samples Average pH of milk samples 
Control 6.76 
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30 s 6.74 
60 s 6.72** 
90 s 6.69** 
120 s 6.67** 
Pasteurized 6.74** 
Note: The untreated milk (control) samples were left in the treatment chamber for two minutes 
with bubbling argon. The statistical significance (** indicate P ≤ 0.01) was calculated between 
the control, plasma treated and pasteurized milk samples.  
Figure 3.5. Temperature measurement in plasma treated milk samples at 4 kHz and at different 
plasma treatment times (seconds) in the presence of cooling jacket. The untreated milk 
(control) samples were left in the treatment chamber for two minutes with bubbling argon. The 
error bars indicate the mean ± SEM of samples and the statistical significance (**, *** and 
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**** indicate P ≤ 0.01, ≤ 0.001 and ≤ 0.0001) was calculated between the control and other 
milk samples. 
3.5.4 Bacterial reduction in plasma treated milk 
The total bacterial population was found to be 6.8 log CFU/mL in untreated (control) milk. The 
number of CFUs were decreased with the increase in plasma dose (Figure 3.6). The 90 (at 34 
°C) and 120 seconds plasma treatment (at 42 °C) achieved a 4.6 and 4.9 log CFU/mL bacterial 
reduction in milk. The pasteurization (63.3 °C for 30 minutes) achieved a 4.6 log CFU/mL 
bacterial reduction in milk. This showed that the 120 seconds plasma treatment significantly 
achieved a higher bacterial reduction (0.3 log CFU/mL) than pasteurisation. Interestingly, the 
90 seconds plasma treatment and pasteurization achieved the same amount of bacterial 
reduction in milk. The 90 and 120 seconds plasma treatment has achieved an industrial standard 
bacterial reduction (4.3 log bacterial reduction) in milk according to the USFDA pasteurized 
milk ordinance 2011.405, 406 
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Figure 3.6. Bacterial count in milk following plasma treatment at 4 kHz and at different plasma 
treatment times (seconds) in the presence of the cooling jacket. The untreated milk (control) 
samples were left in the treatment chamber for two minutes with bubbling argon. The error 
bars indicate the mean ± SEM of samples and the statistical significance (*, **, *** and **** 
indicate P ≤ 0.05, P ≤ 0.01, ≤ 0.001 and ≤ 0.0001) was calculated between the control, plasma 
treated and pasteurized milk.   
Although, the plasma interaction in milk and water are different, the H2O2 concentration 
produced in 90 (62 ppm at 24 °C) and 120 s (75 ppm at 34 °C) plasma treated DI water (Figure 
3.4 and 3.2) and the bacterial reduction achieved at 90 (4.6 log) and 120 s (4.9 log) plasma 
treated milk (Figure 3.6) was correlated to see the role of H2O2 and temperature in plasma-
mediated bacterial reduction in milk. This correlation showed that the plasma treatment 
requires a lower temperature and ten times lesser H2O2 concentration to effect milk 
decontamination. As mentioned earlier, an incubation of pure 800 ppm H2O2 concentration in 
milk at 49-51 °C for 30 minutes is necessary to cause decontamination.391 This implied that, in 
addition to H2O2, the other plasma components such as nanosecond pulsed electric field (PEF), 
UV radiation, short lived species (OH radicals) and joule heating might have played a role in 
reducing the bacterial population in milk. Moreover, the interface reactions between the Ar 
gas-plasma (including UV radiation and reactive species, such as OH and H2O2) and milk were 
greatly increased through the bubbles (size, number and movement), enabled more efficient 
reaction.  
It has also been reported that the electrical discharges in gas bubbles immersed in liquid 
produces both physical (PEF and UV radiation) and chemical processes (short lived species 
mainly O, OH radicals and long lived species mainly H2O2, NO3).17, 358 Craven et al. showed 
that high intensity PEF has the capability to effect 1-5 log bacterial reductions in milk based 
on the energy input and treatment temperature.407 Krishnamurthy et al. has reported that pulsed 
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UV has a higher penetration depth than continuous mode and has effectively reduced bacteria 
in milk.329 The key elements such as UV wavelength, intensity, thickness of the radiation path 
and flow turbulence determines the UV effects in milk. Werrrs et al. showed that the 
combination of H2O2 and UV radiation with or without heat produces a greater lethal effect on 
bacterial spores (in phosphate buffer solution) compared to their individual counterpart 
effects.330 They explained that the UV irradiation breaks down the H2O2 into OH radicals which 
then enter into the bacterial spore to achieve the bactericidal effect and the presence of heat 
enhanced this effect.  
All these above reports suggest that the plasma components such as nanosecond PEF, UV 
radiation, short lived species (OH radicals) and joule heating might have an additive effect to 
effect milk decontamination. However, the measurement of H2O2 in milk after plasma 
treatment will be necessary to understand the bacterial reduction process. 
3.5.5 Shelf life of plasma treated milk 
The plasma treated milk samples were stored at 4 °C and assayed for bacterial count each week 
to assess shelf life of milk for a period of 6 weeks (Figure 3.7). There were no significant 
changes in the bacterial count for up to six weeks in plasma treated milk samples (in both 90 
and 120 s) while the pasteurized sample showed bacterial counts were significantly increased 
from ~2.2 to 4.2 log CFU/mL at 2 weeks. This confirms that the plasma treatment reduced the 
viable bacteria load at 90 and 120 s and the treatment continued to protect the milk for a further 
6 weeks. Gurol et al. also observed an immediate E.coli in milk and found the milk could be 
stored for six weeks after atmospheric corona discharge.360 The immediate reduction of bacteria 
could be due to the plasma reactive species which can directly target the bacterial cell wall.408 
They also observed the further reduction of bacterial load during the first week of storage, 
suggesting the presence of a post plasma effect. Similarly, Song et.al showed that the number 
of Listeria monocytogenes were decreased during storage after plasma treatment.409 In our 
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work, the argon bubble discharge immediately reduced the bacteria and demonstrated a 
continued effect in the milk to maintain the same bacterial load during storage by restricting 
bacterial growth. This suggests that plasma treatment has the potential to reduce the bacteria 
and also to arrest its growth during the treatment time. It is well known that pasteurized milk 
stored at ≤ 4 °C can only be consumed for up to 14 days after processing and this was in good 
agreement with our results.410 The bacteria that survived after pasteurization has the potential 
to proliferate after two weeks which limits the shelf stability of the pasteurized milk. Thus in 
comparison to pasteurization, plasma treatment in this study demonstrated an advantage of 
increasing shelf life by limiting further bacterial growth in milk. 
Figure 3.7. Shelf life comparison (up to 6 weeks) of plasma treated and pasteurized milk. The 
error bars indicate the mean ± SEM of samples and the statistical significance (* and ** 
indicate P ≤ 0.05 and ≤ 0.01) was calculated between 90 s, 120 s and pasteurized milk samples. 
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3.5.6 DNA sequencing of survived bacteria after plasma treatment 
DNA sequencing was performed for the bacteria that survived after highest plasma dose (4 kHz 
for 120 seconds). The DNA sequencing results showed that B. licheniformis was predominantly 
identified as the surviving bacterial species after plasma treatment (Table 3.2). A detailed report 
on the DNA sequencing results were provided in the supplementary information (Table S3.1 
and Figure S3.1).  
Table 3.2. Shows the identified bacterial species that survived after highest plasma dose (4 kHz 
for 120 seconds) 
B. licheniformis is a common aerobic spore forming bacteria that exists in all stages of dairy 
processing in Australian milk.411 However, there are arguments related to B. licheniformis 
strains acting both as probiotics and also as a disease-causing agent through foods.412, 413 Unlike 
the vegetative cells, the bacterial spores are highly resistant to a number of stress factors such 
as heat, UV radiation, chemicals and high pressure.414 This could be the reason for B. 
licheniformis survival after plasma treatment. However, in plasma-treated milk no increase in 
CFUs was observed during the shelf life assessment (Figure 3.7). The effect of plasma 
treatment on major nutritional components such as protein, lipids and carbohydrates needs to 
be studied in detail to ensure food safety and quality before extending this plasma approach for 
practical applications. 
Sample Identified species Z Score 
colony 1 B. licheniformis strain B26_13 424 (229) bits 
colony 2 Bacillus sp. B4.5 776 (420) bits 
colony 3 Bacillus sp. B4.5 793 (429) bits 
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3.6 Conclusion 
We have shown that the argon gas bubble discharge in milk significantly reduced the bacterial 
concentration than pasteurization. The plasma treatment also significantly increased the storage 
life of milk for up to six weeks compared to pasteurization. The plasma treatment caused only 
a small change in pH and a moderate increase in temperature of all milk samples. This 
demonstrated that the argon gas plasma treatment could be a promising alternative method to 
decontaminate and increase shelf life of milk. 
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1) Table S3.1. Top 10 Blastn hits for each colony sequenced 
COLONY 1 
Max 
score 
Total 
score 
Query 
cover 
E value Ident Accession 
Uncultured Bacillus sp. clone GJ_(3)_11 16S rRNA 
gene 
904 904 98% 0.0 100% KX603482.1 
Bacillus licheniformis strain BNR111 16S rRNA gene 904 904 98% 0.0 100% KT166431.1 
Bacillus licheniformis strain PF3A_1 16S rRNA gene 904 904 98% 0.0 100% KT720050.1 
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Bacillus licheniformis WX-02 genome 904 7159 98% 0.0 100% CP012110.1 
Bacillus licheniformis strain IRC3 16S rRNA gene 904 904 98% 0.0 100% KP172618.1 
Uncultured Bacillus sp. clone LZQX-13 16S rRNA gene 904 904 98% 0.0 100% KF444940.1 
Bacillus sp. TT402 gene for 16S rRNA 904 904 98% 0.0 100% AB374325.1 
Uncultured Bacillus sp. clone CBHOS-08 16S rRNA 
gene 
904 904 98% 0.0 100% EU371582.1 
Uncultured Bacilli bacterium clone MS105A1_E05 16S 
rRNA gene 
904 904 98% 0.0 100% EF703705.1 
Uncultured Bacilli bacterium clone MS073A1_C03 16S 
rRNA gene 
904 904 98% 0.0 100% EF697456.1 
COLONY 2 
     
  
Bacillus licheniformis strain YS65 16S rRNA gene 898 898 100% 0.0 100% KU551256.1 
Bacillus licheniformis strain RS12 16S rRNA gene 898 898 100% 0.0 100% KU551239.1 
Bacillus licheniformis strain DS42 16S rRNA gene 898 898 100% 0.0 100% KU551230.1 
Bacillus licheniformis strain Z71 16S rRNA gene 898 898 100% 0.0 100% KU551224.1 
Bacillus licheniformis strain Z11 16S rRNA gene 898 898 100% 0.0 100% KU551215.1 
Bacillus licheniformis strain P61 16S rRNA gene 898 898 100% 0.0 100% KU551207.1 
Bacillus licheniformis strain L74 16S rRNA gene 898 898 100% 0.0 100% KU551185.1 
Bacillus licheniformis strain L13 16S rRNA gene 898 898 100% 0.0 100% KU551158.1 
Bacillus licheniformis strain D72 16S rRNA gene 898 898 100% 0.0 100% KU551154.1 
Bacillus licheniformis strain D61 16S rRNA gene 898 898 100% 0.0 100% KU551150.1 
COLONY 3             
Bacillus sp. S3SM473 16S rRNA gene 891 891 100% 0.0 100% KT183558.1 
121 
 
Bacillus licheniformis strain D12 16S rRNA gene 891 891 100% 0.0 100% KU551144.1 
Bacillus licheniformis strain C44 16S r RNA gene 891 891 100% 0.0 100% KU551126.1 
Bacillus megaterium strain NCIM2475 16S rRNA gene 891 891 100% 0.0 100% KX018393.1 
Bacillus licheniformis strain VTB12 16S rRNA gene 891 891 100% 0.0 100% KX011165.1 
Bacillus licheniformis strain HRBL-15TDI7, complete 
genome 891 7057 100% 0.0 100% CP014781.1 
Bacillus licheniformis strain 2D55 16S r RNA gene 891 891 100% 0.0 100% KT799651.1 
Bacillus licheniformis strain A1 16S rRNA gene 891 891 100% 0.0 100% KT153613.1 
Bacillus licheniformis strain MK7 16S rRNA gene 891 891 100% 0.0 100% KP322016.1 
Bacillus licheniformis strain KRB1 16S rRNA gene 891 891 100% 0.0 100% KP965752.1 
 
2) Nucleotide sequence comparison of colonies 
COLONY1         TTGCACACGCTGGCGGCGTGCCTAATACATGCAAGTCGAGCGGACCGACGGGAGCTTGCT 
COLONY2         ------ACGCTGGCGGCGTGCCTAATACATGCAAGTCGAGCGGACCGACGGGAGCTTGCT 
COLONY3         ----------TGGCGGCGTGCCTAATACATGCAAGTCGAGCGGACCGACGGGAGCTTGCT 
                          ************************************************** 
 
COLONY1         CCCTTAGGTCAGCGGCGGACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGA 
COLONY2         CCCTTAGGTCAGCGGCGGACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGA 
COLONY3         CCCTTAGGTCAGCGGCGGACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGA 
                ************************************************************ 
 
COLONY1         TAACTCCGGGAAACCGGGGCTAATACCGGATGCTTGATTGAACCGCATGGTTCCAATCAT 
COLONY2         TAACTCCGGGAAACCGGGGCTAATACCGGATGCTTGATTGAACCGCATGGTTC-AATCAT 
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COLONY3         TAACTCCGGGAAACCGGGGCTAATACCGGATGCTTGATTGAACCGCATGGTTC-AATCAT 
                ***************************************************** ****** 
 
COLONY1         AAAAGGTGGCTTTTAGCTACCACTTACAGATGGACCCGCGGCGCATTAGCTAGTTGGTGA 
COLONY2         AAAAGGTGGCTTTTAGCTACCACTTACAGATGGACCCGCGGCGCATTAGCTAGTTGGTGA 
COLONY3         AAAAGGTGGCTTTTAGCTACCACTTACAGATGGACCCGCGGCGCATTAGCTAGTTGGTGA 
                ************************************************************ 
 
COLONY1         GGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTG 
COLONY2         GGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTG 
COLONY3         GGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTG 
                ************************************************************ 
 
COLONY1         GGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGA 
COLONY2         GGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGA 
COLONY3         GGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGA 
                ************************************************************ 
 
COLONY1         CGAAAGTCTGACGGAGCAACGCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAACTCTG 
COLONY2         CGAAAGTCTGACGGAGCAACGCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAACTCTG 
COLONY3         CGAAAGTCTGACGGAGCAACGCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAACTCTG 
                ************************************************************ 
 
COLONY1         TTGTTAGGGAAGAACAAGTACCGTTCGAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
COLONY2         TTGTTAGGGAAGAACAAGTACCGTTCGAATAGGGCGGCACCTTGACGGTACCTAACCAGA 
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COLONY3         TTGTTAGGGAAGAACAAGTACCGTTCGAATAGGGCGGTACCTTGACGGTACCTAACCAGA 
                ************************************* ********************** 
 
COLONY1         AAGCCACGGCTAACT- 
COLONY2         AAGCCACGGCTAA-- 
COLONY3         AAGCCACGGCTA--- 
                ************ 
Figure S3.1. Nucleotide sequence comparison of colonies that survived after highest plasma 
dose (4 kHz for 120 seconds). Identical base pairs between all 3 sequences are indicated by an 
asterisk while differences are highlighted in yellow. 
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Chapter 4 Plasma Treatment- A potential alternative to minimize damage in nutritional 
bio-actives of bovine milk 
Ponraj, SB, Sharp, JA, Roy, K, Stevenson, PG, Adcock, JL, Smith, Z, Kanwar, JR, Sinclair, 
AJ, Nicholas, KR and Dai, XJ, manuscript preparation is in progress and will be submitted 
soon. 
Abstract 
A first study to address the effects of argon plasma treatment on proteins, lipids, carbohydrates 
and miRNA present in bovine milk compared to commercially pasteurized milk and raw milk. 
High performance liquid chromatography analysis showed that α, β and κ-casein proteins were 
significantly increased in 90 and 120 s plasma treated milk whereas in pasteurized milk, the α 
and β-casein proteins were significantly reduced and κ-casein was significantly increased 
compared to raw milk. Beta-lactoglobulin (β-LG) was significantly reduced in 120 s plasma 
treated milk compared to pasteurized milk, and it was also significantly reduced in 90 and 120 
s plasma treated and pasteurized milk compared to raw milk. SDS-PAGE analysis of whey and 
skim fractions of milk showed that α-lactalbumin (α-LA) protein was significantly reduced in 
120 s plasma treatment compared to raw milk. Among the minor whey proteins like lactoferrin 
(Lf), immunoglobulins (Ig) and bovine serum albumin (BSA), the 120 s plasma treatment 
significantly reduced Ig compared to raw milk. This showed that, next to β-LG, Ig were 
sensitive to higher plasma treatment time. Western blotting and SDS-PAGE analysis of whey 
showed that Lf was significantly reduced in pasteurized milk compared to 90 s plasma treated 
and raw milk. The total lipids and the saturated fatty acids, and carbohydrates were 
significantly reduced in pasteurized milk compared to both 90 and 120 s plasma treated and 
raw milk. No major significant change in fatty acids were observed in both 90 and 120 plasma 
treated milk compared to raw milk. The miRNA concentration in 90 s plasma treated milk was 
significantly increased compared to pasteurized milk. Overall, the least changes in the 
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nutritional components were observed in 90 s plasma treated milk compared to pasteurized and 
120 s plasma treated milk. The changes in the composition of milk samples was reflected in 
the cell viability of human fetal intestinal cells (FHs 74 Int) and human colon adenocarcinoma 
cells (Caco-2). The raw and 90 s plasma treated milk did not effect the cell viability of FHs 74 
Int whereas the pasteurized and 120 s plasma treated milk significantly reduced viability 
compared to untreated cells. The cell viability of Caco-2 cells was significantly reduced by all 
milk samples compared to untreated cells. Our results demonstrated that 90 s plasma treatment 
has the potential to maintain or minimally alter the nutritional components in milk compared 
to pasteurization. 
Graphical Abstract 
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The plasma reactive components in the gas phase (bubble) and at the gas-milk interface, diffuse 
to interact with components in milk. The proposed order of higher interaction are labelled from 
1 to 4 based on the results obtained. The plasma reactive components might effectively interact 
with micro-organisms, whey proteins, carbohydrates, enzymes, salts, and water soluble 
vitamins present in the water phase of milk. Whilst, the interaction with casein micelle and milk 
fat globule membrane might be less effective compared to water phase components in milk. 
Note: Some of the elements in this figure are inspired from Pankaj et al.415 and re-drawn 
according to the results obtained. 
4.1 Introduction 
Milk is a nutritious food enriched with protein, lipids, carbohydrates, vitamins, salts and 
bioactive substances like growth factors, enzymes and peptides.274 However, milk can also 
contains harmful microorganisms such as Escherichia coli, Staphylococcus aureus, 
Streptococcus sp, Micrococcus sp, spores and etc.166, 248, 249 The presence of these type of 
microorganisms adversely affect the quality of milk and human health through dairy borne 
diseases such as listeriosis, brucellosis, salmonellosis and tuberculosis.254, 257, 258, 260, 416 
Pasteurization and ultra-high pasteurization are the current techniques to kill bacteria and 
extend the shelf life of milk. But these processes damage the immunological properties, 
bioactive proteins, peptides and vitamins present in milk.263, 267-272 A non-thermal technology 
is therefore required to ensure the microbial safety whilst reducing the nutritional damage in 
milk, to fulfil the increasing consumer demands for fresh-like, nutritious milk and milk 
products.  
Alternative non-thermal technologies such as high hydrostatic pressure (HHP), pulsed electric 
field (PEF), UV radiation and ultrasound have been developed to replace conventional thermal 
methods in milk decontamination and nutrition preservation.302, 337, 395, 417 HHP treatment 
induces changes in milk appearance and casein particle size, denaturation of whey proteins 
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(particularly β-lactoglobulin (β-LG) and lactoferrin (Lf)) and interaction of whey proteins with 
casein micelles.293-295 The effect of HHP on milk components mainly depends upon pH, 
treatment temperature and time. Limited number of papers reported the effect of PEF treatment 
on nutritional compounds which caused aggregation of β-LG in whey protein solution, increase 
in peroxide value in oleic acid models and reduction of vitamin C.418-420 Floury et al. found that 
PEF also affected proteins, especially casein micelles, decrease in viscosity and enhanced 
coagulation properties of PEF-treated milk.311 Xiang et al. observed an increase in the effective 
volume of the fat globule due to interaction with denatured skim milk serum proteins.312 The 
electric field intensity, number of pulses, and concentration of proteins in their study 
contributed to the alteration of whey proteins.312 Belloso found that the whey protein denatured 
in the order of α-LA > BSA > β-LG after PEF treatment.313 
Several authors have reported the use of UV-C to decontaminate raw cow and goat milk with 
different fat amounts and at different temperatures.325-327 Choudhary et al. demonstrated that 
the microbial inactivation (Escherichia coli W1485 and Bacillus cereus endospores) of UV-C 
was higher in skimmed compared to non-skimmed cow milk.328 Matak et al. showed that 
ultraviolet irradiation (at 254 nm) induced sensory and chemical changes in goat milk.331 The 
limitations in inactivating the microbes, loss of nutrients, lipid oxidation and formation of off-
flavors in milk after UV treatment still remain as major challenges.324, 327, 331, 332 The effect of 
high intensity ultrasound and heat treatment on fat, proteins and native enzymes in milk has 
been reported in numerous studies.342, 343, 352 It was commonly found that ultrasound have a 
limited effect on enzymes when used alone. On the other hand, the size of the fat globule was 
significantly reduced and distributed evenly, whey proteins such as α-LA and β-LG and native 
enzymes such as alkaline phosphatase, lactoperoxidase and γ-glutamyltranspeptidase in whole 
and skim milk were highly denatured when ultrasound and heat was used combinedly.343, 353 
Although each non-thermal technology discussed above have certain advantages in processing 
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milk, they suffer from lower efficiencies, extensive treatment times, specialized equipment 
requirements and the requirement of additional heat to achieve effective inactivation, energy 
consumption, capital and processing costs. These significant challenges make the emerging 
non-thermal technologies difficult to scale up to an industrial level. 
Plasma can be defined as a quasi-neutral system composed of gaseous and fluid-like mixtures 
of free electrons, ions, neutral particles, heat, UV light, electric field and free radicals like 
reactive oxygen and nitrogen species.421 Plasma technology has been widely investigated in 
applications such as fabrication of nanostructures, textiles, waste water treatment, batteries, 
solar cells and medicine.363, 399, 422 Plasma technology is an environmentally friendly approach 
and it has the potential to reduce viable bacteria on various surfaces including solid and liquid 
foods with lower temperatures, and could be of great interest to food processing industries.357 
Although the decontamination capability of plasma has been demonstrated in medical devices, 
dentistry, dermatology, agriculture and foods, only very few reports are available in processing 
milk. El Aragi and Rahman studied pulsed high voltage arc discharges (AD) in milk and 
explained that the production of shock waves might have played a key role in bacterial death.362 
Gurol et al. reported that the corona discharge (CD) significantly reduced E. coli in whole, 
semi skimmed and skimmed milk without any negative effects on pH and color 
measurements.360 Kim et al. demonstrated that the dielectric barrier discharge (DBD) treatment 
in milk improved the microbial quality with slight changes in the fatty acid composition.361 
Similarly, Korachi et al. also observed a slight but non-significant changes in milk fatty acid 
composition after corona discharge.423 However, the effect of plasma on milk constituents such 
as proteins, lipids and carbohydrates was not largely explored, despite fatty acid analyses in 
two of the above studies. In our previous study, argon bubble discharge (plasma) was generated 
in milk which achieved 4.6 and 4.9 bacterial log reductions in 90 and 120 seconds of treatment 
and increased the shelf life to at least six weeks compared to pasteurization.392 Micro RNAs 
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(miRNAs) have also been identified in bovine, human, rat and other species milk and serve as 
an effective biomarker for milk quality and udder function.227-229 These milk miRNAs are a 
new class of non-coding RNAs ranging from of 18 to 26 nucleotides in length which play an 
important role in gene regulation. Milk miRNAs are encapsulated in exosomes which gives 
them stability and the ability to withstand harsh conditions such as the acid environment of the 
stomach.228-230 To the best of our knowledge, this is the first study which assess the effect of 
argon plasma on proteins, lipids, carbohydrates, total RNA and miRNA content compared to 
pasteurized and raw milk. These are all useful parameters in addressing the milk quality and 
the impact each treatment has on milk integrity. 
4.2 Experimental section 
Raw and full cream pasteurized (63.3 °C for 30 minutes) bovine milk samples from the same 
batch were purchased from a local farm in Geelong, Australia and were stored at 4 °C. The raw 
milk was immediately aliquoted for plasma treatment. A needle to plate electrode configuration 
was used to generate plasma (Scheme 3.1, see previous chapter). The hypodermic stainless 
steel needle (0.6 mm diameter and 32 mm in length) was used as a positive (high voltage) 
electrode through which argon gas (25 sccm) was fed into the system to produce bubbles. The 
flat 316 stainless steel mesh (10 mm × 20 mm) was used as a negative electrode. Both 
electrodes were immersed in milk and spaced at a distance of 1 cm. Plasma was generated 
inside the bubbles immersed in milk by a nanosecond pulse generator FPM 15-10MC2 (FID 
GmbH, Germany). The plasma treatment time was varied from 30 to 120 s in milk while 
keeping the other plasma parameters such as applied voltage at ±9 kV, frequency 4 kHz, rise 
time 2 ns and pulse width 10 ns as constant for all experiments. The plasma treated milk 
samples were compared with the same batch pasteurized milk samples to assess the impact of 
plasma and pasteurization on nutritional components such as protein, lipid, carbohydrate and 
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RNA. The untreated milk samples left in the treatment chamber for two minutes with bubbling 
argon were treated as control. 
4.2.1 Measurement of total proteins 
The total protein content in the diluted (1:1000) milk samples was measured using the 
bicinchoninic acid (BCA) micro protein assay kit (Thermo Scientific, USA).424 Known 
concentration of bovine serum albumin (BSA) standard solutions were prepared. 150μL of 
either standard, water (as blank) or diluted milk samples was pipetted into each microplate 
well. 150μL of working reagent (composed of Micro BCA reagents A, B and C in the ratio of 
25:24:1) was added to each well and the plate was shaken for 30 seconds on a plate shaker. 
The plate was incubated at 37 °C for 2 hours. After cooling the plate to room temperature, the 
absorbance was measured at 562nm using a plate reader. A standard curve was established 
using BSA protein standards to calculate the total protein content in all milk samples. 
4.2.2 High performance liquid chromatography (HPLC) 
HPLC was used to study the changes in individual milk proteins after plasma treatment and 
pasteurization. Skim milk was prepared by centrifuging the milk samples twice at 1000g for 5 
minutes at 4 °C to remove the fat layer. Skim milk was diluted by mixing 100 µL skim milk 
and 900 µL of 50 mM phosphate buffer (pH 6.8). This diluted milk sample was filtered by 0.22 
µm syringe filter to remove any particulate matter and then subjected to HPLC analysis. 
Chromatographic analysis was performed with an Agilent 1260 Infinity 2D-HPLC system 
(Agilent Technologies, Mulgrave, Victoria, Australia) comprised of a binary capillary pump 
with solvent degasser; an auto-sampler; a 1290 Infinity thermostated column compartment and 
DAD UV detector that monitored absorbance a 214 nm. All injection volumes were 20 µL and 
all separations were completed at 40 °C thermally equilibrated for 1 hour prior to the first 
analysis. A Kinetex C18 column (100 mm × 4.6 mm i.d., 2.6 μm, 100 Å, Phenomenex, Lane 
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Cove, New South Wales (NSW), Australia) was used for all separations. A gradient mobile 
phase was used for all separations where Solvent A consisted of deionised water (Continental 
Water Systems, Victoria, Australia), which was filtered through a 0.45 µm filter (Sigma-
Aldrich Pty Ltd, Castle Hill, NSW, Australia) prior to use, and Solvent B was HPLC grade 
acetonitrile (Ajax Finechem Pty. Ltd., Taren Point, NSW, Australia); 0.1% v/v trifluoroacetic 
acid (TFA, Reagent Plus 99%, Sigma-Aldrich, Castle Hill, NSW, Australia) was added to all 
solvents prior to analysis. The mobile phase increased from 20% to 65% Solvent B over 25 
minutes before returning to the initial composition whereby the column was re-equilibrated for 
5 minutes. The flow rate was 1 mL per minute. 
The whey protein peaks were identified by running pure standards of β-LG, α-LA, Lf and 
bovine serum albumin (BSA) whereas the casein protein (α-CN, β-CN and κ-CN) peaks were 
identified based on its retention time described in Yuksel and Erdem work.425 The fold changes 
in each protein were calculated by dividing the protein peak area of plasma treated and 
pasteurized samples by area of the control samples. The protein peak areas were summed for 
proteins which exist in more than one form. For example, β-LG exists in three forms and, the 
three peak areas were summed for the treated samples (plasma treated and pasteurized) and 
divided by the three peak areas of untreated (control) samples. 
4.2.3 Sodium dodecyl sulphate – Poly acrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was used for separating proteins on the basis of their ability to move within an 
applied electrical current, which is directly proportional to the length of their polypeptide 
chains and their molecular weight. The SDS imparts a negative charge to the protein by coating 
them and removes secondary and tertiary structure forms to maintain the proteins as 
polypeptides. Thus, all peptides resent in the milk samples ranging from 250 kDa to 10 kDa 
could be visualized. 
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Skim milk was prepared as mentioned above and the whey fraction was prepared by 
centrifuging the skim milk samples at 10,000xg for 10 minutes at 4 °C. The whey fraction 
(supernatant) and the casein pellet were separated. The protein concentration of skim and whey 
fractions was measured in all samples using Micro BCA protein assay kit. A 1.5 mm, 10 % gel 
was casted using 40% acrylamide (Sigma Aldrich, Australia) and 50 µg of skim and whey milk 
samples were loaded and ran at 200 volts. The gel was stained using coomassie blue stain for 
a period of 30 minutes and kept for de-staining overnight. The gel was imaged using Chemi-
doc with XRS camera (Bio-Rad). The skim milk and whey fraction samples were ran twice 
and densitometry analysis were performed on all gels using microarray plugin tool in ImageJ 
software. The average fold changes in proteins were calculated by dividing the band density of 
plasma treated and pasteurized samples by band density of untreated control samples. 
4.2.4 Western Blot 
1.5 mm gels (10%) were casted using 40% acrylamide and 50 µg of milk samples were loaded 
and ran at 200 volts for approximately 45 minutes. A polyvinylidene difluoride (PVDF) 
membrane (GE healthcare) of size 6 X 8.4 cm was cut and placed in 100% methanol for 30-60 
seconds. The membrane was then transferred into Milli-Q water and kept completely immersed 
for 8 minutes. The membrane was then placed into the 5X transfer buffer for 15-20 minutes in 
order to equilibrate it. The proteins were then transferred from the gel onto a PVDF membrane 
using a Turbo-transfer system (Bio-Rad). In order to do so the membrane gel sandwich was 
assembled as follows: within the turbo transfer box- filter pads-PVDF membrane-gel-filter 
pads. The transfer was run according to the Bio-Rad guidelines. 
After the transfer, the PVDF membrane was washed using tris buffer saline (TBS) twice and 
then incubated in blocking buffer (1% skim milk in TBS) for a period of 1h. The membrane 
was then washed twice with TBS and later incubated in primary antibody (rabbit anti-alpha 
lactoglobullin (Abcam), rabbit anti-beta lactoglobulin (Abcam), goat anti-lactoferrin (Bethyl 
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Laboratories) for 1 h at 37 °C. The membrane was washed thrice using Tris buffer containing 
0.1% Tween-20 (TBS-T) followed by another three washes with TBS. The membrane was then 
incubated with secondary antibody (anti rabbit HRP and anti-goat HRP- R&D systems, 
Australia) for 1 h at 37 °C. The washing steps were repeated and the membrane was developed 
using the HRP substrates Detection reagent 1 (500µl) and Detection reagent 2 (500µl), (Thermo 
Scientific, Australia) and membrane was imaged using a Chemi-doc with XRS camera (Bio-
Rad, Australia). Densitometric analysis and fold changes were performed as mentioned 
previously.  
4.2.5 Measurement of total lipids 
The total lipid content in all milk samples was determined using colorimetric method.426 Milk 
samples without dilution were used for this assay. Triolein standards were prepared using 
chloroform (Chemsupply, South Australia) and methanol (Chemsupply, South Australia) in 
2:1 mixture. 2.5 μL of blank (chloroform: methanol: 2:1), standards and milk samples were 
transferred to microfuge tubes. 600 μL of ethanol (Chemsupply, South Australia) was added to 
each tube followed by the addition of 100 μL of 2 M hydroxylamine hydrochloride (Sigma, 
Sydney, Australia). The contents of the tube were then vortexed. 100 μL of 3.5M Sodium 
hydroxide (NaOH, Merck, Victoria, Australia) was added to each tube, vortexed and the tubes 
were incubated at room temperature for 20 minutes. 100 μL of 4 M hydrochloric acid (HCl, 
Merck, Victoria, Australia) was added to the tubes followed by the addition of 100 μL of 0.37 
M ferric chloride (Sigma, Sydney, Australia) made up with 0.1 M HCl. The tubes were 
vortexed and 250 μL of the contents were transferred to a 96 well plate. The absorbance was 
measured at 540 nm using a plate reader (Biorad xMarkTM microplate absorbance 
spectrophotometer). A standard curve was established using triolein standards to calculate the 
total lipid content in all milk samples. 
4.2.6 Gas chromatography (GC) 
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Prior to analysis by GC, fatty acids in milk were converted to methyl esters following the 
method of Christie and Han with some modifications.427 All milk samples (l mL) were stored 
at -80 °C and subjected to freeze drying. The weight of the freeze dried milk samples was 
recorded and the samples dissolved in 1 mL toluene, and 200 μL of internal standard (5 mg/mL 
methyl nonadecanoate (Sigma–Aldrich) in toluene) and 200 μL of antioxidant (1 mg/mL 2, 6-
di-tert-butyl-4-methylphenol (butylated hydroxytoluene; BHT, Sigma–Aldrich) in toluene) 
were added. To this, 2 mL of acidic methanol reagent (prepared by adding 1 mL of acetyl 
chloride (Sigma–Aldrich) drop wise to 10 mL methanol on ice and stirring for at least an hour) 
was added, the solutions mixed and left overnight at 50 °C in a sealed tube. The solution was 
cooled and 5 mL sodium chloride solution (5% m/v) was added. The fatty acid methyl esters 
were extracted twice with heptane (5 mL) and the heptane layer washed with 5 mL potassium 
bicarbonate solution (2% m/v). The heptane layer was dried over sodium sulphate, and 
subjected to analysis by GC with flame ionisation detector (FID). 
Samples were analysed using an Agilent 6890 GC-FID, equipped with a BPX70 capillary 
column (SGE) (30 m, 0.25 mm i.d., 0.25 μm film thickness). The oven was programmed from 
140 °C (5 minutes hold) to 220 °C (5 minutes hold) at a rate of 4 °C/minute for a total run time 
of 30 minutes. A volume of 1 μL of solution was injected with a split ratio of 50:1 (injector 
temperature, 250 °C). Helium was used as the carrier gas (1.5 mL/minute, constant flow). 
Detector gases were 30 mL/minute hydrogen, 300 mL/minute air and 30 mL/minute nitrogen. 
Peak areas were integrated by ChemStation software and corrected using theoretical relative 
FID response factors.428 The percentage composition of fatty acids in milk samples were 
calculated by dividing the area of particular fatty acid by the sum of the area of all fatty acids. 
The fold changes in fatty acids were calculated by dividing the fatty acid % value of plasma 
treated and pasteurized samples by fatty acid % value of untreated control samples. 
4.2.7 Measurement of total carbohydrates 
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The total carbohydrate content in all diluted (1:1000) milk samples was determined using the 
phenol-sulphuric acid method in micro-plate format.429 A set of various known concentrations 
of glucose (Ajax Finechem, Victoria, Australia) standards were prepared for the assay. 50 μL 
of glucose standards, blank (water) and diluted milk samples were placed in microfuge tubes. 
150 μL of concentrated sulphuric acid (Merck, Victoria, Australia) and 30 μL of 5% phenol 
(Sigma, Sydney, Australia) were added. The tubes were incubated at 90 °C for 5 minutes. The 
tubes were cooled to room temperature for 5 minutes and the contents were transferred to a 96 
well plate, and absorbance was measured at 490 nm using a plate reader (Biorad xMarkTM 
microplate absorbance spectrophotometer). A standard curve was established using glucose 
standards to calculate the total carbohydrate content in all milk samples. 
4.2.8 RNA extraction and estimation 
1 mL of milk was centrifuged at 5000 xg for 10 minutes at 4 °C to remove the fat and cells. 
This skim milk was removed and centrifuged again at 17,000 xg for 20 minute to remove any 
remaining cells and fat. Micro-RNA (miRNA) was isolated from skim milk using a 
commercially available miRNA isolation Kit (mirVana™ miRNA Isolation Kit, Ambion) and 
the isolation was performed as instructed in the manufacturer’s manual. The miRNA was eluted 
with 100 μl of elution solution provided in the kit. The samples were stored at -80 °C until 
further analysis. The total RNA concentration in eluted samples was measured using 
NanoDrop1000 spectrophotometer (Thermo Scientific). The total small RNA and miRNA 
quantity and integrity in milk was estimated using an Agilent 2100 Bioanalyzer (Agilent 
Technologies). 
4.2.9 Cell lines and cell culture 
The colon adenocarcinoma cells (Caco-2) and the normal intestinal cells (FHs-74-Int) were 
obtained from American type culture collection (ATCC, USA). The culture media Dulbecco’s 
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modified eagles medium (DMEM) was obtained from Sigma-Aldrich; (cat.no. D5671), 
supplemented with 10% heat-inactivated newborn calf serum (ThermoFischer Scientific; 
cat.no. A15-043), 2% L-glutamine (ThermoFischer Scientific), penicillin (100 IU/mL) and 
streptomycin (100 μL/mL) (ThermoFischer Scientific). The cells were cultured in incubators 
with 5% CO₂ at 37°C and trypsinized using 0.25% Trypsin/EDTA (Invitrogen) once they 
attained 75% confluence. All the experiments were conducted with cells between passages 13-
22.  
4.2.10 Cell viability using trypan blue assay 
The cell viability was calculated by trypan blue exclusion assay. 1 x 106 colon adenocarcinoma 
cell line (Caco-2) was grown in 6 well plates in DMEM until they reached 80% confluence. 
They were then treated with 3.2 mg/mL protein of filtered whole milk samples for 24 hours, 
an untreated well was maintained as a control. The study was also performed in 1 x 106 normal 
intestinal cells (FHs 74 Int). Following treatment the cells were washed with phosphate buffer 
solution (PBS) twice and trypsinized using trypsin/EDTA (Life Technologies). The cells were 
then pelleted by centrifugation at 1500 rpm and resuspended in sterile 1xPBS. 10 μL of cell 
suspension from each sample was mixed with same quantity of trypan blue stain (Sigma 
Aldrich, Australia) and the live cells were counted under the microscope using a 
haemocytometer. The imaging was performed using invested microscope (Prism optical).  
4.2.11 Annexin V assay 
The annexin-V assay was performed in order to confirm the apoptosis induced by milk samples 
in Caco-2 cells and in order to compare the apoptotic effects in non-cancerous (FHs 74 Int) 
cells. 1 x 106 cells were seeded in 6 well plates and once confluent were treated with milk 
samples for 24 hours. The cells were then washed and stained with annexin-V staining solution 
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provided in the annexin-V staining kit (Invitrogen, Australia). The cells were further analysed 
using BD FACS canto II (BD Biosciences). 
4.2.12 Statistical analysis 
The plasma experiments in milk were repeated at least three times and each sample was 
analyzed in triplicate. The data were analyzed using GraphPad Prism software (version 7.03). 
The statistical significance (P < 0.05) between the samples were calculated using the Holm-
Sidak method in GraphPad Prism software. 
4.3 Results and Discussion  
4.3.1 Analysis of total protein, lipid and carbohydrate in milk 
The chemical composition of milk (protein, lipids and carbohydrates) undergoes changes 
during processing by different methods and under different storage conditions.430, 431 The extent 
of changes in chemical composition of milk mainly depends upon the intensity of the treatment 
technique and the time. In this work, the changes in protein, lipids, carbohydrates and miRNA 
content of milk after plasma treatment and pasteurization have been studied. The total protein, 
lipid and carbohydrate content in raw milk samples were 3.69, 4.02 and 4.81 g/100 mL, 
respectively (Figure 4.1). The total protein content was significantly reduced to 3.54 and 3.57 
g/100 mL in 90 s plasma treated and pasteurized milk compared to control milk samples. In 
120 s plasma treated milk, the protein content remained as 3.65 g/100 mL. The total lipid 
content was significantly reduced in pasteurized milk (2.73 g/100 mL) compared to 90 and 120 
s (3.88 and 3.87 g/100 mL) plasma treated milk. The total carbohydrate content was 
significantly reduced in plasma treated and pasteurized milk compared to control samples. The 
carbohydrates were significantly reduced in pasteurized milk (3.86 g/100 mL) compared to 90 
and 120 s (4.15 and 4.12 g/100 mL) plasma treated milk. The lactose in milk reacts with 
proteins and salts through Maillard reactions due to heating.432 Suyama et al. demonstrated that 
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the concentration of lactose ureide (a by-product formed through Maillard reaction) increased 
with the increase in temperature and treatment time compared to raw milk. They found that, 
the lactose ureide concentration in raw milk was increased from 0.3 to 1.2 and 1.6 mg/L after 
pasteurization (65 °C for 30 min) and UHT.433 In our previous work, it was shown that the 
plasma set up used in this study mainly produced hydroxyl (OH) radicals and hydrogen 
peroxide (H2O2) in de-ionized water, while using argon gas.34 Luck et al. reported that H2O2 at 
high concentrations could reduce the lactose concentration in milk.391 The H2O2 and other 
plasma components (nanosecond pulsed electric field and UV radiation) might have 
contributed to the carbohydrate reduction in plasma treated milk samples. The measurements 
of any by-products formed from the interaction of plasma components with carbohydrates (also 
proteins and lipids) are important to understand the extent of damage and their effects in milk 
quality. The changes in individual protein and fatty acids of lipid in both plasma treated and 
pasteurized milk have been measured and discussed in the below section. 
Figure 4.1. The concentration of total protein, lipid and carbohydrate content in raw (control), 
pasteurized and plasma treated milk samples. The control (raw milk) samples were left in the 
treatment chamber for two minutes with bubbling argon gas. The error bars represent the 
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standard error of the mean (SEM) of samples. Statistical significance (a - P ≤ 0.01 and b - P ≤ 
0.0001) was shown between the raw (control), plasma treated (90 and 120 s) and pasteurized 
milk samples. 
4.3.2 Analysis of skim fraction by HPLC 
Skim milk was prepared according to the method in experimental section and subjected to high 
performance liquid chromatography (HPLC) analysis to study the changes induced by plasma 
treatment and pasteurization on individual proteins (Figure 4.2). In the chromatographic 
profiles of all milk samples, a stark difference in peak 5 (three forms a, b and c were identified 
as β-LG) was found after plasma treatment compared to other peaks. The β-LG (5a+5b+5c) 
whey protein was significantly reduced to 0.74 and 0.41 fold in 90 and 120 s plasma treated 
milk compared to control milk whereas the pasteurization reduced to 0.87 fold. β-LG is a major 
whey protein present in water phase of milk. The plasma reactive species (particularly OH 
radicals and H2O2) might have easily attacked the free sulfhydryl groups (SH) present in β-LG. 
It was also observed that addition of pure H2O2 in milk oxidized the SH groups of β-LG which 
in turn reduced the concentration of β-LG.391 Creamer et al. showed that at 65 °C, the tertiary 
structure of β-LG undergoes reversible changes to initiate a chain reactions involving SH or 
disulphide (S-S) exchange.434  
The casein peaks in Figure 4.2 were identified using the literature work.425 The kappa casein 
(κ-CN) and alpha casein (αs2-CN) are generally present in almost equal concentration, whereas 
alpha casein (αs1-CN) is the most abundant protein in bovine milk.179, 191 The peak 1, 2 and 3 
in Figure 4.2 at retention times 11.98, 13.39 and 14.02 min were likely to be identified as κ-
CN, αs2-CN and αs1-CN. Beta casein (β-CN) exists in one or more variants based on the genetic 
breed varieties and its largely available next to α-CN.435 The peak 4 (three forms a, b and c) 
was considered to be β-CN. The κ-CN, αs1-CN, β-CN (4a+4b+4c) proteins were significantly 
increased to 1.25, 1.09 and 1.18 fold after 90 s plasma whereas the 120 s plasma treatment 
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further increased them to 1.38, 1.13 and 1.21 fold compared to control. The decrease in β-LG 
with respect to increase in plasma treatment time might contribute to a higher increase in casein 
proteins compared to 90 s plasma treatment. In pasteurized milk, the κ-CN was non-
significantly increased to 1.39 fold and αs1-CN was significantly reduced to 0.92 fold and β-
CN was non-significantly reduced to 0.95. Anema et.al also found higher levels of κ-CN, lower 
levels of α-CN and nearly same level of β-CN when milk was heated up to 70 °C.436 The 
dissociated α-CN in pasteurized milk might have moved to serum phase while the denatured 
whey proteins could have associated with κ-CN to increase its concentration. 
The αs2-CN protein was significantly reduced to 0.76 fold in 120 s plasma while it remain 
unaltered in 90 s plasma treatment (0.98 fold) and non-significantly reduced to 0.85 fold in 
pasteurized milk compared to control. Patel et al. found that αs2-CN protein is unlikely to bind 
with whey proteins at temperatures <100 °C or at pressure treatment <150 MPa.294 The increase 
in plasma treatment time (120 s) might attack the disulphide bonds present in αs2-CN and thus 
leads to its reduction. The decrease in β-LG protein and increase in casein proteins in both 
plasma treated (90 and 120 s) and pasteurized milk suggests the possible interaction between 
casein and whey proteins. Considine et al. explained that non-covalent and/or disulphide bonds 
(via thiol-disulphide exchange) exchange are the common interaction pathways involved 
between casein and whey proteins.270 A possible interaction between casein and whey proteins 
in milk after 90 and 120 s plasma treatment is shown in Figure 4.6. However, further 
investigations are required to validate this proposed mechanism.  
The peaks at retention time 13.98 and 14.31 min were unidentified. The component at 13.98 
min was significantly increased to 1.11 and 1.08 fold in 90 and 120 s plasma treated milk while 
it was significantly reduced to 0.85 fold in pasteurized milk compared to control. The other 
component at 14.31 min remains unaltered after 90 s plasma whereas it was significantly 
decreased to 0.89 fold after 120 s plasma treatment. In pasteurized milk, the latter component 
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was significantly increased to 1.06 fold. From HPLC analysis, it was inferred that 120 s plasma 
treatment caused the most significant changes in milk proteins compared to 90 s plasma and 
pasteurized milk.  
 
Figure 4.2. HPLC analysis of individual proteins in raw (control), pasteurized and plasma 
treated milk samples. Protein peak areas 1, 2, 3 and 4 (a, b and c) are kappa, alpha-s1, alpha-
s2 and beta casein proteins, respectively while 5 (a, b and c) are β-LG whey proteins, 
respectively. The error bars represent the SEM of samples. Statistical significance (a - P ≤ 
0.05, b - P ≤ 0.01, c - P ≤ 0.001 and d - P ≤ 0.0001) was shown between the raw (control), 
plasma treated (90 and 120 s) and pasteurized milk samples. 
4.3.3 Analysis of whey proteins using Western blotting 
Western blot analysis followed by densitometry confirmed the reduction of Lf, β-LG proteins 
in both the plasma treated and pasteurized milk samples, while α-LA remained unchanged 
between treatments is shown in Figure 4.3. The Lf band density was significantly reduced to 
0.96, 0.93 and 0.90 fold in 90 and 120 s plasma treated and pasteurized milk compared to 
control. The Lf degradation in pasteurized milk is significant compared to 90 s plasma 
142 
 
treatment. Lf is a minor whey protein which can be easily degraded at 65 °C temperature or 
less.437 
Similar to HPLC, the β-LG was reduced with the increase in plasma treatment time. The band 
densities were significantly reduced to 0.93 and 0.88 fold in 90 and 120 s plasma treated milk 
compared to control. Pasteurization non-significantly reduced the β-LG to 0.94 fold compared 
to control. No substantial change in α-LA protein fold was observed in both plasma treated (90 
and 120 s - 1.01 and 0.99 fold), and pasteurized milk (0.99 fold) compared to control. α-LA is 
a relatively stable protein and it does not have any SH group like β-LG.438 In pasteurized milk, 
β-LG and α-LA, both undergoes smaller changes due to their better heat stability compared to 
Lf protein. Fox et al. showed that the significant changes in β-LG and α-LA occurs only at high 
temperatures (70–75 °C).437 
Figure 4.3. Western blotting of whey proteins following treatments with raw (control), 
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pasteurized and plasma treated milk samples. Western blotting of Lf, β-LG and α-LA (top) and 
the corresponding band density fold changes (bottom) in control (A), pasteurized (B) and 
plasma treated (C-30 s, D-60 s, E-90 s and F-120 s) whey fractions in milk samples were 
shown. Statistical significance (a - P ≤ 0.05 and b - P ≤ 0.01) was shown between the raw 
(control), plasma treated (90 and 120 s) and pasteurized milk samples. 
4.3.4 Analysis of whey proteins using SDS-PAGE 
Whey portions of all milk types were ran in gels to study the changes in electrophoretic mobility 
of proteins using SDS-PAGE. The whey fraction SDS-PAGE and corresponding band 
densitometry analysis of treated milks are shown in Figure 4.4. The Lf protein was significantly 
reduced to 0.97 fold in pasteurized milk compared to control. The Lf degradation is 
significantly different compared to 90 s plasma treatment. No significant differences in Lf were 
found in plasma treated (90 and 120 s) milks compared to control. It appears that the BSA fold 
densities remained largely unaltered in both plasma treated (90 and 120 s) and pasteurized milk 
compared to control samples. The immunoglobulins (Ig) were not significantly reduced in 90 
s plasma treated (0.97 fold) and pasteurized milk (0.98 fold) whereas the 120 s plasma 
treatment (0.93 fold) significantly reduced it compared to control. This showed that Ig was 
sensitive to plasma treatment next to β-LG protein in milk. The β-LG was non-significantly 
reduced to 0.89 and 0.95 fold in 90 s plasma treated and pasteurized milk compared to control. 
The 120 s plasma treatment (0.79 fold) significantly reduced β-LG compared to control. No 
significant change in α-LA protein fold was observed in 90 s plasma treated (0.99) and 
pasteurized milk (1.00) compared to control samples. The 120 s plasma treatment (0.96 fold) 
significantly reduced α-LA compared to control. The significant changes in Ig, β-LG and α-
LA proteins were observed only in 120 s plasma treated milk compared to pasteurized milk 
(Figure 4.4). 
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Figure 4.4. SDS-PAGE of whey proteins following treatments with raw (control), pasteurized 
and plasma treated milk samples. SDS-PAGE of whey proteins (top) and the corresponding 
band density fold changes (bottom) in control (A), pasteurized (B) and plasma treated (C-30 s, 
D-60 s, E-90 s and F-120 s) skim milk samples were shown. The error bars represent the SEM 
of samples. Statistical significance (a - P ≤ 0.05 and b - P ≤ 0.01) was shown between the raw 
(control), plasma treated (90 and 120 s) and pasteurized milk samples. 
4.3.5 Analysis of skim proteins using SDS-PAGE 
SDS-PAGE was performed for skim milk proteins and the corresponding band densitometry 
analysis is shown in Figure 4.5. The Lf protein was significantly reduced in both plasma treated 
(90 and 120 s - 0.90 and 0.91 fold) and pasteurized skim milk (0.87 fold) compared to control. 
BSA was found significantly reduced to 0.88 and 0.85 fold in both 90 and 120 s plasma treated 
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skim milk compared to control. Similarly, pasteurization also significantly reduced the BSA to 
0.85 fold compared to control samples. No significant differences in BSA were found between 
plasma treated (90 and 120 s) and pasteurized skim milk. The 120 s plasma significantly 
reduced the Ig to 0.84 fold while the 90 s plasma treated and pasteurized skim milk were non-
significantly reduced to 0.85, and 0.87 fold compared to control. The 90 and 120 s plasma 
treatment significantly reduced the β-LG band density to 0.85 and 0.81 fold whereas the 
pasteurization reduced it to 0.88 fold compared to control. No significant change in α-LA 
protein was observed between plasma treated (90 and 120 s - 0.86 and 0.84 fold) and 
pasteurized (0.85 fold) skim milk. The casein proteins in skim milk were non-significantly 
reduced to 0.98, 0.88 and 0.91 fold after 90 s, 120 s plasma treatment and pasteurization 
compared to control samples. In HPLC, the κ-CN, αs1-CN, β-CN were significantly increased 
in 120 s plasma compared to 90 s plasma treatment and pasteurization (Figure 4.2). However, 
the 120 s plasma treatment (significantly) and pasteurization (non-significantly) reduced αs2-
CN compared to control which did not occur in 90 s plasma treatment. As mentioned earlier 
that the αs2-CN protein might be dissociated from casein micelles and moved to serum phase 
of milk (Figure 4.6), which could be the reason the casein fold were non-significantly reduced 
in skim milk SDS-PAGE. 
Overall, the 90 s plasma treatment caused the least changes in milk proteins compared to 
pasteurization and 120 s plasma treatment. The 90 s plasma mainly reduced β-LG (more than 
pasteurization) and Lf (lesser than pasteurization) proteins. Pasteurization significantly reduced 
casein, Lf and β-LG proteins. The 120 s plasma treatment was the most effective to reduce 
whey and αs2-CN proteins. Based on the results obtained, we propose that the sensitivity of 
proteins to plasma treatment were in the order β-LG > Ig > Lf > BSA or α-LA. The sensitivity 
of proteins to heat were in the order Lf > Ig > BSA > β-LG > α-LA. Patel et al. found a similar 
trend in sensitivity of proteins to heat treatment.294 
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Figure 4.5. SDS-PAGE of skim milk proteins following treatments with raw (control), 
pasteurized and plasma treated milk samples. SDS-PAGE of proteins (top) and the 
corresponding band density fold changes (bottom) in control (A), pasteurized (B) and plasma 
treated (C-30 s, D-60 s, E-90 s and F-120 s) skim milk samples were shown.  Statistical 
significance (a - P ≤ 0.05) was shown between the raw (control), plasma treated (90 and 120 
s) and pasteurized milk samples. 
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Figure 4.6. Schematic representation of proposed changes of whey and casein proteins in milk 
after 90 and 120 s plasma treatment. The 90 s plasma treatment (left) in milk keep both whey 
(except β-LG association with κ-CN) and casein proteins intact compared to control (top) while 
the 120 s plasma treatment (right) in milk effectively altered the whey (β-LG and α-LA) which 
then associated with disordered α, β and κ-CN proteins through SH or disulphide (S-S) 
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exchange. This figure was inspired from Patel et al.294 and re-drawn according to the results 
obtained. 
4.3.6 Fatty acid analysis by GC  
Milk fat predominantly contains 98% triacylglycerols and 2% other type of lipids (mono and 
diacylglycerols, phospholipids, cholesterol, glycolipids and free fatty acids).439 GC results 
showed the changes in fatty acid content of all milk samples (Table 4.1). The 90 and 120 s 
plasma treatment did not induce any major changes in the fatty acid content of milk samples 
compared to control. This showed that plasma treatment in this study had no negative effects 
on milk fatty acids. The raw milk (control) samples used for plasma treatment in this study 
were not homogenized, which leaves the milk fat globule membrane (MFGM) intact, and could 
be the possible reason for no negative effects on milk fatty acids. It would be interesting to see 
the effects of plasma treatment in milk before and after homogenization. Kim and Korachi et 
al. observed non-significant changes on fatty acids in milk after plasma treatment using DBD 
and CD, respectively.361, 423  
It was reported that the plasma reactive species were effective in oxidizing the polar 
phospholipids present in the bacterial cell wall to cause cell injury.440 The phospholipids are 
present in the MFGM and account for less than 1% by weight of total milk fat.439 The separation 
of phospholipids from other lipid components (tri, di, and monoacylglycerols and others) in 
plasma treated milk and subjecting to analysis will help to understand any plasma mediated 
effects in each lipid components. However, the GC results showed that no major change in 
fatty acid content of plasma treated milk samples compared to control. It is also important to 
mention that the degraded whey proteins might associate with either casein proteins and/or 
MFGM which was observed in heated milks.441 The consequences of this kind of association 
and any by-products such as aldehydes, ketones and acids formed as a result of plasma species 
interaction with fatty acids need to be evaluated. 
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In pasteurized milk, the saturated fatty acids (SFAs) such as caproic acid (0.94 fold), capric 
acid (0.97 fold), lauric acid (0.98 fold), myristic acid (0.99 fold) and palmitic acid (0.94 fold) 
were significantly reduced (Table 4.1). This observed decrease also matches with the decrease 
in the total lipids in pasteurized milk (Figure 4.1). The significant decrease in the percentage 
composition of SFAs in pasteurized milk leads to a significant increase in other fatty acids like 
pentadecanoic acid (1.04 fold), heptadecanoic acid (1.06 fold), stearic acid (1.04 fold), elaidic 
acid (1.22 fold), oleic acid (1.07 fold), linoelaidic acid (1.23 fold), linoleic acid (1.23 fold), α-
linolenic acid (1.05 fold) and arachidic acid (1.06 fold). The measurement of fatty acids 
concentration in milk after pasteurization will show the heat induced changes in unsaturated 
fatty acids. Greenbank and Pallansch found that phospholipid content in milk were reduced 
after heat treatment.442 In contrary, Houlihan et al. reported that the heat treatment reduced the 
triacylglycerols and not phospholipids in milk.443 This showed that heat treatment alters the 
lipid content in milk based on the different treatment conditions. Moreover, it is known that 
homogenization reduces the MFGM size in milk and helps to expose all lipid components to 
heat. Heat treatment in milk before homogenization caused the association of whey proteins 
(particularly β-LG) with MFGM in smaller proportion compared to heat treatment in milk after 
homogenization.444 Notably, the trans fatty acids like elaidic acid (1.22 fold) and linoelaidic 
acid (1.23 fold) and a cis fatty acid, linoleic acid (1.23 fold) were significantly increased 
compared to any other fatty acids in pasteurized milk and also compared to plasma treated and 
raw milk samples. This larger increase in the trans and cis fatty acids might be a direct result 
of the pasteurization in milk. Herzallah et al. observed a significant 1.20 fold increase in trans 
isomer content (elaidic acid) in the milk heated at 63 ± 1.0 °C for 30 min.445 The increase in 
the in-take of trans fatty acids can cause adverse effects on human health.446 Jing et al. reported 
that linoelaidic induced a stronger lesion effect in human umbilical vein endothelial cells 
through lipid rafts (a region rich in cholesterols and sphingolipids as functional microdomain 
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in membrane) compared to elaidic acid.447 It was observed that, linoleic acid also plays a key 
role in clustering of proteins in cholesterol-dependent microdomains.448 
Table 4.1. The percentage fatty acid composition in raw (control), pasteurized and plasma 
treated milk samples.  
Fatty acids Control Pasteurized 30 s plasma 60 s plasma 90 s plasma 120 s plasma 
Caproic 2.76 ± 0.05 2.59 ± 0.02b 2.75 ± 0.02 2.71 ± 0.01 2.74 ± 0.01 2.75 ± 0.01 
Caprylic 1.64 ± 0.01 1.60 ± 0.04 1.66 ± 0.01 1.64 ± 0.01 1.64 ± 0.01 1.65 ± 0.01 
Capric 3.65 ± 0.01 3.55 ± 0.01d 3.62 ± 0.01 3.63 ± 0.01 3.63 ± 0.01 3.63 ± 0.01 
Lauric 4.21 ± 0.01 4.14 ± 0.01d 4.19 ± 0.01 4.20 ± 0.01 4.19 ± 0.01a 4.19 ± 0.01a 
Myristic 13.18 ± 0.03 13.08 ± 0.01b 13.11 ± 0.01 13.13 ± 0.01 13.11 ± 0.01a 13.15 ± 0.01 
Myristoleic 1.29 ± 0.01 1.29 ± 0.01 1.28 ± 0.01 1.28 ± 0.01 1.27 ± 0.01a 1.28 ± 0.01 
Pentadecanoic 1.34 ± 0.02 1.40 ± 0.01c 1.32 ± 0.01 1.33 ± 0.01 1.33 ± 0.01 1.33 ± 0.01 
Palmitic 36.55 ± 0.04 34.40 ± 0.05e 36.66 ± 0.05 36.59 ± 0.03 36.55 ± 0.04 36.65 ± 0.06 
Palmitoleic 1.93 ± 0.01 1.91 ± 0.01 1.99 ± 0.03 1.92 ± 0.01 1.95 ± 0.02 1.93 ± 0.01 
Heptadecanoic 0.70 ± 0.01 0.74 ± 0.01d 0.70 ± 0.01 0.70 ± 0.01 0.69 ± 0.01 0.69 ± 0.01 
Stearic 9.95 ± 0.03 10.45 ± 0.01d 10.01 ± 0.01 10.01 ± 0.01 10.03 ± 0.02a 9.99 ± 0.01 
Elaidic 0.35 ± 0.01 0.43 ± 0.01d 0.36 ± 0.01 0.36 ± 0.01 0.37 ± 0.01 0.36 ± 0.01 
Oleic 19.13 ± 0.06 20.53 ± 0.03d 19.06 ± 0.06 19.20 ± 0.02 19.19 ± 0.02 19.15 ± 0.03 
Linolelaidic 0.38 ± 0.01 0.47 ± 0.01d 0.37 ± 0.01 0.38 ± 0.01 0.38 ± 0.01 0.37 ± 0.01 
Linoleic 1.65 ± 0.01 2.04 ± 0.01d 1.63 ± 0.01 1.65 ± 0.01 1.65 ± 0.01 1.64 ± 0.01 
α-Linolenic 0.61 ± 0.01 0.65 ± 0.01d 0.60 ± 0.01 0.60 ± 0.01 0.60 ± 0.01 0.60 ± 0.01 
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Arachidic 0.61 ± 0.01 0.65 ± 0.01b 0.62 ± 0.02 0.58 ± 0.01 0.62 ± 0.01 0.62 ± 0.02 
Note: Mean ± SEM were calculated and the statistical significance (letters in superscript 
indicate a - P ≤ 0.05, b - P ≤ 0.01, c - P ≤ 0.001 and d - P ≤ 0.0001) was shown between the 
raw (control), plasma treated (90 and 120 s) and pasteurized milk samples. 
4.3.7 RNA and miRNA analysis 
In our study, the total RNA content in raw milk was measured as 5.4 ng/μL (Figure 4.7). The 
90 s plasma treatment non-significantly reduced the RNA content to 4.87 ng/μL compared to 
raw milk. The 120 s plasma treatment and pasteurization significantly reduced the RNA content 
to 4.05 and 4.22 ng/μL compared to control respectively. The RNA content in 120 s plasma 
treated milk was significantly reduced compared to 90 s plasma treatment whereas it was non-
significant compared to pasteurized milk.  
Figure 4.7. Total RNA concentration measurement in raw (control), pasteurized and plasma 
treated milk samples. The error bars represent the SEM of samples. Statistical significance (a 
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- P ≤ 0.001 and b - P ≤ 0.0001) was shown between the raw (control), plasma treated (90 and 
120 s) and pasteurized milk samples. 
miRNAs are a novel class of bioactive compounds which play numerous beneficial roles in 
human health.449 The concentration of small RNA, miRNA and their ratio (miRNA/small 
RNA) was measured in control, 90 s plasma treated and pasteurized milk samples (Figure 4.8). 
The 120 s plasma treated milk sample was not used for this small and miRNA measurement, 
as it had significantly reduced the total RNA content. The small RNA and miRNA content in 
raw milk was measured as 125.36 and 82.46 pg/μL, respectively. Both the small RNA and 
miRNA was non-significantly reduced to 81.9 and 51.03 pg/μL in pasteurized milk. Katherine 
et al. reported that pasteurization and homogenization leads to a significant loss of miRNAs in 
bovine milk.450 Interestingly, the small RNA and miRNA concentration was non-significantly 
increased to 241.93 and 138.56 pg/μL in 90 s plasma treated milk compared to raw milk. This 
increased concentration of small RNA and miRNA might be due to the release of miRNA from 
milk exosomes and RNA from MFG after plasma treatment. Maningat et al. shown that RNA 
is also available in MFG.451 The miRNA/small RNA ratio was not significantly different 
between raw, pasteurized and 90 s plasma treated milk, respectively. The ratio of miRNA to 
small RNA remained the same suggesting that the mechanism or source of miRNA and small 
RNA release may be the same. The conservation of miRNA and RNA integrity suggests that 
90 s plasma treated milk represents good milk quality. 
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Figure 4.8. Small RNA and miRNA concentration measurement in raw (control), pasteurized 
and plasma treated milk samples. The error bars represent the SEM of samples. Statistical 
significance (a - P ≤ 0.05) was shown between the raw (control), plasma treated (90 and 120 
s) and pasteurized milk samples. 
4.3.8 Response of intestinal cells upon exposure to milk samples 
Raw, plasma treated (90 and 120 s) and pasteurized milk were tested in the presence of human 
fetal small intestinal (FHs 74 Int) cells and human colon adenocarcinoma (Caco-2) cell line to 
determine effects of milk treatments on cell viability (Figure 4.9). Cells were incubated for 24 
hours with milk samples prior to determination of cell number. The changes in composition of 
milk samples reflected in the cell number of FHs 74 Int and Caco-2 cells (Figure 4.9). The 
unaltered composition in raw milk samples caused minimal changes in cell number of both 
FHs 74 Int (90.80%) and Caco-2 cells (83.92%, significant) compared to untreated cells. The 
presence of 90 s plasma treated milk non-significantly reduced the cell number to 88.51% in 
FHs 74 Int cells while it significantly reduced the cell viability to 65.80% in Caco-2 cells 
compared to untreated cells. No significant differences were found between raw (control) and 
90 s plasma treated milk in altering FHs 74 Int cell viability whereas the 90 s plasma treated 
154 
 
milk significantly reduced the Caco-2 cells compared to raw (control) milk. With the increase 
in plasma treatment time (120 s) in milk, the cell viability was significantly further reduced to 
62.27 and 64.64% in FHs Int and Caco-2 cells compared to untreated cells. The FHs 74 Int and 
Caco-2 cell viability was significantly reduced to 60.74 and 64.82% in pasteurized milk 
respectively. The 120 s plasma treated and pasteurized milk significantly reduced the FHs 74 
Int cell viability compared to 90 s plasma treated milk. Hongsprabhas et al. demonstrated that 
heat treatment in lactose containing whey protein hydrolysate, increased the Maillard reaction 
products which caused cytotoxicity in FHs 74 Int and Caco-2 cells.452 In this work, the 120 s 
plasma treatment and pasteurization reduced a higher concentration of lactose and proteins 
compared to 90 s plasma treatment (Figure 4.1-4.6). This might be the reason that the cell 
viability of FHs 74 Int were not effectively reduced in 90 s plasma compared to 120 s plasma 
treatment and pasteurization. Interestingly, the 90 s plasma treatment reduced the cell viability 
of Caco-2 cells equivalent to 120 s plasma and pasteurization suggesting that these two cell 
lines display different degrees of sensitivity to cytotoxic reagents. The comparative analysis of 
milk from various sources and their properties has also shown that milk components have the 
capability to specifically induce cell death in cancer cells.453, 454 Unlike plasma treated milk, a 
reverse effect was observed in pasteurized milk, in which the FHs 74 Int cells were slightly 
reduced compared to Caco-2 cells. It is also important to consider the role of lipids and miRNA 
in influencing the cell viability of both FHs 74 Int and Caco-2 cells. 
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Figure 4.9. The relative percentage viability of FHs 74 Int cells and caco-2 after culturing with 
raw (control), pasteurized and plasma treated (90 and 120 s) milk samples for 24 hours as 
determined trypan blue assay. The error bars represent the SEM of samples. Statistical 
significance (a - P ≤ 0.05, b - P ≤ 0.01 and c - P ≤ 0.0001) was shown between the untreated 
cells, raw (control), plasma treated (90 and 120 s) and pasteurized milk samples. 
The cell morphology of FHs 74 Int and Caco-2 cells upon exposure to raw and plasma (90 and 
120 s) treated milk samples are shown in Figure 4.10. The changes in the cell number of FHs 
74 Int and Caco-2 cells after treating with milk samples do not effect overall morphology of 
both cells after 24 hours. 
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Figure 4.10. The response of FHS 74 Int cells (upper panel) and caco-2 cells (lower panel) 
cultured with raw (control), pasteurized and plasma treated (90 and 120 s) milk samples for 
24 hours. The cell images were captured at 20x magnification. 
Annexin-V assay is a standard approach in order to detect the vent of apoptosis in cell culture. 
Annexin V staining was performed to determine the percentage of apoptotic cells following 
exposure to treated milk (Figure 4.11). Cells were exposed to milk samples for 24 hours, 
stained with annexin V and analyzed by flow cytometry. The percentage of apoptosis in all 
quadrants (Q1+Q2+Q4) except Q3 (healthy cells) were added and have been used to discuss 
here. The raw, 90 and 120 s plasma treated milk samples led to 2.13, 1.13 and 1.56% apoptosis 
in FHs 74 Int cells, respectively. Pasteurized milk was the most effective to cause higher 
apoptosis (3.53%) in FHs 74 Int cells compared to other samples. The same analysis was 
performed with Caco-2 cells to measure apoptosis after treating with all milk samples. 
Interestingly, pasteurized milk caused the least apoptosis (6.70%) in Caco-2 cells compared to 
other milk samples. On the other hand, the raw, 90 and 120 s plasma treated milk samples 
caused higher apoptosis 7.90, 11.76 and 10.56% in Caco-2 cells compared to pasteurized milk. 
The apoptosis caused by raw, 90 and 120 s plasma treated milk in Caco-2 cells were higher 
compared to FHs 74 Int cells. The results showed that the FHs 74 Int cells and Caco-2 cells 
exhibited different behaviour upon exposure to all milk samples. The apoptotic and cytotoxic 
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functions of the milk samples was studied in order to determine the functional efficacy of the 
milk proteins after plasma treatment and pasteurization. Milk contains various anticancer 
peptides that are considered as potential candidates for the development of anticancer agents. 
The casein and whey proteins in milk have been evaluated for their anticancer and apoptotic 
potential especially in case of colon tumours suggesting the presence of apoptotic factors in 
milk.453-455  
Dimeric α-LA is a potent Ca2+-elevating and apoptosis-inducing agent with broad activity.456 
It was reported that α-LA dimerizes and induces apoptosis in a variety of tumor cell lines and 
primary cells.456 This dimerization of α-LA in our case needs to be studied and may be 
stimulated by the plasma treatment. Lf is another well-known anti-cancer protein that induces 
apoptosis in cancer cells.453 Lf significantly modulates the molecules involved in apoptosis 
including p53, Bcl-2 family proteins, IAP members and their inhibitors. bLf could also directly 
inhibit the expression of survivin protein (key IAP) and lead to induction of apoptosis.457 In 
this study, Lf protein was effectively reduced in pasteurized milk compared to 90 and 120 s 
plasma treated milk (Figure 4.3 and 4.4). This could be one possible reason that the plasma 
treated milk caused more apoptosis in Caco-2 cells compared to pasteurized milk. Although 
the presence of above mentioned proteins in plasma treated milk likely to be the reason for 
causing apoptosis in cancer cells, further investigation is required to understand the apoptosis 
mechanism.  
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Figure 4.11. Annexin V assay in FHS 74 Int cells (upper panel) and caco-2 cells (lower panel) 
after culturing with raw (control), pasteurized and plasma treated (90 and 120 s) milk samples 
for 24 hours. Inset values represents the percentage of necrotic cells. The quadrant Q1 contains 
the early apoptotic cells, Q2 contains both early and late apoptotic cells, Q3 contains the viable 
cells and Q4 contains the late apoptotic cells. 
4.4 Conclusion 
We have demonstrated that the plasma treatment in this study has the potential to preserve 
nutritional components in milk compared to pasteurization. The increase in plasma treatment 
time (120 s) clearly altered the milk components compared to 90 s plasma treatment and 
pasteurization. However, the results showed that 90s plasma treatment caused the least changes 
and possess the advantages to retain the nutritional benefits in milk compared to pasteurization. 
This suggested that tuning the plasma parameters (input power, gas flow rate and mode of 
operation) will help to gain control in influencing the changes in milk components. The direct 
comparison between plasma treatment and pasteurization in milk with defined quality indices 
will be key before considering this technology for scale up and commercialization. 
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Chapter 5 General discussions and future work 
Several researchers have developed the method of generating plasma in bubbles that are 
externally injected into liquids to reduce the energy consumption, electrode erosion, control 
and increase the gas-liquid interface reactions, thereby improving the productivity of physical 
and chemical processes in liquid.19, 20, 34-38 These advantages have helped to extend the 
application of plasma technology in treating sensitive materials, especially liquid foods. 
In this study, plasma was generated in two ways 
1) In gas phase above the liquid surface to fabricate hybrid nanostructure and  
2) In bubbles that are externally injected in milk to decontaminate, extend shelf life 
whilst maintaining nutrition.  
The general discussions of this study and potential future works have been discussed here. 
5.1 Fabrication of boron nitride nanotube-gold nanoparticle hybrids 
5.1.1 General discussions 
The fabrication of hybrid nanostructures has faced issues such as use of toxic chemicals, longer 
treatment times and damaging the structure of nanomaterials.118-128, 136, 138, 139, 143 To address 
this, in our approach, a simple two-step plasma method was developed to fabricate BNNTs-
GNPs hybrid nanostructure. In the first step, plasma treatment reduced the length and 
functionalized the BNNTs in deionized water. In the second step, GNPs were assembled onto 
the functionalized short BNNTs to fabricate a hybrid nanomaterial. The total fabrication 
process was completed in 30 minutes compared to the other chemical methods which requires 
several hours.  
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Various reports have shown that use of high temperature and pressure, hydrogen peroxide and 
nitric acid can oxidize the BNNTs which help in shortening and then functionalizing the 
nanotubes.118, 132, 140, 148  
In our case, this was achieved without the use of toxic chemicals or longer treatment times and 
altering the nanotube structure. It was proposed that the reactive oxygen and nitrogen species 
from plasma and the presence of physical effects such as UV radiation and nanosecond pulsed 
electric field might have facilitated the oxidation of long BNNTs leads to shortening and 
subsequently introduced the functional groups onto the surface of short BNNTs at the same 
time. 
The assembly of GNPs onto the functionalized short BNNTs was achieved by adding GNPs to 
the functionalized short nanotubes suspension. The addition of GNPs could change the 
conductivity of the liquid, which results in the re-distribution of electrical field during plasma 
treatment. This re-distributed electrical field along with the reactive species and UV radiation 
might have facilitated the attachment of GNPs onto the functionalized short nanotubes. 
Due to shortening, the treated nanotubes carried a higher percentage of drug molecules 
compare to the untreated nanotubes. Similarly, Zhi et al. showed that shortening of BNNTs 
could create hole-rich structure and more ends, which helps in encapsulating more cargoes and 
displaying improved dispersibility.118 These advantages suggest that shortened BNNTs might 
be useful for efficient drug delivery systems. The shortened nanotubes carried more drug 
molecules and effectively killed the human prostate cancer cells.  
5.1.2 Future work 
This new approach, successfully reduced the length and introduced functional groups onto 
BNNTs and assembled GNPs onto them. However, the yield of functionalized short BNNTs 
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and the covering of GNPs onto them need to be increased for applying this hybrid nanomaterial 
for biological applications.  
To address the above challenges, the plasma set up II can be used as one approach, to produce 
a high concentration of selective reactive species with the chosen gas. The use of this method 
on BNNTs suspension could give the option not only to increase the yield of functionalized 
short BNNTs but also has the potential to introduce selective functional groups with the chosen 
gas (for example argon and air to form oxygen (OH) and amine (NH2) functional groups). The 
increased selective functional groups will also help to assemble more GNPs onto them.   
The use of ionic liquids could be another approach, to increase the yield of selective 
functionalized short BNNTs and BNNCs compared to DI water. Ionic liquids have very good 
physical and chemical properties which can be exploited for the preparation and stabilization 
of nanomaterials. The increase in the yield of functionalized short BNNTs and BNNCs possibly 
increase the dispersibility and drug encapsulation which all could make functionalized short 
BNNTs as a potential candidate for effective drug delivery.  
This method will form the basis to produce varieties of hybrid nanostructures with other 
nanoparticles such as Fe, SnO2, Pd, ZnO and CdSe while keeping the functionalized short 
BNNTs as a support to breed properties and utilize them for potential applications such as 
energy conversion and storage, catalysis and optoelectronics. 
5.2 Decontamination of milk to extend shelf life while maintaining nutrition 
5.2.1 General discussions 
Bovine milk is a liquid food that is enriched with nutrients and growth factors but also contains 
micro-organisms.165, 166 The consumption of raw or ineffectively processed milk causes milk-
borne diseases in humans.167-170 Pasteurization is the current technique to kill bacteria in milk 
but heat treatment damages the nutrients in milk.171, 172 The other non-thermal methods such as 
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hydrostatic pressure, pulsed electric field, UV radiation in milk have their own advantages and 
disadvantages. To address these challenges, in our approach plasma was generated in bubbles 
which are externally introduced in milk to decontaminate and extend the shelf life while 
maintaining nutrition and compared with commercially pasteurized milk.  
The 90 and 120 seconds plasma treatment caused a minimal change in milk pH change 
suggesting that the milk quality was not significantly altered. The increase in temperature of 
milk was still within the ambience and hence the heat effects were limited. The 90 and 120 
second plasma treatment has achieved an industrial standard bacterial reduction (4.3 log 
bacterial reduction) in milk according to the USFDA pasteurized milk ordinance 2011.405, 406 
Excitingly, the 90 and 120 s plasma treatment did not allow the bacteria to multiply for at least 
six weeks while the pasteurized milk showed that the bacterial counts were significantly 
increased after 2 weeks suggesting that deterioration of milk quality. The results confirmed that 
the plasma treatment not only immediately reduced the viable bacteria but also inhibited its 
proliferating potential and/or killed spores present in milk.  
It has been reported that the discharge in bubbles that are externally injected into liquids (water) 
produce chemical and physical effects based on the composition of gas in the bubble (and its 
size), conductivity of the liquid and input power.11 In other work, we have shown that the 
discharge at higher frequency created more fragmentation in gas bubbles which decreased the 
size and increased the number of bubbles in DI water.34 This increased the interface reactions 
between the gas-plasma and liquid. The increase in the interface reactions, along with the 
movement of bubbles, enabled higher production of selective reactive species based on chosen 
gas.34 This process might have occurred according to the chemistry of milk. We propose that 
plasma reactive components such as OH radicals and H2O2, UV radiation, nanosecond pulsed 
electric field generated at the bubble and bubble-liquid interface along with the joule heating, 
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might have effectively interacted with the micro-organisms that are present in the water phase 
of milk resulting in reduced bacterial load and proliferative potential.  
Subsequent to the bacterial investigation, the effects of 90 and 120 s argon plasma treatment 
on proteins, lipids, carbohydrates and miRNA present in bovine milk was studied compared to 
commercially available pasteurized milk. The increase in plasma treatment time induced more 
changes in the nutritional profile of milk.  
β-LG was significantly reduced in 90 and 120 s plasma treated milk compared to raw and 
pasteurized milk. α-LA and Igs were significantly reduced in 120 s plasma treatment compared 
to raw milk. Lf was significantly reduced in pasteurized milk compared to 90 s plasma treated 
and raw milk. Casein proteins were significantly increased in 90 and 120 s plasma treated milk 
whereas they were significantly reduced in pasteurized milk compared to raw milk. The 
decrease in whey proteins might have associated with κ-CN and thus lead to the increase in 
casein proteins after plasma treatment. A similar association was also observed by others in 
heat and/or pressure treated milks. 270, 436 
The total lipids and the saturated fatty acids and carbohydrates were significantly reduced in 
pasteurized milk compared to raw and 90 and 120 s plasma treated milk. No major changes in 
fatty acids were observed in both 90 and 120 plasma treated milk compared to raw milk. The 
use of non-homogenized milk means the MFGM was intact and could be the possible reason 
for no negative effects on milk fatty acids. Kim and Korachi et al. observed non-significant 
changes on fatty acids in milk after dielectric barrier and corona discharge.361, 423 The RNA and 
miRNA concentration was effectively higher in 90 s plasma treated milk compared to 
pasteurized milk. 
Overall, the 90 s plasma treatment caused the most minimal changes in milk nutritional 
composition compared to pasteurization and 120 s plasma treatment. Overwhelmingly, the raw 
and 90 s plasma treated milk did not effect the viability of FHs 74 Int cells whereas the 
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pasteurized and 120 s plasma treated milk significantly reduced viability compared to untreated 
cells. This again verified that the milk quality was retained after 90 s plasma treatment 
compared to other milks. The viability of Caco-2 cells was significantly reduced by all milk 
samples compared to untreated cells. Annexin V staining showed increased apoptosis of cells 
exposed to plasma treated milk compared to untreated cells, but apoptosis was further increased 
in pasteurized milk.  
To the best of our knowledge, this is the first atmospheric pressure plasma study in milk that 
has largely addressed the bacterial reduction, shelf life and its effect on nutritional compounds. 
These results demonstrated plasma treatment as a promising alternative to pasteurization in 
processing milk. 
5.2.2 A potential future of “Plasmarized milk” 
Argon plasma (bubble discharge) treatment in milk successfully reduced the bacterial load, 
increased shelf life and maintained the nutrition compared to commercially pasteurized milk. 
A limitation of the current study was that the mechanism of action was not determined, 
however, the mechanism of interaction between plasma components (such as reactive species 
(OH radicals, H2O2 and others, nanosecond pulsed electric field and UV radiation) and milk 
components (protein, lipids, carbohydrates and other micro-molecular compounds) is very 
important in optimizing and developing the process to a pilot scale. To address this, the 
measurement of H2O2 concentration in milk after plasma treatment, and a separate application 
of nanosecond pulsed electric field and UV radiation in milk without plasma under the same 
conditions (power input) used in this study could help to understand the plasma mediated 
bacterial reduction in milk and decipher if H2O2 plays a role in this process.  
A comparison of the entire bacterial and nutritional profile in plasma treated and pasteurized 
milk with defined quality indices established by dairy industries and FDA could help to identify 
new potential markets to present plasma treated milk as fresh and nutritious milk. Plasma 
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treatment could also be used for modified whey production which could potentially reduce the 
allerginicity of β-LG protein and possibly help in improving the digest-ability or bioavailability 
of its peptides for body-builders and athletes during its consumption. The other whey proteins 
like α-LA, Lf, Ig and miRNAs in milk possess important bio-functionalities that are involved 
in the development of human health. Our study has shown that plasma treatment retained the 
major immune regulatory agents like Lf, Ig and miRNAs in milk compared to pasteurization, 
suggesting that milk quality is superior to pasteurized milk. However, the functionality of 
bovine milk proteins and miRNAs versus human milk proteins and miRNAs need to be taken 
into consideration when addressing bioactivity in milk products. Even if plasma treatment dose 
prove to conserve bioactivity of bovine proteins and miRNAs, their relevance to human 
physiology needs to be addressed. Perhaps, plasma treatment will be best suited to preservation 
of milk proteins and miRNAs in human milk, for example as a treatment in human milk banks 
for preterm babies. 
The current study showed that plasma treatment did not affect the viability of FHs 74 Int cells 
compared to pasteurization, but a detailed in vitro and in vivo study will be necessary to 
understand the immunological properties of plasma treated milk and its implications in human 
health. Studies may include the impact on development of the gastrointestinal tract (GI) using 
embryonic mouse models (explant GI cultures), or mouse models of gut disease in preterm 
babies such as necrotizing enterocolitis (NEC).  
The low birth weight and preterm infants have immature intestine and immune systems, due to 
this they are at increased risk of a number of complications, especially NEC, a disease with a 
mortality rate of 20-40%.458, 459 The other complications are growth retardation, feeding 
intolerance and infections. Preterm infants are fed with pasteurized human donor milk when 
mother’s own milk is insufficient.460 The use of pasteurization damages the immunological 
properties of human milk.461 The pasteurized donor milk is inferior to mother’s own milk in 
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resisting against late-onset sepsis and NEC.462 On the other hand, the formula feed to preterm 
babies have shown six times increased incidence of NEC than if only fed breast milk.463 The 
use of plasma treatment as an alternative to pasteurization, could preserve the immunological 
properties of human milk, thereby it would possibly improve the immunopotency of infants 
and reduce associated medical costs. 
The plasma treatment could be possibly applied for other dairy applications such as cheese 
making, butter and yoghurt production. For example, the plasma treatment in milk could 
possibly introduce new functionalities which might influence the firmness of curd and aging 
time or ripening of cheese. The fatty acids in milk were largely unaltered after plasma treatment 
which suggests that butter making from plasma treated milk would be of higher quality 
compared to butter making from pasteurized milk. This kind of technological innovation in 
milk processing could potentially address the increasing consumer demands of fresh-like, 
nutritious and shelf stable milk and milk products at lower capital and operating costs. 
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